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Abstract !
Regulation of gene expression in the human pathogen Neisseria meningitidis 
remains poorly understood. The meningococcus is a good model for a global 
analysis of transcriptional regulation as it has fewer transcriptional regulators 
and proteins able to modulate gene expression compared to other species with 
genomes of similar size. The genes encoding proteins predicted to modulate 
transcription in the meningococcus were identified using a dedicated database 
for systematical functional analysis (NeMeSys) in this species and mutated by 
utilising an improved in vitro transposon mutagenesis system. The resulting 
mutants were subjected to phenotypic analysis for growth and functions linked 
to one of the major virulence factors of the meningococcus, Type-four pili (Tfp). 
Tfp are essential for adhesion, aggregation, twitching motility and DNA 
competence in pathogenic Neisseria species. However, not much is known about 
the expression of the 16 proteins essential for Tfp biogenesis, and the seven 
proteins playing important roles in Tfp biology. The mutants were assessed for 
the Tfp-dependent phenotypes: aggregation, adhesion to human cells and 
twitching motility. No mutants were found to be dramatically impaired for these 
properties. However, two transcriptional regulators, HexR (NMV_1005) and 
FarR (NMV_2033), were found to influence the aggregative abilities of the 
meningococcus, with mutations in these genes resulting in a slow aggregating, 
and consequently, slow adhering phenotype.  
 
In parallel, two transcriptional regulators were chosen for further 
characterisation because they are encoded on genomic islands absent in the non-
pathogenic Neisseria strain, Neisseria lactamica and could thus contribute to 
virulence. One island encoded an AraC type regulator divergently transcribed 
from genes encoding a putative TonB-dependent iron uptake system, whilst the 
other island encoded a putative LysR type regulator divergently transcribed from 
a putative transporter. These regulators are likely to require specific inducer 
molecules that may be absent from experiments performed in vitro. 
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1 Introduction 
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1.1 Bacterial gene regulation !
Transcription is the first step in gene expression, enzymatically synthesizing 
single-stranded ribonucleic acid (RNA) molecules from double-stranded 
deoxyribonucleic acid (DNA) templates. RNA polymerase is the enzyme 
responsible for transcription. In prokaryotes, the RNA polymerase core enzyme 
consists of five subunits; two copies of the ! subunit, with the ", "’ and # 
subunits (Murakami and Darst, 2003). Although the core enzyme is capable of 
synthesizing RNA, the sigma subunit ($ factor) is required to enable the enzyme 
to initiate transcription at bacterial promoters (Figure 1.1). The core enzyme 
with the $ factor is known as RNA polymerase holoenzyme (RNAP) and is the 
basal transcription machinery in prokaryotes. This machinery initiates the 
synthesis of RNA molecules at specific nucleotides called transcription start sites 
(TSS). Upstream of TSS are conserved DNA sequences denoted as bacterial 
promoters, which include recognition sites for RNAP and other DNA-binding 
proteins capable of modulating transcription. The $ factor recognizes and binds 
to the core promoter, which comprises two six base pair (bp) sequences usually 
located at -10 and -35 bp upstream of the TSS. Once bound to the promoter, 
RNAP initiates transcription. Promoter sequences vary, and prokaryotes encode 
multiple $ factors which have different affinities for different core promoter 
consensus sequences. The $ factor $70, is most frequently incorporated into 
RNAP and recognises a specific consensus sequence at the core promoter (Paget 
and Helmann, 2003). Although not all $70 promoters are identical to the 
consensus sequence, they do share some homology, allowing binding by RNAP 
containing $70. Often the binding of RNAP to the core promoter is not a strong 
interaction due to low binding affinities caused by promoter regions with little 
identity to the consensus sequences. The involvement of other DNA-binding 
proteins and additional promoter regions enhances the interaction between 
RNAP and DNA (Browning and Busby, 2004). 
 
RNAP initially binds to a promoter in a ‘closed’ complex form, which does not 
initiate transcription. Transition of the ‘closed’ complex to an ‘open’ complex 
allows the two DNA strands to separate and a more intimate association with the 
! "#!
RNAP. The enzyme then progresses along the DNA helix, synthesizing the RNA 
in a 5' to 3' direction, separating the two strands of the DNA helix prior to 
polymerization. Next, the elongation phase of transcription is established, 
requiring another structural change in RNAP, allowing the gene to be 
transcribed. Once the whole length of the gene has been transcribed, 
transcription is terminated releasing the synthesized RNA molecule from the 
transcription machinery and template DNA. The resulting RNA molecules are 
then translated into proteins. 
 
Regulation of gene expression allows the necessary genes to be expressed at the 
appropriate time, as the requirement for each gene product varies. Gene 
expression is regulated by transducing extracellular signals, which change as 
bacteria encounter different environments. Rapid and appropriate responses to 
environmental alterations are important for bacterial survival, as genes expressed 
in one environment may be detrimental in another. Gene expression is frequently 
regulated during the initiation of transcription by transcriptional regulatory 
proteins (Browning and Busby, 2004).  
 
! "#!
 
 
 
Figure 1.1 RNAP 
A representation of RNAP bound to a promoter. DNA is represented by the 
black line, with the -10 and -35 promoter regions shown. RNAP is shown with 
the ! and !’ subunits  in blue, the " factor is shown in green and the # subunits 
are shown in yellow with the C-terminal domains binding the promoter. The 
arrow shows the direction of transcription from the TSS located at the +1 
nucleotide. The small $ subunit is not shown. (Adapted from Browning and 
Busby 2004.)  
 
 
1.2 Bacterial proteins that modulate transcription 
 
In general, the binding affinity of RNAP to promoters is low in the absence of 
regulatory proteins. Prokaryotes contain multiple factors that are capable of 
modulating transcription by altering the binding affinities of the basal 
transcription machinery. The most abundant and diverse factors are one-
component transcriptional regulators, which commonly bind to the promoter and 
interact with RNAP. They are responsive to a wide variety of inducers and co-
factors, which mediate extracellular signals and alter the action of the regulators. 
Two-component regulatory systems (TCS) receive extracellular signals through 
a membrane-bound sensor protein, which interacts with a cytoplasmically 
located response regulator, that binds DNA and influences transcription. The " 
factors of RNAP are also important for regulating gene expression, with each " 
factor having varying affinities for different promoters. Although one-
component transcriptional regulators, TCS and " factors are the main 
contributors to transcriptional regulation, other proteins can play a role and some 
of these will be discussed later. The majority of transcriptional regulatory 
-10 -35 
! 
" + "’ 
+1 
TSS 
# + # 
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proteins are able to bind DNA, and this is mediated through a specific and 
evolutionarily conserved motif. 
 
1.2.1 The HTH DNA binding motif 
 
The helix-turn-helix (HTH) motif is a secondary protein structure involved in 
sequence specific DNA binding. Proteins containing the HTH motif are found in 
prokaryotes, eukaryotes and Archaea, and have diverse functions including roles 
in DNA repair and RNA metabolism (Aravind et al., 2005). Their main role is in 
transcriptional regulation, and accordingly transcriptional regulators containing 
the HTH motif are likely to be an ancient conserved feature of the transcription 
apparatus (Aravind et al., 2005, Rosinski and Atchley, 1999, Sauer et al., 1982). 
The majority of prokaryotic transcriptional regulatory proteins contain a HTH 
motif, including regulators of the TCS and one-component systems (Ulrich et 
al., 2005).  
 
The HTH motif consists of two adjacent ! helices separated by a short turn. The 
turn is a chain of amino acids which do not exhibit a secondary structure. One of 
the ! helices is responsible for recognizing the specific DNA sequence to which 
the protein binds. The recognition helix binds at the promoter region and inserts 
in the major groove of double stranded DNA (Brennan and Matthews, 1989). 
The amino acid side chains protruding from the recognition helix are able to 
interact with the chemical groups from the nucleotides in the major groove of the 
DNA, by direct or indirect hydrogen bonds and Van der Waals forces. 
Specificity of the DNA-protein interactions arises from the distinct pattern of 
hydrogen bonding which occurs depending upon the DNA sequence of 
promoters and amino acids of the recognition helix. The second ! helix is 
orientated approximately perpendicular to the recognition helix making contact 
with the DNA backbone; this stabilizies the DNA-protein interaction (Brennan 
and Matthews, 1989). Polypeptides flanking HTH motifs are diverse and 
contribute to the different roles and DNA binding specificities of the HTH 
containing transcriptional regulators (Aravind et al., 2005). 
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1.2.2 One-component transcriptional regulators 
 
One-component HTH transcriptional regulators can either activate or repress 
transcription, or both. They can regulate single or multiple genes, and they can 
mediate responses to a wide variety of signals.  
 
Activating transcriptional regulators promote RNAP binding to the promoter. 
For Class I activation, regulators usually bind upstream of the -35 sequence in 
the promoter, and interact with the C-terminal domain of one of the ! subunits of 
the RNAP, enhancing the binding of RNAP to the promoter (Figure 1.2A). In 
instances where the regulator binds sequences away from the -35 region, the 
DNA has to loop to bring the regulator and RNAP into close contact. Class II 
activation occurs when the transcriptional regulator binds close to the -35 region, 
where it interacts with the " factor of RNAP (Figure 1.2B). Another mode of 
activation involves the regulator realigning the promoter by binding between the 
-35 and -10 promoter elements, allowing RNAP to bind and initiate transcription 
(Figure 1.2C). 
 
Transcriptional regulators repress transcription by disrupting binding of RNAP 
to promoters. Repression can occur by steric hindrance, with the regulator 
binding to the core promoter, thus displacing bound RNAP or preventing RNAP 
from binding (Figure 1.3A). Transcriptional regulators can also bind away from 
core promoters and induce conformational changes in DNA, preventing RNAP 
from accessing the promoter (Figure 1.3B). Repression can also occur by 
modulating the activity of other transcriptional regulators (Figure 1.3C). 
 
These mechanisms of action do not take account of small ligands, which act as 
inducers or co-repressors and contribute to the function of the regulators. For 
example the transcriptional regulator, catabolite activator protein, (CAP), 
although it can bind DNA in its apo form, it is only able to interact with RNAP 
and activate transcription when it is in a complex with cAMP, which is produced 
when glucose levels are high (Harman, 2001). Alternatively the binding of a 
ligand may inactivate a transcriptional regulator. For example, binding of 
! "#!
allolactose to the Lac repressor causes a conformational change in the regulator, 
releasing it from the DNA and exposing the promoter to RNAP (Wilson et al., 
2007). Furthermore many transcriptional regulators can bind multiple ligands.  
 
Many genes are regulated by multiple different transcriptional regulators 
integrating numerous environmental signals. Promoters that can bind multiple 
different transcriptional regulators are termed complex promoters. In the 
majority of cases, the binding of each regulator occurs independently but 
occasionally binding is cooperative or inhibitory. 
! ""!
 
 
Figure 1.2 Activation at simple promoters 
Diagram of mechanisms of activation at simple promoters. A. In Class I 
activation, the transcriptional regulator binds upstream of the -35 sequence and 
enhances the binding of RNAP to the DNA by interacting with the C-terminal 
domain of one of the ! subunits. B. In Class II activation, the transcriptional 
regulator binds close to the -35 promoter element and interacts with the " factor 
of RNAP. C. During activation of transcription by conformational change, the 
regulator binds between the -35 and -10 promoter elements and realigns them, 
allowing binding of the RNAP. (Adapted from Browning and Busby, 2004) 
! "#!
 
Figure 1.3 Repression at simple promoters 
Diagram of mechanisms of repression at simple promoters. A. In repression by 
steric hindrance, the transcriptional repressor binds to the core promoter and 
prevents RNAP from binding. B. In repression by looping, the transcriptional 
regulator binds at distal sites and causes looping of DNA such that the RNAP is 
prevented from binding the promoter. C. In repression by modulation of an 
activator, the transcriptional repressor prevents the activator from functioning. 
(Adapted from Browning and Busby, 2004.) 
-10 -35 
RNAP 
+1 
TSS 
!!
-10 -35 +1 
TSS 
RNAP 
Repressor Activator 
A.  Repression by steric hinderance 
RNAP 
-35 
-10 +1 
TSS 
!!
B.  Repression by looping 
C.  Repression by modulation of an activator 
Repressor 
Repressor 
! 
" + "’ 
! 
" + "’ 
! 
" + "’ 
# + # 
# + # 
# + # 
! "#!
There are several classes of HTH transcription factors (Figure 1.4). The 
simplest version comprises a DNA binding HTH motif with another helix, and 
it is proposed that all the classes have evolved from this structure (Aravind et 
al., 2005). For example, tetra-helical regulators have a further helix, while 
winged HTH (wHTH) regulators have a single HTH motif with a !-strand 
hairpin, and a wHTH C-terminal helix regulator contains an additional helix. 
Within these classes, families of HTH transcriptional regulators are based on 
sequence similarity; and are typically named after the first characterised 
member. For example the Fur family is named after the Ferric uptake regulator, 
from Escherichia coli (Bagg and Neilands, 1987), which belongs to the wHTH 
C-terminal helix class. However, not all family members share the same 
function.  
! "#!
 
 
 
 
 
Figure 1.4 Diagram of different classes of HTH regulators 
Diagram showing the different classes of HTH regulators. The orange arrows 
show the probable routes of transformation from the simple tri-helical regulator. 
!-strands are shown in yellow, and "-helices are shown as blue cylinders. Bold 
shows the class name, with family members shown beneath. (Adapted from 
Avarind et al ., 2005).  
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1.2.3 TCS 
 
TCS are also important for prokaryotic transcriptional regulation. TCS convert 
external environmental conditions into changes in transcription through histidine 
kinase signaling. A membrane located sensor protein detects an external 
stimulus, such as pH, temperature or contact with host cells (Beier and Gross, 
2006). Detection of the stimulus leads to autophosphorylation of a specific 
histidine residue within the dimerisation domain of the sensor protein. The high 
energy phosphoryl group is subsequently transferred from the histidine residue 
of the sensor protein to an aspartic acid residue in the response regulator protein. 
Response regulators consist of a conserved N-terminal regulatory domain, which 
is the site of phosphorylation, and a C-terminal effector domain, which is similar 
to one-component transcriptional regulators and contains a HTH DNA binding 
motif. Phosphorylation of the response regulator induces a conformational 
change in the protein, allowing the effector domain to bind DNA and influence 
transcription. Like one-component regulatory proteins, the response regulators 
exhibit considerable diversity in their mode of action. !
1.2.4 Other proteins capable of modulating transcription 
 
As already mentioned, the ! factor of RNAP is involved in gene regulation, as 
different ! factors exhibit preference for different consensus sequences at core 
promoters. Although !70 is the most common ! factor in RNAP, other ! factors 
are incorporated under certain circumstances. For example, !32 is upregulated 
following heat shock, and replaces !70 in a proportion of RNAP molecules. The 
number of ! factors in bacteria is linked to their genome size and the complexity 
of environments they encounter (Aravind et al., 2005, Wosten, 1998). 
 
Integration host factor (IHF) is a small, DNA binding protein composed of two 
heterologous subunits, IHF-" and IHF-#. IHF is an architectural protein which is 
able to bend DNA by approximately 160 °. Consequently it has roles in 
replication, recombination and transcription. Architectural proteins play a role in 
transcription by mediating DNA looping and altering the binding affinities of the 
transcriptional machinery for DNA.  
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Small ligands can also modulate transcription. For example, guanosine 
tetraphosphate (ppGpp) is a low molecular weight molecule that accumulates 
when amino acid availability is restricted and it is thought to interact with 
RNAP, destabilising the open complex and preventing transcription (Barker et 
al., 2001a, Barker et al., 2001b). A Salmonella strain deficient in the two 
enzymes responsible for ppGpp metabolism, RelA and SpoT, is avirulent in 
mice, and in the absence of ppGpp a number of genes involved in the 
pathogenesis of Salmonella typhimurium are not expressed (Pizarro-Cerda and 
Tedin, 2004, Tedin and Norel, 2001). Consequently ppGpp can have a role in 
virulence through transcription. 
 
1.3 Neisseria meningitidis  
 
Neisseria meningitidis is a Gram negative aerobic diplococcal $-proteobacterium 
from the Neisseriaceae family. Humans are the only known host for the 
meningococcus, which can be isolated as part of the commensal flora from the 
nasopharynx in 8-20% of the population (Stephens, 1999). However, N. 
meningitidis is also a pathogen, with a global estimated annual incidence of 1.2 
million cases of invasive meningococcal disease and 135,000 related deaths 
(WHO, 2001). But incidence rates fluctuate. For example, the annual incidence 
of meningococcal disease is 0.35 per 100,000 of the population in North 
America, whilst Africa can have an incidence rate of 1,000 per 100,000 of the 
population during epidemics (Harrison et al., 2009).  
 
Serological typing of N. meningitidis is based on surface-exposed antigens, with 
serogroups classified according to the structure of the capsular polysaccharide. 
While there are 13 serogroups (A, B, C, E-29, H, I, K, L, M, W-135, X, Y and 
Z), the majority of meningococcal disease is caused by strains belonging to 
serogroups A, B, C, W-135, X or Y (Stephens, 2007). 
 
Once the bacterium has colonised the epithelial surface of the nasopharynx in a 
susceptible host, to cause disease it must breach the mucosa of the nasopharynx 
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and enter the bloodstream. Once in the bloodstream, rapid replication of the 
bacteria can occur, resulting in systemic disease. The bacterium may also 
traverse the blood: cerebrospinal fluid barrier resulting in meningitis. N. 
meningitidis is the most common causative agent of bacterial meningitis (Trotter 
et al., 2007). 
 
1.4 Pathogenesis !
Colonisation by the bacteria of the epithelial cells of the nasopharynx is the first 
step in establishing both carrier status and disease. N. meningitidis possesses 
both major and minor adhesins which contribute to adhesion. However, in 
encapsulated strains the Type-four pili (Tfp), the major adhesin, is responsible 
for mediating attachment to host cells. At the site of bacterial adhesion, the host 
cell undergoes rapid rearrangements resulting in the formation of cortical 
plaques, which are enriched for signal transducers and cytoskeletal components; 
Tfp are required for cortical plaque formation (Merz et al., 1999, Merz and So, 
1997). If colonisation leads to invasive disease, the bacteria need to breach the 
mucosa of the nasopharynx. The mechanism for traversal of the epithelial cells 
remains undefined, although the route is suggested to be transcellular and 
dependent upon microtubules and components within the cortical plaque 
(Sutherland et al., 2010, Merz et al., 1999, Merz et al., 1996, Merz and So, 1997, 
Pujol et al., 1997). A role for the posttranslational modification of the pilin by 
addition of phosphoglycerol has been suggested to assist with the migration of 
the bacteria across the epithelium (Chamot-Rooke et al., 2011). 
 
Once in the bloodstream, bacteria may proliferate rapidly if they can evade 
innate immune responses, including the complement system. The importance of 
complement in protecting individuals from meningococcal disease is highlighted 
by the susceptibility of individuals with complement deficiencies to systemic 
meningococcal infections (Morgan and Walport, 1991). The bacteria are 
protected from complement-mediated lysis by the polysaccharide capsule, which 
prevents insertion of the membrane attack complex (Ram et al., 1999, Vogel et 
al., 1996). In addition Neisseria can negatively regulate complement activation 
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by Factor H binding protein (fHbp). Expressed on the cell surface of bacteria, 
fHbp binds human factor H, a negative regulator of the complement system 
(Schneider et al., 2006). Lipopolysaccharide also provides protection against 
complement-mediated lysis (Hammerschmidt et al., 1994). 
 
From the bloodstream bacteria can gain access to the cerebrospinal fluid. N. 
meningitidis adheres to brain endothelial cells; this has been shown both in vitro 
and in vivo (Pron et al., 1997, Hardy et al., 2000). Upon adhesion to endothelial 
cells, cellular protrusions form, similar to those on epithelial cells, and 
cytoskeleton remodeling results in the formation of cortical plaques (Eugene et 
al., 2002). These changes allow the bacteria to resist the sheer stress forces 
caused by the flow of blood and they multiply, forming colonies (Mairey et al., 
2006, Mikaty et al., 2009). Bacteria traverse human brain endothelial cells 
paracellularly by disrupting intercellular junctions through recruiting 
Par3/Par6/PKC! polarity complexes and inducing the expression of host matrix-
metalloproteinases upon infection (Coureuil et al., 2009, Schubert-Unkmeir et 
al., 2010). 
 
Host transmission of N. meningitidis occurs via airborne droplets. The 
progression to disease can be regarded as an evolutionary ‘dead-end’ for the 
meningococcus (Taha et al., 2002). !
1.5 Adhesion 
 
The adhesion of N. meningitidis is important for colonisation and disease. The 
meningococcus adheres to both the epithelial cells of the nasopharynx and brain 
endothelial cells (Virji et al., 1992a). Meningococcal adhesion is a two-step 
process with the bacteria initially aggregating and attaching to cells as small 
micro-colonies (Pujol et al., 1997). Over time, initial adhesion progresses to 
intimate adhesion when bacteria spread over the apical surface of the host cell 
and adhere firmly, with the loss of piliation (Pujol et al., 1997, Pujol et al., 1999) 
(Figure 1.6). The opacity proteins are minor adhesins and facilitate adhesion in 
the absence of capsule (Virji et al., 1993). Expression of the capsule is not 
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constitutive; a decreased capsule expression facilitates adhesion and invasion. 
Accordingly, carrier isolates from the nasopharynx often express no, or less 
capsule than isolates from the blood and cerebrospinal fluid (Burrage et al., 
2002, Hammerschmidt et al., 1996a, Virji et al., 1993). However, in the 
encapsulated bacteria, Tfp mediate adhesion (Virji et al., 1991, Virji et al., 
1993). 
  
1.5.1. Tfp 
 
Tfp are long, thin, filamentous appendages which occur on the surface of many 
Gram negative and positive bacteria. Meningococcal Tfp are 50-60Å wide and 
several microns long (Craig et al., 2004). Tfp are essential for interbacterial 
interactions (aggregation) (Swanson et al., 1971), adhesion (Swanson, 1973, 
Virji et al., 1991), twitching motility (locomotion based on the rapid extension 
and retraction of the pili) (Merz et al., 2000), and DNA competence (Seifert et 
al., 1990) in pathogenic Neisseria species.  
 
Tfp have been extensively studied in N. meningitidis strain 8013, with 16 
proteins (PilC1, PilC2, PilD, PilE, PilF, PilG, PilH, PilI, PilJ, PilK, PilM, PilN, 
PilO, PilP, PilQ and PilW) shown to be essential for Tfp biogenesis (Figure 1.5) 
(Carbonnelle et al., 2006, Carbonnelle et al., 2005). Seven ‘accessory’ proteins, 
(ComP, PilT, PilT2, PilU, PilV, PilX and PilZ) contribute to Tfp biology but are 
not required for biogenesis (Figure 1.5) (Brown et al., 2010, Carbonnelle et al., 
2006, Carbonnelle et al., 2005). Tfp mainly consist of helical assemblies of the 
major pilin subunit PilE, forming the fibre. PilE can undergo post-translational 
modification with phosphocholine, phosphoethanolamine or phosphoglycerol 
(Stimson et al., 1996, Hegge et al., 2004, Aas et al., 2006). A prepilin peptidase, 
PilD, processes proteins assembled into the pilus (Pelicic, 2008). It is not known 
how exactly Tfp fibres are assembled, but PilF, an inner membrane bound 
ATPase, provides energy for this process (Pelicic, 2008). It is proposed that the 
pilus fibres are assembled in the periplasm and emerge on the bacterial cell 
surface through a channel formed by the secretin PilQ (Figure 1.5) (Carbonnelle 
et al., 2006). 
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The accessory proteins including ComP, PilT and PilX have key roles in Tfp 
biology. ComP is essential for the competence of the meningococcus for DNA 
uptake (Brown et al., 2010). PilT is an ATPase which provides the energy for 
retraction of pili and therefore is essential for many aspects of Tfp biology, 
including DNA transformation and twitching motility (Brown et al., 2010). 
Mutants of pilT form highly irregular aggregates, exhibit increased piliation, and 
are unable to undergo intimate adhesion (Brown et al., 2010, Pujol et al., 1999). 
PilX is incorporated into the pilus fibre and is important for interbacterial 
interactions (Helaine et al., 2005, Helaine et al., 2007). Mutants of pilX are 
unable to form aggregates and are defective for adhesion to human cells (Brown 
et al., 2010, Helaine et al., 2005, Helaine et al., 2007). It is proposed that 
multiple PilX-PilX contacts along the length of interacting Tfp contribute to 
aggregation and counter balance PilT-mediated retraction (Helaine et al., 2005, 
Helaine et al., 2007). The role of PilX confirms the importance of bacterial 
aggregation for efficient adhesion to host-cells. 
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Figure 1.5 Tfp biogenesis 
Four-step model of Tfp biogenesis proposed in N. meningitidis, taken from 
Carbonelle et al ., 2006. 
 !
It has been assumed that at least one of the proteins involved in Tfp biogenesis is 
pilus-tip located and responsible for binding to a host-cell receptor; however, 
investigations are not conclusive. PilC is required for Tfp biogenesis and the 
meningococcus harbours two alleles with high identity, pilC1 and pilC2. Double 
pilC mutants are non-piliated, in contrast to single pilC mutants which express 
Tfp, pilC1 mutants are non-adhesive (Nassif et al., 1994). PilC1 is proposed to 
be the pilus-tip located adhesin of Tfp, and is upregulated upon host-cell contact 
(Taha et al., 1998). The addition of PilC1 or anti-PilC1 antibodies inhibits 
adhesion (Rudel et al., 1995). However, there are conflicting data on the role of 
PilC1 during adhesion, as PilC1 was detected on the bacterial cell surface by 
electron microscopy and not pili associated (Rahman et al., 1997). Furthermore, 
although elevated PilC1 expression is usually associated with increased 
adherence to cells (Virji et al., 1995, Pron et al., 1997), this correlation is not 
always seen, as non-adherent isolates with high levels of PilC1 expression and 
hyperadherent isolates with low levels of PilC1 expression have been identified 
(Virji et al., 1995). 
 
Another area of contention is the host cell receptor for pathogenic Neisseria. The 
complement regulatory protein membrane cofactor, or CD46, has been 
suggested to be the host cell receptor for pilus-mediated adhesion. CD46 is a 
human specific transmembrane glycoprotein which is found on almost all cell 
types except erythrocytes (McNearney et al., 1989). Purified pili were able to 
bind to CD46 in vitro and subsequently cellular signaling was induced 
(Kallstrom et al., 1997, Kallstrom et al., 1998). However, other studies have 
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questioned the role of CD46, with no correlation observed between the amount 
of surface exposed CD46 and bacterial adhesion to cell lines (Gill et al., 2003, 
Kirchner and Meyer, 2005, Tobiason and Seifert, 2001).  It has also been 
demonstrated that the gonococcus binds independently of CD46 (Gill et al., 
2003, Tobiason and Seifert, 2001). Therefore it seems likely that other host-cell 
component(s) play a role in pilus-mediated adhesion. Recently endothelial !2-
adrenoreceptors have been implicated as receptors for the binding of Tfp, 
resulting in cortical plaque formation through !-arrestin signaling (Coureuil et 
al., 2010). 
 
During intimate adhesion, expression of both the capsule and pili is decreased 
(Figure 1.6) (Hammerschmidt et al., 1994, Hammerschmidt et al., 1996a, Pujol 
et al., 1999). The reduced piliation results from retraction of pili by PilT (Pujol 
et al., 1999), and the downregulation of pilC1 (Morand et al., 2004). Pili 
retraction is associated with the relocalisation of pilin subunits to the 
cytoplasmic membrane (Morand et al., 2004), supporting a model in which 
retracted pili disassemble within the cytoplasmic membrane (Merz and Forest, 
2002). However pilE is also downregulated upon intimate adhesion (Deghmane 
et al., 2002), which might also attribute to the loss of piliation. 
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Figure 1.6 Images of N. meningitidis adhesion to epithelial cells 
Images of N. meningitidis adhering to T84 epithelial cells four hours (A & C) 
and nine hours (B & D) post-challenge. A & B show scanning electron 
microscopy images. At four hours a clump of localised adhered bacteria can be 
seen, but by intimate adhesion at nine hours post-challenge a diffuse pattern of 
adherence is visible. Scale bars: 5 µM C & D show fluorescence confocal 
microscopy images of a permeabilised T84 monolayer grown on a transwell at 
!170 magnification. Cells and bacteria are stained with ethidium bromide (red) 
and pili labeled with monoclonal antibody 20D9 (yellow). Less piliation can be 
seen at nine hours (D) compared to fours hours post challenge (C), although the 
cells are still covered with a monolayer of bacteria. (Adapted from Pujol et al ., 
1997.)  
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1.5.2 Opacity proteins 
 
The opacity proteins, Opa and Opc, are outer membrane proteins. They increase 
bacterial colonisation and facilitate efficient intracellular invasion with epithelial 
and endothelial cells in the absence of capsule and pili (Virji et al., 1993, Virji et 
al., 1992b). There are four copies of the opa genes and each can be expressed at 
any time (Carbonnelle et al., 2009). Opa and Opc are basic in nature and bind to 
heparan sulphate proteoglycans and sialic acids (Carbonnelle et al., 2009, de 
Vries et al., 1998, Moore et al., 2005). 
 
1.5.3 Other adhesins !
The minor adhesins include NadA, NhhA, App and MspA. NadA (neisserial 
adhesin A) was identified in a screen for potential vaccine candidates 
(Comanducci et al., 2002, Pizza et al., 2000), and is involved in promoting 
binding to epithelial cells (Capecchi et al., 2005). App (adhesion and penetration 
protein) is an immunogenic protein (Pizza et al., 2000, Hadi et al., 2001) that 
contributes to attachment to epithelial but not endothelial cells (Serruto et al., 
2003). MspA (meningococcal serine protease) is not encoded by all Neisseria 
strains, but promotes adhesion to epithelial and endothelial cells when expressed 
in E. coli (Turner et al., 2006). NhhA, a trimeric autotransporter is expressed by 
most pathogenic strains (Pizza et al., 2000). Although nhhA mutants have 
reduced levels of adhesion to epithelial cells in vitro, this phenotype is cell-type 
dependent (Scarselli et al., 2006, Sjolinder et al., 2008). Furthermore, two 
glycolytic enzymes, fructose-1,6-bisphosphate and glyeraldehyde 3-phosphaste 
dehydrogenase, have been found to be surface exposed and have slight but 
significant effects upon the adhesion of the meningococcus to both epithelial and 
endothelial cells (Tunio et al., 2010a, Tunio et al., 2010b). 
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1.6 Gene regulation in N. meningitidis 
 
Understanding gene regulation of the meningococcus can provide important 
insights into the control of virulence of the bacteria. Meningococcal genomes 
encode a limited number of TCS (five), alternative ! factors (two) and one-
component transcriptional regulators (28) (Aravind et al., 2005, Ashby, 2004, 
Parkhill et al., 2000, Rusniok et al., 2009, Tettelin et al., 2000). Identification of 
the meningococcal regulators is discussed in more detail in Chapter 3. 
Relationships have been established in prokaryotes between the number of 
transcriptional regulators and the number of protein coding genes in a species 
(Aravind et al., 2005, Ashby, 2004). It has also been noted that pathogens have 
the lowest average number of response regulators (Ashby, 2004). These 
correlations between genome size and number of transcriptional regulators are 
also linked to the lifestyle complexity of the bacteria (Aravind et al., 2005, 
Ashby, 2004). Consequently the reduced number of transcriptional regulators 
encoded by the meningococcus is likely a result of the limited environmental 
niches it occupies. The meningococcus has a relatively compact genome of 
approximately 2.1 mega base pairs (Mb). Compared to other respiratory tract 
pathogens, the meningococcal genome is similar in size to Haemophilus 
influenzae (1.9 Mb) (Harrison et al., 2005) and Streptococcus pneumoniae (2.2 
Mb) (Tettelin et al., 2001), but considerably smaller than that of Bordetella 
pertussis (4.1 Mb) (Parkhill et al., 2003). Interestingly, H. influenzae also 
encodes a limited number of transcriptional regulators (Harrison et al., 2005, 
Tatusov et al., 1996). However, S. pneumoniae encodes more (Tettelin et al., 
2001), with 14 response regulators compared to five in the meningococcus. This 
may be a reflection of the more complex lifecycle of S. pneumoniae, which is 
not restricted to the human host.  
 
The meningococcal genome has abundant and diverse repetitive DNA 
sequences. These repetitive sequences contribute to both the genomic and 
antigenic variability the meningococcus displays by playing a role in the 
regulation of gene expression by phase variation. 
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1.6.1 Phase variation 
 
Phase variation is reversible on/off switching of a phenotype, as a consequence 
of genetic changes (van der Woude and Baumler, 2004). Through phase 
variation, a single bacterium can produce progeny with several heritable 
phenotypes, increasing the probability of variants which are able to survive in an 
adverse environment. Phase variation is proposed to promote evasion of host 
immunity and this is supported by the finding that most phase variable structures 
are surface exposed (van der Woude and Baumler, 2004). Several different 
mechanisms are responsible for phase variation, such as insertion sequences and 
Correia elements.  
 
 Insertion sequences are able to reversibly insert into specific locations, and as a 
consequence, disrupt expression. For example, the insertion and excision of the 
insertion sequence IS1301 in siaA alters capsule expression (Hammerschmidt et 
al., 1996a). Correia elements occur throughout Neisserial genomes; they are 
100-155 bp, are flanked by long terminal repeats (Correia et al., 1986, Correia et 
al., 1988), and contain functional IHF binding sites and promoter sequences 
(Buisine et al., 2002). Consequently Correia elements can influence 
transcription, as occurs with the mtr (multiple transferable resistance) operon 
(Rouquette-Loughlin et al., 2004).  
 
The most common mechanism of phase variation is caused by repeated DNA 
sequences normally less than 10 bp in length (Saunders et al., 2000), which are 
subject to slip-strand mispairing during DNA replication. Repetitive sequences 
within coding regions result in frameshift mutations and premature stop codons. 
Expression of both Tfp and the capsule are subject to phase variation by this 
mechanism. Homopolymeric guanine residues occur within the signal peptide 
region of the pilC genes (Jonsson et al., 1991); while siaD contains 
homopolymeric cytosine residues (Hammerschmidt et al., 1996b). Alternatively, 
repetitive tracts can occur outside of coding sequences, either in the promoter or 
other regulatory regions. The outer membrane protein, PorA, is subject to phase 
variation by the presence of a homopolymeric guanine tract between the -10 and 
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-35 core promoter regions; the affinity of RNAP is affected by the number of 
residues (van der Ende et al., 2000). Computational analyses suggest that N. 
meningitidis contains between 65 and 100 phase-variable genes (Saunders et al., 
2000, Snyder et al., 2001), some of which have been experimentally proven 
(Martin et al., 2003).  
  
1.6.2 Transcriptional regulators !
Bacteria are constantly monitoring the changing environments they are exposed 
to and altering their gene expression accordingly by receiving and interpreting 
numerous signals. Phase variation does not respond to these signals, either 
directly, or through transcriptional regulators, thus there is still an important 
requirement for transcriptional regulation by transcriptional regulators in the 
meningococcus. Although N. meningitidis has a limited number of 
transcriptional regulators, few have been examined. Overall, of the 
approximately 33 predicted regulators (28 one-component regulators and five 
TCS) in N. meningitidis (Parkhill et al., 2000, Rusniok et al., 2009, Tettelin et 
al., 2000), only eight have been characterised in any detail.  
 
1.6.2.1 CrgA !
CrgA is a LysR family regulator encoded by NMV_2045. In common with LysR 
family regulators, CrgA negatively regulates its own transcription (Deghmane et 
al., 2000, Ieva et al., 2005). However, in contrast to other LysR family members, 
which form tetrameric oligomers, CrgA assembles into a octamer (Sainsbury et 
al., 2009). CrgA can both activate and repress transcription (Ieva et al., 2005). 
CrgA represses transcription by preventing the dissociation of RNAP from the 
promoter by interactions with its C-terminal domain, thus not allowing the 
establishment of the elongation phase of transcription (Deghmane et al., 2004, 
Deghmane and Taha, 2003). 
 
CrgA was named as Contact Regulated Gene A, as it contains a Contact 
Regulatory Element of Neisseria/REP2 sequence (CREN/REP2) in its promoter 
(Deghmane et al., 2000, Morelle et al., 2003). CREN/REP2 sequences are 
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repeats found throughout the meningococcal genome and are associated with 
genes coordinately upregulated during initial interactions with host-cells 
(Deghmane et al., 2000, Morelle et al., 2003). Upon contact with host-cells, 
crgA is upregulated and the target genes of CrgA were predicted to be 
downregulated upon host-cell contact, such as those involved in capsule (sia 
genes) and pilus biosynthesis (pilC1and pilE) thus promoting intimate adhesion, 
a critical step in colonisation to both epithelial and endothelial cells (Deghmane 
et al., 2002, Deghmane et al., 2000). CrgA binds to the promoters of the pilE, 
pilC1 and sia genes (Deghmane et al., 2002, Deghmane et al., 2000). However, 
primer extension analyses have questioned these results, with no appreciable 
difference in the amount of pilE, pilC1 and sia transcripts seen between the wild-
type (WT) strain and a crgA mutant, although the effect of host-cell contact was 
not assessed (Ieva et al., 2005). Also, the in vivo relevance of these results have 
been questioned, as a crgA mutant is able to adhere to cells at similar levels to 
the WT strain, and retract its pili during the progression to intimate adhesion 
(Ieva et al., 2005, Morelle et al., 2003).  
 
LysR family regulators commonly require the binding of an inducer and !-
methylene-"-butyrolactone (MBL) has been suggested to be an inducer of CrgA 
(Ieva et al., 2005). In the presence of MBL, CrgA dependent repression of crgA 
and activation of mdaB, the adjacent divergent transcribed gene, was increased 
(Ieva et al., 2005). Although, addition of MBL to bacterial cultures had no effect 
upon transcription of pilC1, pilE or sia genes (Ieva et al., 2005).  
 
1.6.2.2 AsnC !
AsnC, encoded by NMV_1850, is a member of the L-leucine responsive 
regulator family. Regulators belonging to this family control genes involved in 
synthesis and degradation of amino acids, as well as a number of other genes, 
depending on amino acid availability (Calvo and Matthews, 1994). L-leucine 
and L-methionine are inducers of AsnC in the meningococcus; when either binds 
to AsnC, the regulator assumes an octameric conformation, which is capable of 
binding DNA and regulating transcription (Ren et al., 2007). By responding to 
levels of L-leucine and L-methionine, AsnC monitors nutrient availability in the 
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environment and alters transcription accordingly. Consequently an asnC mutant 
displayed slower growth than the WT strain in nutrient restricted conditions 
(Ren et al., 2007). Several potential targets for AsnC regulation were identified 
by microarray analysis; AsnC is a global regulator, affecting genes involved in 
aerobic metabolism and genes encoding surface exposed proteins (Ren et al., 
2007).  
 
1.6.2.3 FNR !
The fumarate and nitrate reductase regulator, FNR, is encoded by NMV_0418 in 
N. meningitidis strain 8013 and belongs to the FNR/Crp family of transcriptional 
regulators. FNR is a transcriptional activator which is able to bind to promoters 
under oxygen-limiting conditions. FNR binds an iron-sulphur cluster (4Fe-4S) 
which is oxygen sensitive, and linked to oligomerisation (Edwards et al., 2010). 
In the presence of oxygen, the 4Fe-4S cluster breaks down to 2Fe-2S, and FNR 
containing a 2Fe-2S cluster is unable to form oligomers and bind DNA (Edwards 
et al., 2010). However, in the absence of oxygen, the 4Fe-4S cluster promotes 
the formation of dimeric FNR, which binds DNA and regulates transcription. 
The FNR dependent promoters of the meningococcus are less sensitive to 
oxygen than its E. coli counterpart (Edwards et al., 2010, Rock et al., 2007). 
This is due to a slower rate of 4Fe-4S cluster disassembly in the presence of 
oxygen (Edwards et al., 2010). 
 
Although N. meningitidis is unable to grow in strictly anaerobic conditions, it 
can replicate under oxygen-limiting conditions and FNR contributes to this 
(Rock et al., 2005, Rock and Moir, 2005, Anjum et al., 2002, Bartolini et al., 
2006). A microarray study comparing a fnr mutant to the WT strain grown in 
oxygen-limiting conditions identified 11 genes in nine transcriptional units 
upregulated by FNR, and recombinant FNR was able to bind to the promoters of 
these genes in oxygen-limiting conditions (Bartolini et al., 2006). FNR activates 
genes involved in the denitrification of nitrite which may act as an alternative 
respiratory substrate when oxygen availability is low (Edwards et al., 2010, 
Oriente et al., 2010, Rock et al., 2005, Rock and Moir, 2005, Bartolini et al., 
2006). FNR also regulates galM, mapA and fHbp (Bartolini et al., 2006). 
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Many niches that N. meningitidis inhabits, including the nasopharynx, have 
variable oxygen levels, and the bacterium must respond appropriately to oxygen-
limitation for survival. FNR has a role in virulence, as demonstrated by the 
reduced bacteraemia seen in both murine and infant rat models when infected 
with a fnr mutant compared to the WT strain (Bartolini et al., 2006). The 
reduced bacteraemia was shown to be due to in part to the deactivation of galM 
and mapA, which encode proteins important for sugar metabolism in oxygen-
limiting conditions (Bartolini et al., 2006).  
 
1.6.2.4 Fur !
The ferric uptake regulator, Fur, is encoded by gene NMV_0223, in N. 
meningitidis strain 8013. Typically Fur acts as an iron-responsive repressor, by 
binding ferrous iron as a co-repressor, which alters the confirmation of Fur 
allowing it to dimerise and bind a consensus DNA sequence called the Fur-box.  
 
Fur has been extensively studied in the meningococcus and is non-essential, 
iron-responsive and is suggested to regulate between 80 and 200 genes (Delany 
et al., 2006, Delany et al., 2003, Grifantini et al., 2003). Fur influences genes 
involved in iron metabolism, electron transfer and energy metabolism. Although 
Fur typically acts as a repressor, there are examples of it activating genes in the 
meningococcus such as norB, which is involved in denitrification (Delany et al., 
2004).  
 
Fur can also mediate regulation indirectly. Firstly, Fur can affect transcription of 
other transcriptional regulators, such as the AraC family regulator NMV_2068 
(Delany et al., 2006). Secondly, Fur can regulate small non-coding RNAs 
(sRNA), such as nrrF, which modulates expression of the gene encoding 
succinate dehydrogenase (Mellin et al., 2007, Metruccio et al., 2009a). 
 
Although the role of Fur has not been directly linked to meningococcal 
virulence, numerous models have shown that hindering the ability of the 
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bacterium to acquire iron attenuates virulence (Calver et al., 1976, Klee et al., 
2000, Schryvers and Gonzalez, 1989, Stojiljkovic et al., 1995).  
 
1.6.2.5 NsrR !
NsrR is encoded by gene NMV_0480 in N. meningitidis strain 8013, and 
belongs to the Rrf2 family of transcriptional regulators. NsrR typically acts as a 
repressor and is sensitive to nitric oxide (Beaumont et al., 2004, Tucker et al., 
2010). It is likely that NsrR binds an iron-sulphur cluster, and interactions 
between the cluster and nitric oxide may alter the structure of the regulator and 
attenuate its ability to bind DNA, as in the gonococcus (Isabella et al., 2009). 
 
In N. meningitidis, NsrR has a small regulon of four genes, which have proven 
or predicted roles in denitrification, and one pseudogene (Heurlier et al., 2008, 
Rock et al., 2007). Both NsrR and FNR have roles in oxygen-limiting conditions 
when denitrification is required, and both regulate aniA, which encodes the 
nitrite reductase enzyme (Heurlier et al., 2008). In oxygen-limiting conditions, 
low levels of AniA are expressed due to the activity of FNR, even in the 
presence of NsrR; as nitric oxide levels start to increase, NsrR is inactivated and 
full transcription of aniA occurs by FNR (Heurlier et al., 2008, Rock et al., 
2007). Further increase of nitric oxide levels lead to the inactivation of FNR and 
aniA expression decreases, as high levels of nitric oxide are toxic. 
 
NsrR has not been directly implicated in the virulence of the meningococcus. 
However, as the meningococcus inhabits environments with variable oxygen 
levels, NsrR, as with FNR, may be required to ensure the bacteria are able to 
survive optimally in adverse conditions. 
 
1.6.2.6 FarR  !
FarR, encoded by NMV_2033 in N. meningitidis strain 8013, is member of the 
MarR family of transcriptional regulators (Schielke et al., 2009). The MarR 
family regulators normally act as dimers, are commonly repressors and bind 
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inducers which prevent interaction with DNA and leads to derepression 
(Wilkinson and Grove, 2006).  
 
In the meningococcus, FarR is a growth dependent regulator that represses nadA 
transcription (Metruccio et al., 2009b, Schielke et al., 2009, Capecchi et al., 
2005, Schielke et al., 2010) and 4-hydroxyphenylacetic acid (4HPA) has been 
suggested as its inducer (Metruccio et al., 2009b). The regulation of nadA by 
FarR is complex, as phase variation and IHF also play a role. A phase variable 
tetranucleotide tract is located upstream of the nadA promoter and differences in 
the number of this repeat sequence affect nadA transcription (Martin et al., 2003, 
Metruccio et al., 2009b). FarR is thought to bind to three operator sequences, 
with one upstream of the phase variable sequences, one overlapping the repeats, 
and the other within the core promoter (Metruccio et al., 2009b). IHF may also 
bind the tetranucleotide tract and bring the operator sequences into close 
proximity with each other (Martin et al., 2005, Metruccio et al., 2009b).  
 
As 4HPA is known to be secreted in human saliva and may therefore be present 
in the nasopharynx, a model of nadA regulation has been proposed (Takahama et 
al., 2003). It has been suggested that in the nasopharynx 4HPA binds FarR, 
altering its conformation and releasing it from the nadA operator sites, resulting 
in derepression; and nadA is upregulated increasing adhesion to the epithelial 
surface (Metruccio et al., 2009b). Accordingly FarR is important for host 
colonisation, and a farR mutant shows increased adherence to epithelial cells 
compared to the WT strain (Schielke et al., 2009). 
 
Microarray data suggests that four other genes are also under the control of 
FarR, although it remains to be seen if regulation of these genes is biologically 
relevant (Schielke et al., 2011). 
 
Interestingly the gonococcal FarR homologue has a well characterised but 
distinct function (Lee et al., 2003), suggesting a divergent adaptation advantage 
for their differing environmental niches between the two pathogenic Neissera 
species (Schielke et al., 2010). 
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1.6.2.7 MisR/MisS !
MisR/MisS is a TCS encoded by genes NMV_1818 and NMV_1819 
respectively, in N. meningitidis strain 8013. They are one of the most studied 
transcriptional regulatory components in the meningococcus; however, many 
findings are inconsistent. The TCS was originally named after the magnesium 
sensing PhoP/PhoQ TCS in Salmonella typhimurium, due to similarities of the 
phenotype of a misR mutant in both bacterial species (Johnson et al., 2001). A 
serogroup C meningococcus misR mutant demonstrated an inability to grow in 
low magnesium levels, increased sensitivity to antimicrobial peptides and loss of 
magnesium controlled gene regulation (Johnson et al., 2001, Newcombe et al., 
2004, Newcombe et al., 2005). However, the magnesium dependent growth was 
not found in a serogroup B strain (Tzeng et al., 2004, Tzeng et al., 2006). This 
led to the TCS being renamed as MisR/MisS for Meningococcal Inner Core 
Structure due to alterations of the lipopolysaccharide inner core seen in the misR 
mutant (Tzeng et al., 2004). The TCS has also been implicated in ability of the 
meningococcus to utilize haemoglobin as an iron source, through activation of 
hmbR (Zhao et al., 2010). The TCS also represses transcription of hlyB and 
hlyDC, which encode a type I secretion system (Sannigrahi et al., 2009).  
 
MisR/MisS contributes to virulence, as a misR mutant is avirulent in a murine 
model (Newcombe et al., 2004). MisR/MisS has also been implicated in the 
upregulation of genes upon host-cell contact, by binding promoters containing 
CREN/REP2 sequences (Jamet et al., 2009).  
 
Interestingly, microarray analysis of the MisS/MisR regulon by two groups only 
showed a 30% concordance of differentially expressed genes (Newcombe et al., 
2005, Tzeng et al., 2008). Although the differences could be due to the different 
experimental conditions used or the strains tested, MisR/MisS have nearly a 
100% sequence similarity in the two strains.  
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1.6.2.8 NarP/NarQ !
NarP/NarQ is a TCS encoded by genes NMV_1178 and NMV_1179 
respectively, in strain 8013. Although it has not been extensively characterised 
in the meningococcus, NarP/NarQ is suggested to be involved in denitrification, 
as a narPQ mutant exhibits restricted growth in oxygen-limiting conditions and 
reduced nitrite utilisation (Rock et al., 2005). The promoter region of narPQ 
contains an NsrR binding motif, although there is no direct evidence that NsrR 
regulates this TCS (Heurlier et al., 2008, Rock et al., 2007). 
 
1.6.2.9 NMV_0773/0774 !
Recently the TCS encoded by genes NMV_0773 and NMV_0774 in strain 8013 
has been implicated in the repression of pilC1 upon host-cell contact (Jamet et 
al., 2010); this was unexpected as pilC1 expression is upregulated upon host-cell 
contact (Morand et al., 2004, Taha et al., 1998). Recombinant purified 
NMV_0773 binds to the DNA upstream of the TCS, but its role in the regulation 
of pilC1, potentially alongside MisR remains to be elucidated (Jamet et al., 
2009, Jamet et al., 2010).  
 
1.7 Aims of this study !
To date, only eight of the 33 one-component transcriptional regulators and TCS 
in N. meningitidis have been characterised in any detail, and more research 
remains to be completed on the remaining 25 uncharacterised transcriptional 
regulators, as well as further characterisation of the eight regulators already 
under investigation and other proteins capable of modulating transcription.  !
Investigations of gene regulation through the systematic study of all 
transcriptional regulators in a model organism has been undertaken in the 
eukaryotic species Saccharomyces cerevisiae (Harbison et al., 2004, Lee et al., 
2002). The relatively limited number of transcriptional regulatory proteins in the 
meningococcus means a systematic approach to the analysis of regulation by 
transcriptional regulators in this prokaryotic, pathogenic model organism is also 
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possible. Analysis of transcriptional regulation will be assisted by construction 
of a mutant library. Screening of the library to determine the role of 
transcriptional regulators in the control of virulence factors will help to better 
understand the pathogenesis of the meningococcus.  !
Therefore, the aim of this study was to identify and mutate all 43 of the genes 
encoding proteins predicted to modulate transcription in the sequenced, 
serogroup C, N. meningitidis strain 8013 (Rusniok et al., 2009). This strain is 
encapsulated, does not express opacity proteins and expresses highly adhesive 
pili (Nassif et al., 1993). Our group has used this strain to create the publically 
accessible biological resource NeMeSys (Neisseria meningitidis sequence for 
systematic functional analysis) (Rusniok et al., 2009). The genes were identified 
using NeMeSys, and mutated using an improved in vitro transposon mutagenesis 
tool. Furthermore the roles of the transcriptional regulators with regard to 
growth and phenotypes linked to the major virulence factor, the Tfp were 
investigated. Additionally, attempts were made to characterise further, two one-
component transcriptional regulators, found only in pathogenic Neisseria strains. 
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!
2 Materials and Methods 
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2.1 Chemicals and Reagents  !
All chemicals and reagents used in this study were purchased from Sigma-
Aldrich, UK, unless otherwise stated. 
 
2.2 Bacterial Strains and Growth Conditions !
Neisseria strains were grown in Modified Catlin medium 4 (MC4) (Fu et al., 
1995), (5.8 g NaCl, 0.27g KH2PO4, 3.5 g K2HPO4, 0.22 g NH4Cl, 1 g K2SO4, 10 
g glucose, 3.9 g L-glutamic acid, 0.75 g L-arginine, 0.125 g glycine, 0.25 g L-
serine, 0.1 g L-cysteine HCl, 0.1 g MgCl2.6H2O, 28 mg CaCl2.6H2O, 40 mg 
Fe(III)citrate, dissolved in 1 L of double-deionised water (ddH2O) with 100 mM 
HEPES, pH 7.0 and then filter-sterilised) or in Gonococcal Medium Base (GCB) 
broth, (15 g Proteose peptone, 4 g K2HPO4, 1 g KH2PO4 and 5 g NaCl dissolved 
in 1 L of ddH2O) or  on GCB agar (36.25 g of GCB [Difco, DB, USA] and 5 g of 
Bacto Agar [Difco] in 1 L of ddH2O). GCB broth and GCB agar were autoclaved 
before addition of the following filter-sterilised supplements; Supplement 1: 400 
g glucose and 20 mg thiamine dissolved in 1 L of ddH2O, added to a final 
concentration of 1%; Supplement 2: 5 g Fe(NO3)4 dissolved in 1 L of ddH2O, 
added to a final concentration of 0.1%; and Supplement 3: 10 g L-glutamine 
dissolved in 1 L of ddH2O, added to a final concentration of 1%.  
 
For Chelex-100 treatment of MC4, 1 g of Chelex resin was used for every 40 ml 
of MC4. Chelex was washed with ddH2O for 30 minutes by stirring, then the 
water was replaced with MC4 and stirred for a further 90 minutes, after which 
the iron-depleted MC4 was ready for use.  
 
Various supplements were added to Chelex-treated MC4 as appropriate: 10% 
Foetal Bovine serum (FBS) (Premium FBS [Lonza, Switzerland], or FBS Gold 
[PAA laboratories, Austria]), 0.5% heat inactivated human serum, 5 µM 
siderophore (EMC microcollections, Germany), 50 µM Catechol, or 5% cell 
lysate. Cell lysates were prepared from Detroit and Chang cells as follows. 
Confluent cells were detached using 3 ml Trypsin (Lonza) from 75 cm2 flasks 
and incubated at 37 °C for 5 minutes, 8 ml of DMEM (Lonza) with 10% FBS 
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Gold (PAA) was then added. Cells were centrifuged at 2000 revolutions per 
minute (rpm) for 10 minutes, the cell pellet was resuspended in 3 ml phosphate 
buffer saline (PBS), lysed by sonication, and 500 µl of lysate was added to 10 ml 
of culture. For iron starved cell lysates, cells were grown without FBS for 12 
hours before harvesting. 
 
GCB agar plates were inoculated with N. meningitidis from frozen stocks stored 
in GCB broth with 15% glycerol at -80 °C. Cultures were incubated for 
approximately 16 hours at 37 °C with 5% CO2 in a humid environment. Liquid 
cultures were grown in 10 ml of broth, inoculated with bacteria to give an optical 
density at 600 nm (OD600nm) of 0.1 or 0.05 and grown at 37 °C with shaking at 
170 rpm. 
 
Escherichia coli was grown in Luria-Bertani (LB) broth (25 g LB broth (Merck 
Biosciences, UK) dissolved in 1 L ddH2O), or on LB agar (37 g LB agar (Merck 
Biosciences) dissolved in 1 L ddH2O). All bacterial cultures were grown 
overnight in media inoculated from a single colony at 37 °C with 200 rpm. If 
necessary 5-bromo-4-chloro-3-indolyl-!-D-galatopyranoside (X-gal) was added 
at 40 µg/ml. 
 
Antibiotics were used where appropriate at the concentrations shown in Table 
2.1. Strains and plasmids used in this study are shown in Tables 2.2, 2.3 and 2.4. 
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Table 2.1 Antibiotics used in this study 
  Antibiotic Concentrations 
Antibiotic Abbreviation E. coli N. meningitidis 
Ampicillin Amp 100 µg/ml - 
Chloramphenicol Cam 50 µg/ml - 
Erthromycin Ery 30 µg/ml 3 µg/ml 
Kanamycin Kan 50 µg/ml 100 µg/ml 
Spectinomycin Spec 100 µg/ml - 
 
 
Table 2.2 N. meningitidis strains used in this study 
Ab: Antibiotic resistance 
Strain Description Ab Reference 
Wild-type (WT) Serogroup C, strain 8013 N/A (Nassif et al., 1993) 
!pilD transposon mutant in pilD Kan (Geoffroy et al., 2003) 
!pilT deletion of pilT Ery (Pujol et al., 1999) 
!0125 transposon mutant in NMV_0125 Kan This study 
!0126 transposon mutant in NMV_0126 Kan This study 
!0773 transposon mutant in NMV_0773 Kan This study 
!0774 transposon mutant in NMV_0774 Kan This study 
!1178 transposon mutant in NMV_1178 Kan (Geoffroy et al., 2003) 
!1179 transposon mutant in NMV_1179 Kan (Geoffroy et al., 2003) 
!1819 transposon mutant in NMV_1819 Kan (Geoffroy et al., 2003) 
!1937 transposon mutant in NMV_1937 Kan (Geoffroy et al., 2003) 
!0188 transposon mutant in NMV_0188 Kan (Geoffroy et al., 2003) 
!0323 transposon mutant in NMV_0323 Kan This study 
!0418 transposon mutant in NMV_0418 Kan (Geoffroy et al., 2003) 
!0419 transposon mutant in NMV_0419 Kan This study 
!0433 transposon mutant in NMV_0433 Kan This study 
!0480 transposon mutant in NMV_0480 Kan (Geoffroy et al., 2003) 
!0652 transposon mutant in NMV_0652 Kan This study 
!0658 transposon mutant in NMV_0658 Kan This study 
!0733 transposon mutant in NMV_0733 Kan (Geoffroy et al., 2003) 
!0757 transposon mutant in NMV_0757 Kan This study 
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Strain Description Ab Reference 
!0789 transposon mutant in NMV_0789 Kan (Geoffroy et al., 2003) 
!0837 transposon mutant in NMV_0837 Kan (Geoffroy et al., 2003) 
!0839 transposon mutant in NMV_0839 Kan (Geoffroy et al., 2003) 
!1005 transposon mutant in NMV_1005 Kan This study 
!1019 transposon mutant in NMV_1019 Kan This study 
!1093 transposon mutant in NMV_1093 Kan This study 
!1134 transposon mutant in NMV_1134 Kan This study 
!1164 transposon mutant in NMV_1164 Kan (Geoffroy et al., 2003) 
!1222 transposon mutant in NMV_1222 Kan (Geoffroy et al., 2003) 
!1586 transposon mutant in NMV_1586 Kan (Geoffroy et al., 2003) 
!1850 transposon mutant in NMV_1850 Kan This study 
!1868 transposon mutant in NMV_1868 Kan (Geoffroy et al., 2003) 
!2033 transposon mutant in NMV_2033 Kan (Geoffroy et al., 2003) 
!2045 transposon mutant in NMV_2045 Kan (Geoffroy et al., 2003) 
!2068 transposon mutant in NMV_2068 Kan This study 
!2160 transposon mutant in NMV_2160 Kan This study 
!2258 transposon mutant in NMV_2258 Kan This study 
!0628 transposon mutant in NMV_0628 Kan (Geoffroy et al., 2003) 
!0715 transposon mutant in NMV_0715 Kan (Geoffroy et al., 2003) 
!2359 transposon mutant in NMV_2359 Kan (Geoffroy et al., 2003) 
Indaat IPTG inducible aat Ery This study 
!2071 transposon mutant in NMV_2071 Kan (Geoffroy et al., 2003) 
2068" NMV_2068 lacZ reporter fusion in ectopic locus Ery This study 
2069" NMV_2069 lacZ reporter fusion in ectopic locus Ery This study 
2069"N NMV_2069 lacZ reporter fusion in native locus Ery This study 
2071"N NMV_2071 lacZ reporter fusion in native locus Ery This study 
2069"/!2068 2069" with NMV_2068 transposon mutant  Ery Kan This study 
2071"/!2068 2071"N with NMV_2068 transposon mutant  Ery Kan This study 
2069"N/Ind2068 2069"N with IPTG inducible NMV_2068 Ery Kan This study 
2071"N/Ind2068 2071"N with IPTG inducible NMV_2068 Ery Kan This study 
!1163 transposon mutant in NMV_1163 Kan (Geoffroy et al., 2003) 
1163" NMV_1163 lacZ reporter fusion in ectopic locus Ery This study 
! "#!
Strain Description Ab Reference 
1163!N NMV_1163 lacZ reporter fusion in native locus Ery This study 
1164! NMV_1164 lacZ reporter fusion in ectopic locus Ery This study 
1164!N NMV_1164 lacZ reporter fusion in native locus Ery This study 
1163!/"1164 1163! with NMV_1164 transposon mutant Ery Kan This study 
1163!N/Ind1164 1163!N with IPTG inducible NMV_1164 Ery Kan This study 
 
 
Table 2.3 E. coli strains used in this study 
Strain Genotype Ab Reference 
DH5# F- $80lacZ"M15 "(lacZYA-argF) U169 
recA1 endA1 hsdR17 (rK-,mK+) phoA supE44 
%-thi-1 gyrA96 relA1 
 Invitrogen 
BL21 F- ompT hsdSB(rB-, mB-) gal dcm (DE3)  Invitrogen 
BL21pLysS F- ompT hsdSB(rB-, mB-) gal dcm (DE3) T7 
page lysozyme 
Cam Invitrogen 
MC1060 F- hsdR2(r-m+) relA   
 
Table 2.4 Plasmids used in this study 
Plasmid Description Ab Reference 
pSCA Cloning plasmid Amp Stratagene 
pCR8/GW/TOPO Cloning plasmid Spec Invitrogen 
pYU29 Transposon donor plasmid Amp Kan (Rusniok et al., 2009) 
p0125 NMV_0125 target plasmid Amp This study 
p0126 NMV_0126 target plasmid Amp This study 
p0773 NMV_0773 target plasmid Amp This study 
p0774 NMV_0774 target plasmid Amp This study 
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Plasmid Description Ab Reference 
p1818 NMV_1818 target plasmid Amp This study 
p0223 NMV_0223 target plasmid Spec This study 
p0323 NMV_0323 target plasmid Spec This study 
p0419 NMV_0419 target plasmid Spec This study 
p0433 NMV_0433 target plasmid Spec This study 
p0652 NMV_0652 target plasmid Spec This study 
p0658 NMV_0658 target plasmid Spec This study 
p0757 NMV_0757 target plasmid Spec This study 
p1005 NMV_1005 target plasmid Spec This study 
p1019 NMV_1019 target plasmid Spec This study 
p1093 NMV_1093 target plasmid Spec This study 
p1134 NMV_1134 target plasmid Spec This study 
p1850 NMV_1850 target plasmid Spec This study 
p2068 NMV_2068 target plasmid Spec This study 
p2160 NMV_2160 target plasmid Spec This study 
p2258 NMV_2258 target plasmid Spec This study 
p1094 NMV_1094 target plasmid Spec This study 
p1688 NMV_1688 target plasmid Spec This study 
p0125-IS NMV_0125 mutagenised target plasmid Amp Kan This study 
p0126-IS NMV_0126 mutagenised target plasmid Amp Kan This study 
p0773-IS NMV_0773 mutagenised target plasmid Amp Kan This study 
p0774-IS NMV_0774 mutagenised target plasmid Amp Kan This study 
p1818-IS NMV_1818 mutagenised target plasmid Amp Kan This study 
p0223-IS NMV_0223 mutagenised target plasmid Spec Kan This study 
p0323-IS NMV_0323 mutagenised target plasmid Spec Kan This study 
p0419-IS NMV_0419 mutagenised target plasmid Spec Kan This study 
p0433-IS NMV_0433 mutagenised target plasmid Spec Kan This study 
p0652-IS NMV_0652 mutagenised target plasmid Spec Kan This study 
p0658-IS NMV_0658 mutagenised target plasmid Spec Kan This study 
p0757-IS NMV_0757 mutagenised target plasmid Spec Kan This study 
p1005-IS NMV_1005 mutagenised target plasmid Spec Kan This study 
p1019-IS NMV_1019 mutagenised target plasmid Spec Kan This study 
p1093-IS NMV_1093 mutagenised target plasmid Spec Kan This study 
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Plasmid Description Ab Reference 
p1134-IS NMV_1134 mutagenised target plasmid Spec Kan This study 
p1850-IS NMV_1850 mutagenised target plasmid Spec Kan This study 
p2068-IS NMV_2068 mutagenised target plasmid Spec Kan This study 
p2160-IS NMV_2160 mutagenised target plasmid Spec Kan This study 
p2258-IS NMV_2258 mutagenised target plasmid Spec Kan This study 
p1094-IS NMV_1094 mutagenised target plasmid Spec Kan This study 
p1688-IS NMV_1688 mutagenised target plasmid Spec Kan This study 
pGCC4 Complementation vector Ery Kan (Mehr and Seifert, 
1998) 
pGCC4-aat Complementation vector containing NMV_0224 Ery Kan This study 
pGCC4-2068myc Complementation vector containing C-myc tagged 
NMV_2068 
Ery Kan This study 
pGCC4-1164myc Complementation vector containing C-myc tagged 
NMV_1164 
Ery Kan This study 
pLKC480 Plasmid containing lacZ Kan (Tiedeman and 
Smith, 1988) 
p2068! NMV_2068 lacZ reporter fusion construct Spec This study 
pGCC4-2068! NMV_2068 lacZ reporter fusion construct for ectopic 
integration 
Ery Kan This study 
p2069! NMV_2068 lacZ reporter fusion construct Spec This study 
p2069!-Kan NMV_2068 lacZ reporter fusion construct  Spec Kan This study 
p2069!-Ery NMV_2068 lacZ reporter fusion construct Spec Ery This study 
pGCC4-2069! NMV_2069 lacZ reporter fusion construct for ectopic 
integration 
Kan Ery This study 
p2071! NMV_2071 lacZ reporter fusion construct Spec This study 
p2071!-Kan NMV_2071 lacZ reporter fusion construct Spec Kan This study 
p2071!-Ery NMV_2071 lacZ reporter fusion construct Spec Ery This study 
p1164! NMV_1164 lacZ reporter fusion construct Spec This study 
p1164!-Kan NMV_1164 lacZ reporter fusion construct Spec Kan This study 
pGCC4-1164! NMV_1164 lacZ reporter fusion construct for ectopic 
integration 
Kan Ery This study 
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Plasmid Description Ab Reference 
p1163! NMV_1163 lacZ reporter fusion construct Spec  This study 
p1163!-Kan NMV_1163 lacZ reporter fusion construct Spec Kan This study 
pGCC4-1163! NMV_1163 lacZ reporter fusion construct for ectopic 
integration 
Kan Ery This study 
pET28b(+) Protein expression vector Kan Invitrogen 
pET28b-1164 Protein expression vector containing NMV_1164 Kan This study 
pET28b-2068 Protein expression vector containing NMV_2068 Kan This study 
 !
2.3 Recombinant DNA methods !
2.3.1 Polymerase Chain Reaction (PCR) !
All analytical PCRs were performed with Taq DNA polymerase (New England 
Biolabs, (NEB) USA), whilst PCRs for amplifying products for cloning were 
amplified using high fidelity DNA polymerases: Easy-A High Fidelity PCR 
cloning enzyme (Stratagene, USA), Herculase II Fusion Enzyme (Stratagene) 
and PfuUltra II Fusion HS DNA Polymerase (Stratagene). Reagent 
concentrations and cycle parameters were used as indicated in the manufacturer’s 
instructions. Control reactions contained no template DNA. For colony PCR, E. 
coli colonies were picked directly from plates and mixed with the reaction, the 
initial denaturation step at 95 °C was increased to 5 minutes. Sequences and 
details of primers used are shown in Table 2.5.  !
Table 2.5 Primers used in this study 
Name Sequence 5' to 3' Use 
0125F TCCTGTTGTACGGACTGACG Amplify and sequence NMV_0125 
0125R CCGTTTTTGGCAAGATGATT Amplify and sequence NMV_0125 
0126F AAGGTTATTCGGTCGCATTG Amplify and sequence NMV_0126 
0126R GTTCCAAACCGACTTTCTGC Amplify and sequence NMV_0126 
0773/0774F AAAGACCGGATTCCCAATCT Amplify and sequence NMV_0773/0774 
0773/0774R AGGCTGACGGTATCGTGTTC Amplify and sequence NMV_077230774 
1818F AGCAAAACCCTGCAAATGAC Amplify and sequence NMV_1818 
1818R GTCTTTCCATTCCGTCAGGA Amplify and sequence NMV_1818 
0223F TCGAGTTCGTTGCCCTGTAT Amplify and sequence NMV_0223 
0223R AGACGTTCGGGAACAATCAC Amplify and sequence NMV_0223 
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Name Sequence 5' to 3' Use 
0323F TGCAGCAATCGGACATAAAA Amplify and sequence NMV_0323 
0323R AATCCAAATGCCGATAATGG Amplify and sequence NMV_0323 
0419F CAACAAACACAACGGCAAAG Amplify and sequence NMV_0419 
0419R AGATGGTATCCGGTTGTTCG Amplify and sequence NMV_0419 
0433F CGCTCGTTGGACATAGGTTT Amplify and sequence NMV_0433 
0433R CGTTGACGCAATAGACATTGA Amplify and sequence NMV_0433 
0652F GCAAAGCAGGTTATGCCTGT Amplify and sequence NMV_0652 
0652R CCAAGAGAATGTCCATGCAA Amplify and sequence NMV_0652 
0658F GTCATTAGAATCCGCCCTGA Amplify and sequence NMV_0658 
0658R TCTGGCGGATAATGATTGGT Amplify and sequence NMV_0658 
0757F GCCTTTAGGCAACGAAACAT Amplify and sequence NMV_0757 
0757R GCAGGGTCATACCGTGTTTT Amplify and sequence NMV_0757 
1005F TCCCGTGTATGTCGTCTTGA Amplify and sequence NMV_1005 
1005R ATGCGGGTAAGTCGTGAAAG Amplify and sequence NMV_1005 
1019F CAAGTCTTCGATGCAGGTCA Amplify and sequence NMV_1019 
1019R TGATGAGGTGTTTGCCTTTG Amplify and sequence NMV_1019 
1093F AGGGAATACGCCTTCAGGAT Amplify and sequence NMV_1093 
1093R ATACCTTGAGCCAAGCAAGC Amplify and sequence NMV_1093 
1134F ATGGACGGCAAGAATTTGTC Amplify and sequence NMV_1134 
1134R GATTTCCAAAAGGCTGTCCA Amplify and sequence NMV_1134 
1850F GCAGTCCCTGATACCTGAGC Amplify and sequence NMV_1850 
1850R TACGTCGAAATCGGGGAATA Amplify and sequence NMV_1850 
2068F TTAAGCAAACAACCTGCAGAAA Amplify and sequence NMV_2068 
2068R CCCCATCAGCACTTCTTCAC Amplify and sequence NMV_2068 
2160F GGCATACGGACGGTAAATGT Amplify and sequence NMV_2160 
2160R CCATTTTCATTGGTTCCAACA Amplify and sequence NMV_2160 
2258F CCTGCGCAATACCATCTTTT Amplify and sequence NMV_2258 
2258R AAAAACTGCCGGGTATGGTT Amplify and sequence NMV_2258 
1094F GCAACTTCATCAGCGTGAAC Amplify and sequence NMV_1094 
1094R CAGGATTTTTGTCCTGTTCG Amplify and sequence NMV_1094 
1672F CTATCGGGCCGTATCGAAAT Amplify and sequence NMV_1672 
1672R CAAAAACAGCAGCACCAAAA Amplify and sequence NMV_1672 
1688F TACTGCATCCCAACACAGCA Amplify and sequence NMV_1688 
1688R AGTGTCTGGTGCATGTCTGC Amplify and sequence NMV_1688 
ISL AATCATTTGAAGGTTGGTACTATA Mini-transposon specific for colony PCR 
ISR CGCTCTTGAAGGGAACTATGTTGA Mini-transposon specific for colony PCR 
aatF CCTTAATTAAGGAGTAATTTTATGCGTATTCCG
CTGCTTGC 
Cloning aat into pGCC4 
aatR CCTTAATTAATCAAAGCCCCCTGCACGCCACT Cloning aat into pGCC4 
lacPext TTTACACTTTATGCTTCCGGCTCGTATGTT pGCC4 specific, sequencing 
lctPH CAAAGATGCCTGGACGATTT pGCC4 specific, sequencing 
up2068F CCGGTAATGACAAGCTGAGG Nm lacZ fusions NMV_2068 
up2068R AGTCACGACGTTGTAAAACGACGATGGCGGCG
GTGTTCAT 
Nm lacZ fusions NMV_2068 
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Name Sequence 5' to 3' Use 
down2068F CAGTTGGTCTGGTGTCAAAAATAAGGTTAA
TTAAGGCGGCGGCATAGATATTTTGA 
Nm lacZ fusions NMV_2068 
down2068R CAACGGCGGTCTGATTACC Nm lacZ fusions NMV_2068 
up2069F GACGAACAAGGCGCAGTT Nm lacZ fusions NMV_2069 
up2069R AGTCACGACGTTGTAAAACGACACGCGGTT
TCACGGTGTG 
Nm lacZ fusions NMV_2069 
down2069F CAGTTGGTCTGGTGTCAAAAATAAGGTTAA
TTAAGGTGCAAAAGAAGCAAAAAGCA 
Nm lacZ fusions NMV_2069 
down2069R TCAGTGGGCGGAGTTGTAA Nm lacZ fusions NMV_2069 
up2071F AACCCCATGCAAAACGAA Nm lacZ fusions NMV_2071 
up2071R AGTCACGACGTTGTAAAACGACATATTTGA
AGCGTGTCAT 
Nm lacZ fusions NMV_2071 
down2071F CAGTTGGTCTGGTGTCAAAAATAAGGTTAA
TTAAGGTTTCTGCGAAGCTATAGTGGA 
Nm lacZ fusions NMV_2071 
down2071R ATGTGCCGCTTGTGGTGTAT Nm lacZ fusions NMV_2071 
up1163F CGCTTCGGGCAACAGTAT Nm lacZ fusions NMV_1163 
up1163R AGTCACGACGTTGTAAAACGACCCCATTAT
GTTTTTCCAT 
Nm lacZ fusions NMV_1163 
down1163F CAGTTGGTCTGGTGTCAAAAATAAGGTTAA
TTAAGGGCTGAAATCGGAAATGCCGTCT 
Nm lacZ fusions NMV_1163 
down1163R GACGCAAGCGCAAATCTT Nm lacZ fusions NMV_1163 
up1164F CTCATAGCGCACATTTTCCA Nm lacZ fusions NMV_1164 
up1164R AGTCACGACGTTGTAAAACGACTTTTAATT
GTACGGCATCCAT 
Nm lacZ fusions NMV_1164 
down1164F CAGTTGGTCTGGTGTCAAAAATAAGGTTAA
TTAAGGTCCTGCTTTGCTGATTGTTTT 
Nm lacZ fusions NMV_1164 
down1164R CAAAGCCGTCAAGGGAAATA Nm lacZ fusions NMV_1164 
lacZF GTCGTTTTACAACGTCGTGACT Nm lacZ fusions to amplify lacZ 
lacZR CCTTAATTAACCTTATTTTTGACACCAGACC
AACTG 
Nm lacZ fusions to amplify lacZ 
lacZInt GGCCTCTTCGCTATTACGC Sequencing 
DMTSS1-T GACTCGAGTCGACATCGATTTTTTTTTTTTT
TTTT 
For DMTSS and 5' RACE 
DMTSS1-G GACTCGAGTCGACATCGAGGGGGGGGGGG
GGGGGG 
For DMTSS and 5' RACE 
DMTSS4-T GACTCGAGTCGACATCGATT For DMTSS and 5' RACE 
DMTSS4-G GACTCGAGTCGACATCGA For DMTSS and 5' RACE 
DM2068 GGTTGATGCACATTTCCAGA NMV_2068 gene specific primer 
1163gsp1 TCAAATCCTCCCACTCGAAG NMV_1163 gene specific primer 
1163gsp2 CAGCGTTTTGGTTGCATAA NMV_1163 gene specific primer 
1163gsp3 GCAAATTCCGAAGCTGGA NMV_1163 gene specific primer 
1164gsp1 CGTGCCGACATATTCTTCAA NMV_1164 gene specific primer 
1164gsp2 AGGCTGGGAAAGGAAAAGTC NMV_1164 gene specific primer 
1164gsp3 GACGGCGACAAATGATTTTA NMV_1164 gene specific primer 
2068HisF GGCATATGAACACCGCCGCCATCTA NMV_2068 into pET28b(+) 
2068HisNR GGCTCGAGTCAGCACTTCTTCACATCCGA NMV_2068 into pET28b(+) 
1164HisF GGCATATGGATGCCGTACAATTAAA NMV_1164 into pET28b(+) 
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Name Sequence 5' to 3' Use 
1164HisNR GCGGCCGCTCAGTTGTCCGAGACAACGG NMV_1164 into pET28b(+) 
Int1164F-Bio Biotin-TGTTTTTCCATAACCTTCCTCC Amplify EMSA 1164 region 1-Biotin 
Int1164F TGTTTTTCCATAACCTTCCTCC Amplify EMSA 1164 region 1 
Int1164R ACGGCATCCATATATCCCTC Amplify EMSA 1164 region 1 
1164EM2R AGTTTTCCGGATGATGGTTA Amplify EMSA 1164 region 2 
1164EM3F-Bio Biotin-CTGATACAATTTACAAACCACTTGAT Amplify EMSA 1164 region 3-Biotin 
1164EM4F-Bio CGTAACCCCATTTAAAGCCC Amplify EMSA 1164 region 4-Biotin 
1164EM4R TTAATCAAGTGGTTTGTAAATTGTATC Amplify EMSA 1164 region 4 
1164EM5R TGGTTTTATTGCCTGTTTGG Amplify EMSA 1164 region 5 
1164EM6F-Bio Biotin-ATAACCATCATCCGGAAAAC Amplify EMSA 1164 region 6-Biotin 
Int2068F GCGGTGTTCATGATTGGATA Amplify EMSA unspecific competitor  
Int2068R CGCGGTTTCACGGTGTGC Amplify EMSA unspecific competitor  
NG886 AGTTTTACGACATTACCGGCG gpdh for RT-PCR 
NG887 TCAAGATAGCCGTTCATGCCT gpdh for RT-PCR 
NMB1878F GCTATTTCAAAGCGCAAACC NMV_2068 for RT-PCR 
NMB1878R ATCCGTAATGCCGTCTGAAC NMV_2068 for RT-PCR 
2069RNAF AATTGAAGGCGCAGATTGAC NMV_2069 for RT-PCR 
2069RNAR AAATCCAATCGGGGTTTTTC NMV_2069 for RT-PCR 
NMB1881F AACTTTTGGGCGATTACGG NMV_2070 for RT-PCR 
NMB1881R TCGGACAACTCAATCAGCAC NMV_2070 for RT-PCR 
NMB1882F ACTACCAGCAGGCGAAAGAA NMV_2071 for RT-PCR 
NMB1882R TTCGGCTTTGAGTTTCCAGT NMV_2071 for RT-PCR 
mtrFF CTACTCAATGCCGACGGTTT mtrF for RT-PCR 
mtrFR GTGAGCAATAAGCGCATCAA mtrF for RT-PCR 
fetAF CCAACATCGTTACGCTTCAA fetA for RT-PCR 
fetAR AATAGGCGTTGTCCACCTTG fetA for RT-PCR !
2.3.2 Gel electrophoresis of DNA/RNA !
Agarose gel electrophoresis was used to resolve DNA and RNA. The percentage 
of agarose was chosen according to the size of the nucleic acid to be resolved. 
Agarose Ultra Pure (Invitrogen, USA) was dissolved in 1! TBE (89 mM Tris, 89 
mM boric acid, 2 mM EDTA) by heating in a microwave, followed by addition 
of SYBR Safe (Invitrogen) after slight cooling. Samples loaded on the gels were 
mixed with 1/6 volume of 6 ! DNA loading buffer (0.25% bromophenol blue, 
0.25% xylene cyanol FF, 30% glycerol in water). Electrophoresis was performed 
in a mini-gel electrophoresis tank, at 100 V for approximately 40 minutes, unless 
greater separation was required. An ultra-violet transilluminator was used to 
visualise DNA fragments which were photographed using a gel-documentation 
imager (BioDoc-It, Anachem, UK). !
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2.3.3 DNA purification !
Digested plasmids and PCR products used in this study were purified using 
NucleoSpin Extract II kit (Macherey-Nagel, Germany), either from solution or 
purification from agarose gels. The procedures were carried out as described in 
the manufacturer’s protocols. Purified DNA was stored at -20 °C. 
 
2.3.4 Restriction Endonuclease Digestion of DNA !
All restriction enzymes were manufactured by NEB. Timings, buffers and 
temperatures were used as recommended by the supplier. Digested products were 
visualised and purified as described previously. 
 
2.3.5 Ligations !
To ligate inserts and linearised plasmids, 30 fmoles of each were used in Ready-
To-Go T4 DNA ligase kit (Amersham Biosciences, UK) following 
manufacturer’s instructions. 
 
2.3.6 Cloning into commercial vectors !
All amplified constructs to be transformed into N. meningitidis were cloned 
using the pCR/GW/TOPO TA Cloning kit (Invitrogen) following the 
manufacturer’s instructions. Subsequently 2 µl of the reaction was used to 
transform competent E. coli DH5!. 
 
 The majority of genes for in vitro transposition mutagenesis were cloned into 
pCR8/GW/TOPO. However some were cloned into pSCA using the StrataClone 
PCR Cloning kit (Stratagene) following the manufacturer’s instructions. 
Subsequently 2 µl of the reaction was used to transform competent E. coli DH5!. 
 
2.3.7 Cloning into pGCC4 !
All fragments that were ligated into pGCC4 were first introduced into 
pCR8/GW/TOPO.  
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For inducible genes, both pGCC4 and the vector containing the gene to be cloned 
were digested with PacI. After digestion, pGGC4 was dephosphorylated with 
Rapid Alkaline Phosphatase (Invitrogen) according to manufacturer’s 
instructions and both the insert and pGGC4 were purified then ligated together. 
For transformation, E. coli DH5! were transformed with 2 µl of the ligation 
reaction.  
 
For reporter fusions, both pGCC4 and the lacZ reporter fusion construct vectors 
were digested to generate fragments with blunt ends. The lacZ reporter fusion 
constructs were restricted with PsiI, and the fragment purified by gel extraction. 
pGCC4 was digested with PmeI then dephosphorylated with rapid alkaline 
phosphatase (Invitrogen) according to manufacturer’s instructions, and purified. 
The resulting linearised pGCC4 and lacZ reporter fusion construct were ligated 
together and 2 µl of the ligation reaction was used to transform E. coli DH5!. 
 
2.3.8 Plasmid preparation !
Small-scale isolation of plasmid DNA was performed using the Nucleospin 
plasmid kit (Macherey-Nagel). Larger-scale preparations were performed using 
the Qiagen midi-prep kit (Qiagen, UK). All plasmid preparations were performed 
according to the manufacturer’s instructions, except mid-scale mini-preps, that 
were used to increase the plasmid DNA concentration for transformation into N. 
meningitidis. Then, a 10 ml bacterial suspension was used with 250 µl of A1, 
300 µl of A2 and 360 µl of A3 from the Nucleospin plasmid kit. 
 
2.3.9 DNA sequencing !
DNA was sequenced at either the Service de Sequence Institut Cochin/Inserm or 
the Genomics Laboratory, MRC, Clinical Sciences Centre, Imperial College. 
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2.4 Preparation and transformation of competent cells !
Chemically competent E. coli cells were prepared using the Inoue method (Inoue 
et al., 1990). A 250 ml flask of salt optimised broth (SOB, Difco) was inoculated 
with 10-12 colonies of E. coli DH5! and incubated at 18 °C shaking at 250 rpm 
until an OD600nm of 0.6-0.8 was reached. The culture was then incubated on ice 
for 10 minutes before centrifugation at 2500 xg for 10 minutes at 4 °C. The pellet 
was resuspended in 80 ml ice-cold Inoue transformation buffer (55 mM 
MnCl2.4H2O, 15 mM CaCl2.2H2O, 250 mM KCl and 0.5 mM PIPES) and 
centrifuged at 2500 xg for 10 minutes at 4 °C. The pellet was then resuspended in 
20 ml ice-cold Inoue transformation buffer, to which 1.5 ml dimethyl sulfoxide 
was added and incubated on ice for 10 minutes before being aliquoted into pre-
chilled tubes and flash-frozen. 
 
For transformation 200 µl of competent cells were thawed slowly on ice, DNA 
was added (!5 µl), and incubated on ice for 30 minutes. The cells were subjected 
to a heat shock at 42 °C for 30 seconds then returned to ice and 800 µl pre-
warmed SOB with 20 mM glucose was added. The cells were incubated at 37 °C 
for 1 hour, shaking at 200 rpm, and were then spread on to pre-warmed LB agar 
plates containing the relevant antibiotics and incubated overnight in a 37 °C 
incubator.  !
2.5 Construction of recombinant N. meningitidis strains !
2.5.1 Construction of transposon mutants !
Genes for mutation were amplified by PCR and ligated into either 
pCR8/GW/TOPO or pSCA as described above. The resulting plasmids were then 
subjected to in vitro transposon mutagenesis. 
 
2.5.1.1 In vitro transposon mutagenesis !
Transposition reactions were performed in a final volume of 20 µl with 100 
fmoles each of pYU29 (the donor plasmid), and the target plasmid, 2 µl Buffer 4 
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(NEB), 1 µl Himar1 mariner transposase (Pelicic et al., 2000) and completed 
with ddH2O. The reaction mix was incubated at 37 °C overnight, and then 2.5 µl 
of the transposition reaction was used to transform competent E. coli DH5!. 
 
2.5.1.2 Screening !
E. coli transformants were analysed using colony PCR with three primers: ISL 
and ISR, and a gene-specific forward primer. Suitable plasmids were purified 
and verified by restriction digestion and sequencing, and were then used to 
transform N. meningitidis. Constructed mutants in the meningococcus were 
confirmed by PCR analysis. 
 
2.5.2 Construction of lacZ translational reporter fusions !
Translational reporter fusions were constructed by overlap extension PCR before 
cloning into pCR8/GW/TOPO.  
 
2.5.2.1 Overlap extension PCR !
Three rounds of PCRs were required to construct the lacZ reporter fusions 
(Figure 5.5). In the first round of PCR, three amplifications were performed.  
 
The upF and upR primers amplify a fragment containing the first six codons of 
the gene, the promoter sequences and approximantly 500 bp of upsteam 
sequence. The upR primer contains sequences complementary to the lacZ gene 
beginning at the tenth codon of lacZ. The downF and downR primers amplify 
approximately 500 bp downstream of the gene, with the downR primer including 
a region complementary to eight codons at the end of the lacZ gene and a PacI 
restriction site. The lacZF and lacZR primers amplify the lacZ gene starting at its 
tenth codon, using pLKC480 as the template DNA. Once amplified, all PCR 
products were checked by agarose gel electrophoresis and purified. 
 
For the second round of PCR the fragment generated from amplification with 
upF and upR was amplified with the lacZ fragment, with primers upF and lacZR. 
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The resulting PCR product was checked by agarose gel electrophoresis, purified, 
and quantified.  
 
For the third round of PCR the downstream fragment was amplified with the 
upstream-lacZ fragment, with primers upF and downR. The resulting lacZ 
reporter fusion constructs were purified, cloned into pCR8/GW/TOPO, and used 
to transform competent E. coli DH5!. The plasmids were purified and verified 
by restriction digestion and sequencing. 
 
2.5.2.2 Testing LacZ production !
To confirm activity of the reporter fusion constructs, fusions were used to 
transform E. coli strain MC1060, which does not contain lacZ. Transformants 
were plated on to LB agar containing X-gal. 
 
2.5.2.3 Introduction of lacZ reporter fusions into N. meningitidis !
To introduce the lacZ gene reporter fusions into the native locus in the N. 
meningitidis genome, the pCR8/GW/TOPO cloned constructs were linearised at 
the PacI site, and the appropriate antibiotic resistance cassette was ligated into 
the vector. The resulting plasmids were linearised and used to transform N. 
meningitidis. To introduce reporter fusions into an ectopic locus, lacZ fusions 
were cloned into pGCC4 as previously described and used to transform 
competent E. coli DH5!. The resulting plasmids were purified, linearised and 
transformed into N. meningitidis. Integration by homologous recombination was 
verified by PCR. 
 
2.5.3 Transformation of N. meningitidis !
 N. meningitidis was grown overnight at 37 °C on GCB agar. A loop of bacteria 
was suspended in 1.5 ml GCB transformation buffer (GCB broth with 5 mM 
MgCl2), 200 µl of which was pipetted into the wells of a 24-well tissue culture 
plate. DNA was added to the well, a concentration of 1 µg/ml is saturating and 
no more than 20 µl should be added. Plates were incubated at 37 °C, with gentle 
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shaking for 30 minutes, then 1.8 ml of GCB transformation buffer was added to 
the wells and incubated at 37 °C, without shaking for 3 hours. Finally the 
mixture was spread on to GCB agar plates containing the appropriate antibiotics. 
For transformation with genomic DNA, 100 µl of the total transformation was 
spread on to plates; for linearised plasmids the entire transformation was spread 
on to plates. !
2.5.4 Genomic DNA extraction !
Genomic DNA extraction was performed using the Wizard Genomic DNA 
purification kit (Promega, USA). Bacteria were streaked onto GCB plates 
containing relevant antibiotics and incubated overnight at 37 °C. A loop of cells 
was resuspended in 600 µl Nuclei Lysis Solution and incubated at 80 °C for 5 
minutes; after returning the suspension to room temperature, 200 µl of Protein 
Precipitation Solution was added, vortexed vigorously, then incubated on ice for 
5 minutes. Samples were centrifuged at 15,000 xg for 10 minutes, the supernatant 
transferred to 1.5 ml tubes containing 600 µl isopropanol, mixed, and centrifuged 
at 15,000 xg for 2 minutes. DNA pellets were washed with 70% ethanol added, 
and left to air-dry then resuspended in 100 µl of DNA Rehydration Solution.   
 
2.6 Preparation of protein extracts !
For E. coli, protein extracts were prepared by centrifuging 1 ml of culture at 
13,000 xg for 3 minutes before removing the supernatant and resuspending the 
pellet in 10 µl of Laemmli buffer (Bio-rad) per 0.1 OD600nm of the culture. 
Samples were boiled for 5 minutes and stored at -20 °C. !
For N. meningitidis, a loop of bacteria harvested from plates was resuspended in 
500 µl of Protein Extraction Buffer (0.2 M Tris pH 8.0, 40 mM EDTA, 20% 
acetone, 0.1% Triton X-100). Alternatively, bacteria from liquid culture were 
centrifuged for 3 minutes at 13,000 xg and the pellet resuspended in Protein 
Extraction Buffer. Following resuspension, the mixture was incubated on ice for 
15 minutes. The protein concentration was quantified and standardised to 300 
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ng/µl in Laemmli buffer and boiled for 5 minutes. Samples were stored at -20 
°C. 
 
2.7 Analysis of protein samples !
2.7.1 Protein quantification !
Protein was quantified using the Bio-Rad Protein assay according to the 
manufacturer’s instructions. 
 
2.7.2 Sodium Dodecyl Sulphate Poly-Acrylamide Gel Electrophoresis (SDS-
PAGE) 
 
SDS-PAGE was carried out as described previously (Sambrook and Russell, 
2001). SDS-polyacrylamide gels were poured and run in the Mini-PROTEAN 
Tetra cell system (Bio-rad), as described in the manufacturer’s handbook. 
Samples were electrophoresed for 45-60 minutes at 200 V.  
 
2.7.3 Coomassie staining !
Gels were stained using Bio-Safe Coomassie (Bio-rad) as directed by the 
manufacturer. 
 
2.7.4 Immunoblotting !
Immunoblotting was carried out using the Mini-Trans-Blot electrophoretic 
transfer cell system (Bio-Rad). The transfer from SDS-PAGE to Hybond ECL 
nitrocellulose membrane (Amersham Biosciences) was carried out according to 
manufacturer’s instructions. Transfer was completed in cold transfer buffer (50 
mM Tris, 40 mM glycine, 0.037% SDS and 20% isopropanol). The membrane 
was incubated overnight at 4 °C in blocking solution (Tris buffered saline with 
0.1% Tween-20, pH 8.0 [TBS-T], with 5% skimmed milk powder). The primary 
antibody was Anti-C-myc developed in rabbit (Sigma), it was used at a 
concentration of 0.6 µg/ml in TBS-T. After incubation with the primary antibody 
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the membrane was washed several time with TBS-T. The secondary antibody 
was ECL anti-rabbit IgG Horseradish peroxidase linked whole antibody (GE 
Healthcare, UK), and after incubation the membrane was washed several times 
with TBS-T. Detection was carried out using ECL plus as described by the 
manufacturer (Amersham Biosciences). The signal was captured using 
Hyperfilm ECL (GE Healthcare) in an X-ray film cassette and developed in an 
automated developer (Agfa Curix). !
2.8 Phenotypic analyses !
2.8.1 Growth curves !
Growth curves were performed by resuspending bacteria grown overnight on 
GCB agar plates into 10 ml of pre-warmed MC4 media to a final OD600nm of 0.1. 
Cultures were grown for 10 hours at 37 °C with shaking at 170 rpm.  
 
2.8.2 Aggregation !
Aggregation was monitored by resuspending bacteria grown overnight on GCB 
agar plates containing the relevant antibiotics in 1 ml of pre-warmed RPMI-S 
(RPMI 1640 [PAA laboratories] supplemented with 10% FBS Gold [PAA 
laboratories]). Suspensions were adjusted to an OD600nm of 0.1 and added into the 
wells of a 24-well plate. The plates were then incubated for 3 hours at 37 °C in 
the presence of 5% CO2; aggregates were visualised by phase-contrast 
microscopy using a Nikon TS100F microscope at !40 magnification. A Sony 
HDR-CX11 high definition camcorder mounted on the microscope was used to 
record digital images. For the time-course experiments, plates were removed 
from the incubator at 60, 90, 120 and 180 minutes, and images recorded using 
the camcorder. 
 
2.8.3 Twitching motility !
Twitching motility was assessed as for aggregation, observing the movement of 
the bacteria within the aggregates at !40 magnification. 
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2.8.4 Adhesion 
 
The adhesion of N. meningitidis to Human Umbilical Vein Endothelial Cells 
(HUVECs) (Lonza) was quantified as previously (Helaine et al., 2005). 
HUVECs were grown in EGM-2 media (Lonza) at 37 °C, 5% CO2 and with high 
humidity. HUVECs were seeded into 24 well plates at a density of 105 cells per 
well and left to attach to the bottom of the wells overnight. The following day, 
the media was aspirated, the wells were washed, then 1 ml of RPMI-S was 
added, and the cells were incubated at 37 °C, 5% CO2 for 2 hours. In the 
meantime, bacteria grown overnight on GCB plates with the relevant antibiotics 
were gently resuspended in pre-warmed RPMI-S and adjusted to an OD600nm of 
0.01 (this is approximately 2!107 colony forming unts [CFU] per ml) and 
incubated for 2 hours at 37 °C, 5% CO2. A total of 1 ml of the bacterial 
suspension was added to the cells, and incubated for 30 minutes at 37 °C, 5% 
CO2. The input of the bacteria was measured by preparing serial dilutions of the 
inoculum in PBS, and spreading onto GCB agar plates. After 30 minutes, the 
cells were washed with fresh RPMI-S three times. The infection was then 
continued for 4 hours, with the media replaced every hour. At the end of this 
time, the cells were washed 3 times with RPMI-S, and detached using 500 µl of 
saponin (1% w/v) with incubation at 37 °C 10 minutes. The wells were scraped 
and the contents transferred to microfuge tubes. Suspensions of cell lysates were 
serially diluted in PBS, and 100 µl of the dilutions plated onto GCB agar plates 
and incubated overnight. Results were expressed as the number of CFU/ml 
recovered, normalised for an inoculum of 107 cells. The cells were observed 
using phase-contrast microscopy and images were recorded if necessary. For 
assays of early adhesion, the infection was terminated after 30 or 90 minutes. !
2.9 !-galactosidase assays !
N. meningitidis was grown at 37 °C in 10 ml of liquid media with shaking at 170 
rpm until mid-logarithmic stage was reached. Cultures were centrifuged at 
13,000 xg for 3 minutes, and the pellets resuspended in 1.5 ml of M63 (15 mM 
(NH4)2SO4, 100 mM KH2PO4, 9 µM FeSO4.7H2O, 3 µM Vitamin B1, pH 7.0) to 
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an OD600nm of between 0.2 and 0.6. To permeabilise the cells, 20 µl chloroform 
and 20 µl of 0.1 % SDS were added to the bacteria, and vortexed for 10 seconds 
before shaking at 37 °C for 40 minutes. Either 200 µl or 400 µl of the 
permeabilised bacteria was mixed with 800 µl or 600 µl of PM2 (70 mM 
Na2HPO4.12H2O, 30 mM NaH2PO4H2O, 1 mM MgSO4, 0.2 mM MnSO4) 
respectively, and incubated at 28 °C for 5 minutes. To start the assay, 200 µl of 
ONPG (2-Nitrophenyl !-D-galatopyranoside) at 40 mg/ml was added to the 
reaction, which was incubated at 28 °C. Reactions were terminated by the 
addition of 500 µl Na2CO3, either when the reaction mix turned a ‘straw yellow’ 
or after 2 hours. The OD at 420 nm and 550 nm were measured and Miller units 
calculated using the following formula (Miller, 1972): 
 
 
time = reaction time 
volume = volume in ml of cells added to reaction 
 
2.10 RNA isolation and reverse transcription !
N. meningitidis was grown in liquid culture to mid-logarithmic phase for RNA 
isolation. RNA was stabilised by the addition of RNAprotect Bacteria Reagent 
(Qiagen) according to manufacturer’s instructions and the mixture was 
centrifuged at 5000 xg for 10 minutes. The resulting pellet was resuspended in 
TE buffer (Ambion, USA). RNA was then isolated using the SV Total RNA 
Isolation System (Promega) following the manufacturer’s instructions. The 
samples were treated with DNase I (Amplification Grade, Invitrogen) according 
to manufacturer’s instructions. RNA was then purified by addition of 1 in 10 of 
the volume of 3 M Sodium acetate (Ambion), 1 in 50 of the volume 5 mg/ml 
Glycogen (Ambion) and 3 volumes of ice cold 100% ethanol. Samples were 
vortexed and RNA precipitated by incubation at -80 °C for 1 hour. RNA was 
pelleted by centrifugation at 10,000 xg for 30 minutes, and washed with ice-cold 
70% ethanol and then centrifuged at 10,000 xg for 5 minutes. The RNA pellet 
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was solubilised in nuclease free water (Ambion), then digested with DNase. The 
integrity and purity of the RNA was determined by agarose gel electrophoresis 
and by measuring the OD of the samples at 260 nm and 280 nm.  !
RNA was reverse transcribed using SuperScript III Reverse Transcriptase 
(Invitrogen). A 20 µl reaction was used to reverse transcribe 10 pg – 5 µg of 
RNA, with 1 µl 10 mM dNTP mix, 250 ng random primers (Invitrogen) and 
nuclease-free water. The mixture was heated to 65 °C for 5 minutes, then 
incubated on ice for at least one minute. Next, 4 µl 5! First strand buffer, 1 µl 
0.1 M DTT, 1 µl RNaseOUT Recombinant RNase Inhibitor (Invitrogen) and 1 µl 
SuperScript III Reverse transcriptase were added. The reaction was gently mixed 
and incubated at 25 °C for 5 minutes, then at 45 °C for 2 hours and finally at 70 
°C for 15 minutes. 
 
2.11 Real Time-PCR (RT-PCR) !
RT-PCR was performed using the QuantiFast SYBR Green PCR kit (Qiagen). 
For each 400 ng RNA sample, 3 reverse transcription reactions were performed 
with enzyme, and a control was included without reverse transcriptase. RT-PCRs 
was performed with 0.3 µM of each primer, 12.5 µl of the QuantiFast SYBR 
Green PCR Master Mix and 1 µl of cDNA. Reactions were reformed in a 
RotorGene 3000 (Corbett Research, USA) with an initial denaturing step of 95 
°C and then a two-step process repeated 40 times of 95 °C for 10 seconds and 60 
°C for 30 minutes. Comparative quantification was performed using the Rotor-
Gene 3000 Real-Time Analysis software. The software calculates the efficiency 
of amplification and take off point for each reaction. Melting curve analysis 
verified single product formation. No template controls and no reverse 
transcriptase controls were run. Primers amplifying the glyceraldehyde-3-
phosphate dehydrogenase (gdph) gene were used as controls. 
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2.12 Locating TSS !
RNA was isolated and reverse transcribed as previously described. The TSS for 
NMV_2068 was mapped by Directed Amplification of TSS (DMTSS) 
(Mendoza-Vargas et al., 2009) whilst Rapid Amplification of cDNA Ends (5’ 
RACE) was used to map the TSS of NMV_1163. 
 
2.12.1 DMTSS !
After reverse transcription of 1.5 µg of RNA, the cDNA was purified using the 
High Pure PCR clean-up kit (Roche) following maufacturer’s instructions and 
eluted in 50 µl of elution buffer. A homopolymeric nucleotide 5’ tail (either 
polyA or polyC) was then added to the cDNA using Terminal Transferase 
(NEB). In brief, 3 µl of 1!Terminal Transferase buffer, 3 µl 2.5 mM CoCl2, 3 µl 
2 mM dNTP (either dATP or dCTP), and 1 µl Terminal Transferase were added 
to the purified cDNA and incubated at 37 °C for 30 minutes followed by 70 °C 
for 10 minutes and finally placed on ice. The polynucleotide-tailed cDNA was 
mixed with 1 µl DMTSS1 primer (20 µM), 1 µl dNTPs (10 mM), 0.5 µl Taq 
DNA Polymerase, 5 µl Taq buffer, in a 50 µl reaction. Samples were then 
subjected to the following cycles: initial denaturation at 94 °C for 10 minutes; 30 
cycles of 1 minute at 94 °C, 2 minutes at 45 °C, 3 minutes at 72 °C; final 
extension of 10 minutes at 72 °C. Finally, a gene-specific PCR was performed 
using primers DM2068 and DMTSS4, using 0.2 µl AmpliTaq Gold (Applied 
Biosystems) and 1 µl of the amplified cDNA. Reactions were performed 
according to manufacturer’s instructions and subjected to the following cycles: 
initial denaturation of 10 minutes at 95 °C, 30 cycles of 30 seconds at 95 °C, 30 
seconds at 55 °C, 45 seconds at 72 °C; and a final extension of 10 minutes at 72 
°C. Products were analysed by agarose gel electrophoresis, purified and 
sequenced.  
 
When dATP was used for generating the polynucleotide tail, the primers 
DMTSS1-T and DMTSS4-T were used, whilst DMTSS1-G and DMTSS4-G 
were used if dCTP was incorporated at the ends of the products. 
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2.12.2 5' RACE !
For 5' RACE, 1.5 µg of RNA was reverse transcribed with gene specific primers. 
The resulting cDNA was purified, a homopolymeric tail added and amplified as 
for DMTSS. Gene specific PCRs were then performed using a second gene 
specific primer and DMTSS4 with 1 µl of linearly amplified cDNA as the 
template. The reactions were performed according to manufacturer’s instructions 
with Taq DNA polymerase. The product was included as the template for a 
further gene specific PCR with a third gene specific primer. The products were 
analysed by agarose gel electrophoresis, purified and sequenced. 
 
2.13 Protein purification !
2.13.1 Generation of Protein Expression Vectors !
The vector pET28b(+) (Invitrogen) was used for protein expression. Genes 
NMV_1164 and NMV_2068, were amplified with primers 1164HisF and 
1164HisNR, and 2068HisF and 2068HisNR respectively. The NMV_1164 
product, and pET28b(+) were digested with NdeI and NotI, and ligated together. 
While the NMV_2068 product, and pET28b(+) were digested with NdeI and 
XhoI, and ligated together. The resulting protein expression vectors were verified 
by sequencing. 
 
2.13.2 Protein expression !
The pET28b-1164 vector was used to transform E. coli BL21pLysS and pET28b-
2068 was used to transform E. coli BL21. For protein expression, 5 ml from an 
overnight culture were used to inoculate 500 ml of LB containing the relevant 
antibiotics. The cultures were grown at 37 °C, shaking at 200 rpm until an 
OD600nm of approximately 0.4 was reached. Then the cultures were transferred to 
25 °C for 20 minutes before protein expression was induced by the addition of 
Isopropyl-!-D-1-thiogalactopyranoside (IPTG) to a final concentration of 1 µM. 
Cultures were grown at 25 °C for a further 3 hours. The bacteria were pelleted by 
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centrifugation for 10 minutes at 10,000 xg, and the bacterial pellets stored at -20 
°C. 
 
2.13.3 Protein Purification !
For purification of NMV_1164, the bacterial pellet was resuspended in 30 ml 
ice-cold HEPES Buffer A (20 mM HEPES, pH 8.3, 15 mM imidazole, 3 mM !-
mercaptoethanol, 1M NaCl, 1% Glycerol), and lysed by French pressing twice at 
1500 p.s.i. The lysed cells were spun at 16,000 xg for 20 min at 4 °C, the 
supernatant containing the soluble fraction was filtered through a 0.4 µm pore 
filter, then applied to a 1 ml His-Trap column (GE Healthcare) equibriliated with 
4 ml HEPES Buffer A. To remove non-specifically bound protein, 10 ml of 
HEPES Buffer A was passed through the column, followed by 10 ml of HEPES 
Buffer A with 2% of HEPES Buffer B (20 mM HEPES, pH 8.3, 1 M imidazole, 
3 mM !-mercaptoethanol, 1M NaCl, 1% Glycerol), and again 10 ml of HEPES 
Buffer A. Proteins were eluted in 2 ml fractions, by an increasing gradient of 
imidazole (15 mM to 1 M) in HEPES Buffer A, over a volume of 40 ml. 
Fractions 7 to 11 were dialysed overnight into Storage Buffer (10 mM Tris-Cl, 
pH 8.0, 50 mM NaCl 50% Glycerol, 0.1 mM EDTA, 1 mM DTT). 
 
Purification of NMV_2068 was performed as directed in the QIAexpressionist 
handbook (Qiagen) for the purification of 6"His-tagged proteins from E. coli 
under denaturing conditions. Briefly, the bacterial pellet was resuspended in 
Buffer B (100 mM NaH2PO4, 10 mM Tris-Cl, 8 M urea, pH 8.0) and the mixture 
was stirred for 60 minutes. The bacteria lysed due to the high urea concentration. 
The resulting lysate was centrifuged at 10,000 xg for 30 minutes. The supernatant 
was then mixed with 50% Ni-NTA slurry and loaded on to a column. The 
mixture was washed with Buffers C and D (same composition as Buffer B, but 
with decreasing pH) and eluted in Buffer E (100 mM NaH2PO4, 10 mM Tris-Cl, 
8 M urea, pH 4.5). To renature the purified protein, the protein was dialysed 
against decreasing concentrations of urea in the presence of salmon sperm DNA: 
20 µl of the denatured protein with 230 µl of Buffer E with either 0.05% or 0.1% 
of salmon sperm DNA was injected into a Slide-A-lyzer Dialysis cassette 
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(Thermo Scientific, USA). The first dialysis was for 1 hour against Buffer B 
(100 mM NaH2PO4, 10 mM Tris-Cl, 8 M urea, pH 8.0) with 3M urea, this was 
repeated and then followed by a 1 hour dialysis against Buffer B without urea, 
followed by overnight dialysis against the same buffer. 
 
2.14 Electrophoretic Mobility Shift Assays (EMSA) 
 
DNA fragments for EMSA were amplified using primers with one primer 
biotinylated; the products were purified and quantified. DNA-protein binding 
reactions were performed in a final volume of 10 µl in binding buffer (2.5 mM 
HEPES pH 7.9, 5.0 mM NaCl, 0.25 mM MgCl2, 5 ng/ml BSA) at room 
temperature for 25 minutes. Samples were mixed with DNA loading dye and 
separated on a 10% native polyacrylamide gels (3.3 ml 30% acrylamide, 5.8 ml 
ddH2O, 1 ml 5!TBE, 70 µl 10% APS, 6 µl TEMED) which had been pre-run in 
0.5! TBE at 100 V for 1 hour. After loading the DNA-protein mixture the gels 
were run in 0.5! TBE, with the voltages and time of running altered depending 
on the size of the products. The DNA products were then transferred to Hybond-
N+ membranes (GE Healthcare), which had been pre-incubated in 0.5! TBE for 
10 minutes, using a Semi-dry apparatus at 10 V for 1 hour. DNA was then cross-
linked on the membranes using a UV Stratalinker 1800 (Stratagene), and 
biotinylated DNA was detected using the Nucleic Acid Detection Module from 
LightShift Chemiluinescent EMSA kit (Thermo scientific). The signal was 
captured using Hyperfilm ECL (GE Healthcare) in an X-ray film cassette and 
developed in an automated developer (Agfa Curix).  
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3 Identification and systematic mutagenesis of 
Neisseria meningitidis genes encoding proteins 
modulating transcription
! "#!
3.1 Introduction !
The aim of the work described in this chapter is to identify and mutate all the 
genes encoding transcriptional regulators in N. meningitidis strain 8013. This is 
feasible within the remit of this thesis due to the lower than expected number of 
transcriptional regulators the meningococcus encodes with respect to its genome 
size (Aravind et al., 2005). To do this, the manually annotated genome of N. 
meningitidis strain 8013 (Rusniok et al., 2009) was interrogated using the 
NeMeSys database and MaGe bioinformatic tool (Vallenet et al., 2006). This 
resulted in the identification 28 putative HTH one-component transcriptional 
regulators and four complete TCS. Additionally, seven other genes were 
identified because homologues in other species are involved in transcriptional 
regulation. Genome-wide mutagenesis had already been completed in strain 
8013, utilising in vitro transposon mutagenesis (Geoffroy et al., 2003), thus 47% 
(20 of 43) of the selected genes had already been inactivated. The same in vitro 
transposon mutagenesis technique could be used for targeted mutagenesis 
(Pelicic et al., 2000), although it was not deemed sufficiently efficient for the 
larger-scale targeted mutagenesis required in this study. Consequently, work was 
undertaken to improve the transposon mutagenesis tool (Rusniok et al., 2009), 
which was then validated in this study. Attempts were then made to mutate the 
remaining 53% of the target genes with the improved in vitro transposon 
mutagenesis approach. 
 
3.2 Identification of all the genes encoding transcriptional 
regulators and other regulatory proteins !
Identification of all regulatory genes to be considered for mutagenesis was 
performed by examining the annotated genome of N. meningitidis strain 8013. 
Our group sequenced the genome of strain 8013 and the resulting data are hosted 
by MicroScope, a powerful platform for microbial genome annotation (Rusniok 
et al., 2009, Vallenet et al., 2006). MicroScope provides tools for fast and 
accurate analysis of the sequence, with gene products being subjected to 
exhaustive analysis through numerous embedded software tools and 
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bioinformatic methods. The resulting annotated genome of strain 8013 has led to 
the creation of a biological resource named NeMeSys (Rusniok et al., 2009). 
NeMeSys is stored in the thematic database NeisseriaScope within MicroScope, 
which is publically accessible using the graphical web interface MaGe, that 
allows for easy data visualisation and exploration (Vallenet et al., 2006). This 
platform also incorporates examination of synteny, allowing comparison of the 
physical localisation of genetic loci within all bacterial genomes available in the 
Prokaryotic Genome Database (PkDGB), which contains more than 400 
microbial genomes. Included are: four N. meningitidis clinical isolates MC58 
(serogroup B), Z2491 (serogroup A), FAM18 (serogroup C) and 053442 
(serogroup C) (Bentley et al., 2007, Parkhill et al., 2000, Peng et al., 2008, 
Tettelin et al., 2000); one unencapsulated N. meningitidis carrier isolate, strain 
!14 (Schoen et al., 2008); two N. gonorrhoeae clinical isolates; strains FA1090 
and NCCP11945 (Chung et al., 2008) and one isolate of the commensal species 
N. lactamica (serotype-640). By utilising the keyword search facility in the 
NeMeSys toolbox to recover the genes annotated with terms such as HTH and 
two-component, 44 genes were identified with potential roles in transcription 
regulation, representing 2.1% of the genome. !
3.2.1 One-component transcriptional regulators !
As transcriptional regulators containing the HTH DNA-binding motif are the 
most common proteins modulating transcription in prokaryotes, searches for this 
motif in the genome of strain 8013 were conducted initially. Additional searches 
with other appropriate keywords, such as activator and transcriptional regulator, 
were completed and identified three transcriptional regulators which contain the 
HTH motif, but were not annotated as such. Of the 2126 protein encoding genes 
in strain 8013 (Rusniok et al., 2009), there are 30 one-component regulators 
containing HTH motifs (Table 3.1). The gene annotation also indicated the HTH 
families of the regulators (Table 3.1). However, NMV_0859/0860 and 
NMV_1312 are truncated, thus 28 genes encoding HTH one-component 
transcriptional regulators were selected for mutagenesis. 
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Table 3.1 One-component transcriptional regulators present in N. meningitidis strain 8013 
Gene Family Protein Comment                                                    
NMV_0789 MtrA Characterised in N. gonorrhoeae (Rouquette et al., 1999) 
NMV_0859/0860 - Truncated. 
NMV_2068 - Absent in non-pathogenic strains. 
NMV_2160 
AraC 
- - 
NMV_0433 ArsR - - 
NMV_0733 Lrp Protein deduced from homology studies 
NMV_1850 AsnC/Lrp AsnC Characterised in N. meningitidis (Ren et al., 2007) 
NMV_0839 DeoR - - 
NMV_0418 FNR/Crp FNR Characterised in pathogenic Neisseria species (Bartolini et al., 2006, Overton et al., 2006, Whitehead et al., 2007) 
NMV_0223 Fur Characterised in pathogenic Neisseria species (Delany et al., 2006, Delany et al., 2003, Delany et al., 2004) 
(Ducey et al., 2005, Jackson et al., 2010) 
NMV_1134 
Fur 
PerR Characterised in N. gonorrhoeae (Seib et al., 2006, Wu et al., 2006) 
NMV_0658 - - 
NMV_0837 GntR - - 
NMV_0757 - Absent from N. meningitidis MC58, FAM18, Z2491 and N. gonorrhoeae 
NMV_1222 - - 
NMV_1868 
Lambda  
repressor like 
- - 
NMV_1312 LexA - Truncated 
NMV_0188 OxyR Characterised in N. gonorrhoeae (Seib et al., 2007, Tseng et al., 2003) 
NMV_0323 - - 
NMV_0419 - - 
NMV_1164 - Absent in non-pathogenic strains. 
NMV_2045 CrgA Characterised in N. meningitidis (Deghmane et al., 2002, Deghmane et al., 2004, Deghmane et al., 2000) 
NMV_2258 
LysR 
- - 
NMV_2033 MarR FarR Characterised in pathogenic Neisseria species  (Lee et al., 2003, Schielke et al., 2009) 
NMV_1093 MerR NmlR Characterised in N. gonorrhoeae (Kidd et al., 2005) 
NMV_1005 RpiR/YebK/YfhH HexR Protein deduced from homology studies 
NMV_0480 NsrR Characterised in pathogenic Neisseria species  (Heurlier et al., 2008, Isabella et al., 2009, Overton et al., 
2006, Rock et al., 2007)  
NMV_1019 
Rrf2 
IscR Protein deduced from homology studies 
NMV_0652 MtrR Characterised in N. gonorrhoeae (Folster et al., 2007, Folster and Shafer, 2005, Warner et al., 2007) 
NMV_1586 TetR - - 
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3.2.2 TCS !
Searches revealed the presence of four pairs of complete TCS and one pair with 
a truncated response regulator, NMV_1938, but a complete cognate sensor 
NMV_1937 (see Table 3.2). Although rare, it is possible for a TCS sensor to 
interact with a response regulator from another TCS (Laub and Goulian, 2007), 
hence the sensor was also included in this study. 
 
Table 3.2 TCS in N. meningitidis strain 8013 
Gene Sensor Regulator Protein Comment 
NMV_0125 !  NtrY 
NMV_0126  ! NtrX 
Identified in signature tagged 
mutagenesis in Nm (Sun et al., 
2000) 
NMV_0773  !  
NMV_0774 !   
Characterised in Nm (Jamet et al., 
2010) and Ng (Carrick et al., 2000) 
(termed PilR/S) 
NMV_1178  ! NarP 
NMV_1179 !  NarQ 
Characterised in Ng (Overton et al., 
2006, Whitehead et al., 2007) and 
Nm (Rock et al., 2007) 
NMV_1818  ! MisR/PhoP 
NMV_1819 !  MisS/PhoQ 
Characterised in Nm (Jamet et al., 
2009, Johnson et al., 2001, 
Newcombe et al., 2005, Tzeng et al., 
2004, Tzeng et al., 2008, Tzeng et 
al., 2006) 
NMV_1937 !   Absent from non-pathogenic strains 
NMV_1938  !  Truncated in all Nm, absent from Ng 
* Nm for N. meningitidis and Ng for N. gonorrhoeae 
 
3.2.3 Other proteins potentially affecting transcription !
In addition to the one-component transcriptional regulators and TCS, another 
eight genes were selected in the present study for their known roles in 
transcriptional regulation in other species (Table 3.3). These include ! factors, 
which are a key part of the RNAP machinery, critical for bacterial promoter 
selection. N. meningitidis strain 8013 encodes only three putative ! factors i) 
!32/RpoH (NMV_1688), ii) ECF (extracytoplasmic function) family ! factor 
(NMV_2359), and iii) !70/RpoD (NMV_0851) the major ! factor that is likely 
to be essential (Laskos et al., 2004). Thus only two require mutating. There is 
also a remnant of !54 (RpoN) that is truncated and non-functional (Laskos et al., 
1998). 
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The genes NMV_0628 and NMV_0715 which are predicted to encode RelA and 
SpoT respectively, were also selected for mutagenesis. RelA and SpoT are 
responsible for ppGpp metabolism. When amino acid availability is restricted 
ppGpp accumulates and is able to bind to RNAP and alter its activity, thus 
changing the transcriptional profile (Barker et al., 2001a, Barker et al., 2001b). 
Genes NMV_1672 and NMV_1094, which encode the two subunits of IHF, 
were also selected for mutagenesis. IHF is able to alter gene regulation by 
binding to regulatory DNA regions and bending the DNA, thus altering the DNA 
binding affinities of components of transcription. 
 
Table 3.3 Other genes that might modulate transcription in N. meningitidis 
strain 8013 
Gene Protein Comment 
NMV_0628 RelA 
NMV_0715 SpoT Characterised in Ng (Fisher et al., 2005) 
NMV_1094 IhfB 
NMV_1672 IhfA 
Characterised in both Nm and Ng (Buisine et al., 2002, Hill et 
al., 1997, Hill et al., 2002, Lee et al., 2006) 
NMV_0237 RpoN RNA polymerase !54 factor. Truncated (Laskos et al., 1998) 
NMV_0851 RpoD RNA polymerase !70 factor 
NMV_1688 RpoH RNA polymerase !32 factor. Characterised in Ng (Du and 
Arvidson, 2006, Gunesekere et al., 2006) 
NMV_2359 ECF ECF-family RNA polymerase ! factor 
* Nm for N. meningitidis and Ng for N. gonorrhoeae 
 
3.3 Systematic mutagenesis !
3.3.1 Improving the in vitro mutagenesis tool !
An in vitro transposon mutagenesis tool has been established in N. meningitidis 
by our group (Pelicic et al., 2000), which utilises the natural competence and 
efficiency of homologous recombination of the species. A transposon donor 
plasmid, pSM1, was constructed containing a mini-transposon consisting of 
Himar 1 mariner inverted repeats flanking a kanamycin resistance cassette; this 
plasmid is incubated with the target DNA in the presence of purified transposase 
and then the mixture was used to transform N. meningitidis. The in vitro 
transposon mutagenesis tool has already been used for both genome-wide 
(Geoffroy et al., 2003) and targeted mutagenesis (Carbonnelle et al., 2005). For 
the genome-wide mutagenesis the target was chromosomal DNA, while for 
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targeted mutagenesis the target DNA consisted of the gene amplified by PCR. 
To construct a library of mutants containing transposon insertions in all of the 
above genes, a targeted mutagenesis approach is needed. With the existing in 
vitro transposon mutagenesis tool, the genes are amplified by PCR, cloned into a 
commercial cloning vector, subjected to in vitro transposition and used to 
directly transform N. meningitidis. However, the efficiency of this method was 
too variable for high-throughput use. Typically, between zero and 10 kanamycin 
resistant N. meningitidis colonies were obtained per single mutagenesis reaction 
(Pelicic et al., 2000, Rusniok et al., 2009). Thus using this technique to attempt 
to mutate 43 genes by targeted mutagenesis would be time-consuming and waste 
resources. 
 
The rationale to improve the approach was to isolate mutated target plasmids in 
E. coli before transformation of N. meningitidis. This was not achievable 
previously, as it was impossible to distinguish between the transposon donor 
plasmid, pSM1, and mutated target plasmids, as both are able to replicate in E. 
coli. Consequently pSM1, which contains a ColE1 origin of replication, was 
engineered so that it was unable to replicate in E. coli DH5!. The mini-
transposon was excised from pSM1 by digestion with EcoRI and XbaI, and 
ligated into the vector pGP704, restricted by the same enzymes. The resulting 
plasmid, pYU29, has a R6K origin of replication, and can only replicate if the 
Pir protein is present in the host bacteria (Miller and Mekalanos, 1988). Most E. 
coli strains, including DH5!, do not encode Pir. Thus, when the transposition 
mix is used to transform E. coli DH5!, pYU29 is a suicide vector that is unable 
to replicate. However, the mutated target plasmid will be able to replicate, 
allowing for selection of cells containing the target plasmid with the mini-
transposon inserted (Rusniok et al., 2009).  
 
3.3.2 Testing the mutagenesis tool !
To test the efficiency of the improved in vitro transposition mutagenesis tool, 
two different target plasmids were used. The genes NMV_0323 and NMV_2258 
were amplified along with approximately 500 bp of flanking DNA either side of 
the gene to facilitate homologous recombination. The resulting PCR fragments 
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were cloned into pCR/8/GW/TOPO, to produce the target plasmids p0323 and 
p2258, respectively. For in vitro transposition, the reaction was performed in a 
final volume of 20 µl; 100 fmoles of the target plasmid and pYU29 were mixed 
with 1 µl of purified transposase. The reaction was performed in duplicate, with 
negative controls lacking transposase. Following transposition, 2.5 µl of the 20 
µl reaction was used to transform E. coli DH5!, which was then plated on to LB 
agar plates containing Kan and Spec. The resultant bacterial colonies were 
counted (Table 3.4).  
 
As expected, no colonies were present on the negative control plates. For the in 
vitro transposition of p0323 an average of 49 colonies were present following 
transformation with 2.5 µl of the 20 µl transposition reaction, giving an average 
of 388 colonies per transposition reaction. The number of colonies was greater 
for in vitro transposition of p2258, yielding an average of 1012 transformants 
per transposition reaction.  
 
Table 3.4 Analysis of in vitro transposition mutagenesis 
Target plasmid: p0323 p2258 
Reaction: A B A B 
Number of transformants from 
2.5 µl of 20 µl transposition 53 44 132 121 
Reactions were performed in duplicate, represented by A and B. 
 
To confirm that the transformants were recombinants in which the mini-
transposon had inserted into the target plasmid and, preferably, within the gene 
insert, plasmid DNA was prepared from 10 transformants from each plate and 
analysed by restriction with EcoRI. This enzyme cleaves pCR/8/GW/TOPO 
twice at sites flanking any insertion and does not cleave within the 1.6 kilo base 
pair (kb) mini-transposon or gene inserts. This allows the location of the mini-
transposon to be readily ascertained. An example of the restriction analysis is 
shown in Figure 3.1 for 10 transformants of transposition reaction A of p0323. 
When cut by EcoRI the target plasmid, p0323, consists of a 1.2 kb (NMV_0323 
gene insert) and a 2.8 kb (vector backbone) fragment. For three of the 
transformants, the mini-transposon has clearly transposed in NMV_0323 insert, 
causing a 1.6 kb increase in length to the gene insert to give two bands of 2.8 kb 
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(see Figure 3.1A, lanes 1, 4 and 5). In four of the transformants, the mini-
transposon has inserted into the vector backbone, resulting in bands of 1.2 kb 
and 4.4 kb (see lanes 2, 7, 8 and 10). Lanes 3, 6 and 9 show plasmids with an 
unexpected pattern of banding, at approximately 1.2 kb, 2.8 kb and 4.4 kb, 
suggesting that multiple plasmids may be present in the bacteria. To establish if 
co-transformation had indeed taken place, the plasmids were digested with XbaI 
which cleaves p0323 once (Figure 3.1B). For transformants 3, 6 and 9, co-
transformation has occurred as two bands are present of approximately 4 kb and 
5.6 kb, indicating the presence of the original target plasmid, p0323, and the 
target plasmid with the mini-transposon inserted.  
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Figure 3.1 Analysis of 10 transformants after transposition on p0323 
Plasmids were digested with EcoRI (A) and XbaI (B). Lane number corresponds 
to the transformant number. A Lanes 1, 4 and 5 show plasmids with the mini-
transposon in the NMV_0323 insert of p0323, as there is no fragment at 1.2 kb 
and two indistinguishable bands are present at 2.8 kb. Lanes 2, 7, 8 and 10 show 
transformants with the mini-transposon present in p0323, but not within the 
0323 insert as a band is present at 1.2 kb, the mini-transposon has transposed in 
the vector backbone giving a band of 4.4 kb. Lanes 3, 6 and 9 show plasmids 
yielding bands of 1.2 kb, 2.8 kb and 4.4 kb, suggesting the presence of multiple 
plasmids. The negative control (-ve) is EcoRI digestion of p0323 B XbaI digests 
p0323 once and has no sites in the mini-transposon or gene inserts. For 
transformants 3, 6 and 9 bands are present at 4 kb and 5.6 kb, indicating the 
presence of both p0323 and p0323 with a mini-transposon inserted. 
Transformants 1 and 2 were digested as controls. The negative control is XbaI 
digestion of p0323.  
 
A summary of the analysis of mini-transposon location in the transformants is 
shown in Table 3.5. Where the location of the mini-transposon is indicated as 
unknown, the bands produced from EcoRI digestion are the same as for EcoRI 
digestion of the target plasmid. In these cases it is assumed that co-
transformation has taken place, with the mutated target plasmid containing a 
mini-transposon in such low numbers that it is not visible on the gel. This was 
verified for a few transformants, by diluting the plasmid preperation and using 
them for transformation. Upon analysis of the resultant transformants, the target 
plasmid containing the mini-transposon could be found in a proportion of 
transformants (data not shown). 
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Table 3.5 Analysis of 10 transformants 
p0323 p2258 Target plasmid: 
Reaction: A B A B 
Location of transposon      
In the gene insert 3 1 1 2 
In the vector backbone 7 6 8 6 
Unknown 0 3 1 2 
Expected % of transformants with 
transposon in the gene insert 30% 38% 
Observed % of transformants with 
transposon in gene insert 20% 15% 
 
 
The mini-transposon is known to insert most frequently at TA dinucleotides 
(Pelicic et al., 2000). By comparing the number of TA dinucleotide sites in the 
vector backbone and gene insert, it can be predicted how often the transposon 
might insert in those regions. The expected and observed insertion frequencies 
are shown in Table 3.5. Although the observed frequency is lower than the 
expected, 15-20% of all transformants harboured the mini-transposon in the gene 
insert. 
 
Therefore evaluation of the improved in vitro transposition mutagenesis tool 
using two different target plasmids demonstrated that by analysing just 10 
transformants, at least one had the transposon located in the gene region. 
Considering that the number of transformants obtained from a 20 µl 
transposition reaction produces in the range of 700 transformants, this is an 
efficient technique suitable for large-scale targeted mutagenesis. 
 
3.3.3 Systematic mutagenesis !
All genes selected for mutagenesis were amplified by PCR along with 
approximately 500 bp of flanking DNA, to allow homologous recombination in 
the meningococcal genome. All PCR products were examined for their size and 
purity by agarose gel electrophoresis and if necessary, purified by gel extraction. 
To construct the target plasmids, the resulting fragments were cloned into 
commercially available vectors. Five genes were cloned into pSCA, while the 
remaining genes were cloned into pCR/8/GW/TOPO (Table 3.7). Plasmid DNA 
was prepared for the target plasmids and subjected to in vitro transposition 
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mutagenesis as above. Of the 20 µl transposition reaction, 2.5 µl was used to 
transform E. coli DH5! and colonies were selected on plates containing Kan, for 
the cassette in the mini-transposon, and either Spec or Amp, depending on which 
plasmid vector had been used. Transformants containing mutated target plasmids 
suitable for N. meningitidis mutagenesis, i.e. with the mini-transposon located 
near the centre of the gene insert, were selected by colony PCR. Briefly, a mix 
of three primers were used, two primers, ISL and ISR, specific for the mini-
transposon which anneal facing out of the transposon and the forward 5' primer 
used to amplify the gene insert, thus allowing an approximate determination of 
location of the mini-transposon within the gene.  
 
Appropriate mutated target plasmids were prepared and sequenced to determine 
the exact site of mini-transposon insertion. Suitable plasmids, with the mini-
transposon inserted in the target gene, were used to transform N. meningitidis 
and subjected to Kan selection. Finally, chromosomal DNA from transformants 
was extracted and analysed by PCR to confirm successful mutagenesis. Genomic 
DNA from the parental strain was amplified alongside DNA from the 
transformants and a 1.6 kb increase in size in the product from the transformant 
DNA compared to the WT product indicated the presence of the mini-transposon 
and successful construction of a mutant.  
 
3.3.3.1 Mutants from existing library !
The bioinformatic approach identified 48 genes predicted to encode proteins 
with roles in transcription regulation. Of these, four do not require mutagenesis 
as they are truncated, NMV_0859/0860, NMV_1312, NMV_1938 and rpoN 
(NMV_0237), and it was decided not to attempt to mutate rpoD (NMV_0851) 
which encodes "70 as it is likely to be essential. Hence, 43 genes were selected 
for mutagenesis. The results from the genome-wide transposon mutagenesis of 
strain 8013 (Geoffroy et al., 2003) have already been incorporated into the 
NeMeSys database (Rusniok et al., 2009). Searches of the database indicated 
that 20 of the selected genes have been mutated, leaving 23 requiring 
mutagenesis to construct a comprehensive library of mutants in genes likely to 
modulate transcription in the meningococcus (Table 3.6). 
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Table 3.6 Analysis of existing mutant library 
Gene Mutant present in 
existing library 
Nucleotide number of transposon 
insertion (length of gene) 
NMV_0789 ! 120 (906) 
NMV_2068 - - 
NMV_2160 - - 
NMV_0433 - - 
NMV_0733 ! 377 (465) 
NMV_1850 - - 
NMV_0839 ! 420 (774) 
NMV_0418 ! 472 (735) 
NMV_0223 - - 
NMV_1134 - - 
NMV_0658 - - 
NMV_0837 ! 508 (717) 
NMV_0757 - - 
NMV_1222 ! 76 (321) 
NMV_1868 ! 169 (687) 
NMV_0188 ! 597 (921) 
NMV_0323 - - 
NMV_0419 - - 
NMV_1164 ! 168 (915) 
NMV_2045 ! 394 (900) 
NMV_2258 - - 
NMV_2033 ! 27 (441) 
NMV_1093 - - 
NMV_1005 - - 
NMV_0480 ! 46 (444) 
NMV_1019 - - 
NMV_0652 - - 
NMV_1586 ! 262 (651) 
NMV_0125 - - 
NMV_0126 - - 
NMV_0773 - - 
NMV_0774 - - 
NMV_1178 ! 305 (657) 
NMV_1179 ! 533 (1773) 
NMV_1818 - - 
NMV_1819 ! 526 (1407) 
NMV_1937 ! 396 (1251) 
NMV_0628 ! 1640 (2214) 
NMV_0715 ! 1458 (2517) 
NMV_1094 - - 
NMV_1672 - - 
NMV_1688 - - 
NMV_2359 ! 435 (588) 
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3.3.3.2 Mutants constructed in this study !
Suitable mutated target plasmids were isolated for 21 of the 23 genes selected for 
mutagenesis. For some genes multiple plasmids were isolated (Table 3.7). On 
average 27 colonies were screened to identify one suitable mutated target plasmid. 
In all cases except p0433, only one in vitro transposition reaction was required. 
Initially not all of the transformation reactions were plated out. If a suitable plasmid 
was not identified initially, more transformants were analysed, or if necessary, as for 
NMV_0658, another transformation was performed. 
 
No suitable mutated target plasmid could be obtained for p0757, most likely due to 
the small size of NMV_0757 (357 bp). However, analysis of the sequence of this 
gene revealed that it had a suitable PstI restriction site located near the centre of the 
gene, into which the Kan resistance cassette present in the mini-transposon was 
ligated.  
 
All suitable mutated target plasmids were isolated, sequenced and used to transform 
N. meningitidis. Transformation was successful for 18 of the 22 recombinant 
plasmids. For the majority of transformation reactions there were at least 50 N. 
meningitidis transformants, although in a few cases less than five transformants 
were obtained.  
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Table 3.7 Summary of systematic mutagenesis 
Gene 
Number 
of 
colonies 
analysed 
Number of 
suitable 
mutated 
target 
plasmids 
constructed 
Mutant 
obtained in N. 
meningitidis 
Nucleotide number of 
transposon insertion 
(length of gene) 
NMV_2068 42 1 ! 317 (957) 
NMV_2160 30 2 ! 175 (918) 
NMV_0433 178 1 ! 280 (282) 
NMV_1850 70 2 ! 41 (483) 
NMV_0223 43 1 - - 
NMV_1134 57 2 ! 121 (477) 
NMV_0658 66 2 ! 554 (780) 
NMV_0757 196 - ! 84 (354) 
NMV_0323 34 2 ! 369 (912) 
NMV_0419 58 2 !  589 (951) 
NMV_2258 18 2 ! 372 (930) 
NMV_1093 38 2 ! 133 (408) 
NMV_1005 38 2 ! 175 (849) 
NMV_1019 38 2 ! 122 (447) 
NMV_0652 32 1 ! 264 (633) 
NMV_0125 36 2 ! 1087 (2121) 
NMV_0126 52 2 ! 625 (1278) 
NMV_0773 30 1 ! 324 (468) 
NMV_0774 30 4 ! 457 (1179) 
NMV_1818 30 4 - - 
NMV_1094 60 1 - - 
NMV_1672 - - - - 
NMV_1688 60 1 - - 
 
3.3.3.3 Mutants not obtained !
Of the 23 genes to be mutagenised, 18 were successfully mutated, leaving five 
mutants which could not be obtained (Table 3.7). Gene NMV_0223 encoding Fur, 
NMV_1818 encoding MisR, NMV_1094 and NMV_1672 encoding IHF subunits ! 
and " respectively, and NMV_1688 encoding RpoH were not disrupted. 
 
Gene NMV_1672, encoding IHF-", was found to be refractory to cloning in E. coli, 
and a target plasmid could not be constructed. Troubleshooting steps as directed by 
the pCR8/GW/TOPO cloning kit were followed but without success. As previously 
described (Pelicic et al., 2000, Rusniok et al., 2009), in vitro transposition was 
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attempted directly on to the NMV_1672 PCR product, followed by treatment with 
DNA polymerase and DNA ligase to repair single stranded breaks. The 
transposition mix was used to transform the meningococcus, but this did not yield 
any transformants.  
 
The four other genes that could not be mutagenised did not yield any transformants 
in N. meningitidis although mutated target plasmids were obtained. It should be 
noted that transformation was attempted at least three times. It is not unexpected 
that mutants were not obtained for the subunits of IHF and RpoH, as they are likely 
to be essential. For NMV_1818, four different mutated target plasmids suitable for 
mutagenesis were obtained and transformation was attempted with each of them.  
 
Surprisingly, other groups have successfully constructed meningococcal mutants of 
genes NMV_1818 and NMV_0223, which encode MisR and Fur, respectively. 
Mutants of misR have been constructed in a variety of serogroup B and serogroup C 
strains and but not in N. meningitidis strain 8013 (Johnson et al., 2001, Newcombe 
et al., 2004, Newcombe et al., 2005, Tzeng et al., 2004, Tzeng et al., 2008, Tzeng et 
al., 2006). We were able to obtain genomic DNA from a serogroup C NMV_1818 
mutant from Professor McFadden (Johnson et al., 2001). However attempts to 
introduce this mutation into N. meningitidis strain 8013 by direct transformation of 
the genomic DNA were not successful. Therefore it remains possible that MisR is 
essential in strain 8013.  
 
Until 2003, attempts to mutate fur in the meningococcous by allelic exchange were 
unsuccessful (Thomas and Sparling, 1994, Delany et al., 2003). It was suggested 
that this might be due to polar effects on the gene downstream of fur, NMV_0224 
which encodes a homologue of leucyl/phenylalanyl-tRNA-protein transferase, Aat 
(Shrader et al., 1993) and is likely to be essential in N. meningitidis. To circumvent 
this potential problem, Delany et al., succeeded in constructing a fur mutant in N. 
meningitidis strain MC58 by orientating the Kan resistance cassette used to disrupt 
the gene so that it could direct expression of the downstream gene. To check if polar 
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effects might explain the failure to obtain a fur mutant, aat was cloned under the 
control of an IPTG-inducible promoter and introduced into N. meningitidis in trans. 
To do this, aat was cloned into the vector pGCC4 (Mehr and Seifert, 1998). This 
vector contains a DNA fragment corresponding to an intragenic region of the 
gonococcal chromosome which is present in the meningococcus. There is a unique 
PacI site in this region which allows placement of a gene under the IPTG-inducible 
lacP promoter, that works in both E. coli and N. meningitidis. The aat gene was first 
amplified using primers to introduce PacI sites and subcloned into 
pCR8/GW/TOPO. The resulting plasmid was then PacI digested and ligated into 
pGCC4. Expression of aat induced by IPTG was confirmed in E. coli. Induced 
whole cell lysates were subjected to SDS-PAGE and Coomassie staining, and a 
band at the appropriate molecular mass was present in induced cultures (data not 
shown). The plasmid was introduced into the meningococcus by homologous 
recombination, resulting in the strain Indaat in which aat expression could be 
induced by IPTG. Attempts were made to mutate fur in this strain by introducing the 
mutated fur target plasmid in the presence of IPTG. However, no transformants 
were obtained. Therefore, it is likely that fur is essential in strain 8013. Although 
IPTG-mediated expression of aat in the meningococcal strain Indaat could not be 
confirmed.  
 
3.4 Summary !
In conclusion, the systematic mutagenesis produced suitable recombinant plasmids 
for 95% of the target genes, of which 81% were successfully introduced into the 
meningococcus, proving the efficiency of the modified in vitro mutagenesis tool in a 
large-scale targeted mutagenesis (Rusniok et al., 2009). Taken together with the 
mutants produced by the genome-wide mutagenesis, 88% of the target 43 genes 
have now been mutated within N. meningitidis strain 8013. !!
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4 Phenotypic analyses of mutants in genes 
encoding putative transcriptional regulators !!!!!!! !!
!! "#!
4.1 Introduction !
The aim of the work in this chapter was to initiate phenotypic analyses of the 
library of mutants in genes encoding proteins likely to modulate transcription 
constructed in this study. Mutants were analysed for growth and for Tfp-
mediated functions (i.e. aggregation, adhesion and twitching motility), which are 
critical for virulence. Despite the role of Tfp in pathogenesis of the 
meningococcus, the regulation of pilus biogenesis is poorly understood, although 
there is some evidence Tfp are under transcriptional control (Deghmane et al., 
2002, Grifantini et al., 2002, Morand et al., 2004, Taha et al., 1998). By 
screening the library of mutants, the aim was to identify proteins critical for the 
regulation of Tfp, and thus the regulation of virulence. 
 
4.2 General Phenotypic Analyses 
 
Before embarking upon Tfp-linked phenotypic analyses, which is the main 
interest of our group, simple phenotypic screens of the 38 mutants constructed 
here, were completed by assessing their colony morphology and their growth.  
 
4.2.1 Colony morphology !
A simple screen that can be performed on a large number of mutants is the 
assessment of colony morphology. Mutants were plated on GCB agar and grown 
overnight at 37 °C; individual colonies were observed for their shape, size and 
pigmentation. All mutant strains had colonies with morphologies identical to 
those of the WT N. meningitidis strain 8013, except for one. Disruption of 
NMV_0419 resulted in colonies that were considerably smaller than those of the 
WT strain (Figure 4.1). NMV_0419 encodes a one-component transcriptional 
regulator belonging to the LysR family of regulators. NMV_0419 has not been 
studied in the meningococcus, but has 50% amino acid identity with CysB from 
E. coli. Studies of CysB in both E. coli and S. typhimurium show it regulates 
genes involved in cysteine biosynthesis (Jones-Mortimer, 1968, Kertesz, 2000, 
Kredich, 1971). Although some Neisseria strains have an absolute requirement 
for cysteine (or cystine) (Catlin, 1973), most can utilise numerous alternative 
!! "#!
sulphur sources (Baart et al., 2007, Port et al., 1984) and the meningococcus 
encodes genes necessary for cysteine biosynthesis. 
!
Figure 4.1 Colony morphology of the WT strain and the NMV_0419 mutant  
Bacteria were plated on to GCB agar and grown for approximately 16 hours at 
37 °C with 5% CO2. Scale bar, 1 cm. !
4.2.2 Growth in liquid culture !
Growth in liquid media is another simple assay for the assessment of multiple 
mutants. Bacteria were grown in MC4 (Fu et al., 1995), a chemically defined 
media (CDM), developed by excluding components from the extensively used 
multi-component Neisseria defined media developed by Catlin (Catlin, 1973). 
MC4 was used as its composition is known, in contrast to the more commonly 
used but undefined GCB broth. In brief, the media was inoculated to give an 
OD600nm of 0.1 and grown with shaking at 170 rpm at 37 °C for 10 hours and the 
OD600nm of the cultures measured every two hours. All strains were grown in 
duplicate. Of the 38 mutant strains tested, 32 grew at the same rate as the WT 
strain; a representative graph is shown in Figure 4.2 (other results are in the 
Appendix). Due to considerable temperature fluctuations in the laboratories 
where the growth was conducted the growth of the WT strain varied between 
experiments.  
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Figure 4.2 Representative growth curves of three mutants 
Bacteria were grown in MC4 for 10 hours, with the OD600nm measured every two 
hours. Graph shows growth of mutants: !0789 (red), !2033 (blue) and !2045 
(green); and the WT strain (black). Error bars show standard deviation (SD) of 
experiments performed in duplicate.  
 
Growth of six mutants was significantly slower compared to the WT strain 
(Figure 4.3 (i)) as determined by the Student’s t-test. The slower growing strains 
include mutants of three one-component transcriptional regulators: NMV_0419 
which encodes a LysR type regulator, NMV_1019 which is predicted to encode 
IscR and NMV_1868, a lambda repressor like regulator. The other slow growing 
strains have mutations in genes that encode a TCS, NMV_0125 and NMV_0126, 
and NMV_0628 which encodes RelA. All displayed significantly slower growth 
at all time points from two hours onwards, except for the NMV_1019 mutant, 
which grew significantly slower from four hours (P " 0.05). For these slower 
growing strains, CFU counts were determined for cultures at 0, 6 and 10 hours 
(Figure 4.3 (ii)). The CFU counts are significantly lower than those of the WT 
strain, as expected. For mutants of NMV_0125 and NMV_0419 the difference is 
only significant at ten hours, while for the other mutant strains the difference is 
significant at both six and ten hours (P " 0.05). The relA (NMV_0628) mutant 
has the greatest decrease in CFU number compared with the WT strain.  
 
It is unclear why mutations in these six genes cause slower growth. Interestingly, 
the NMV_0419 mutant also has small colonies on GCB agar (Figure 4.1). The 
NMV_0419 is predicted to be involved in the regulation of genes involved in 
sulphur utilisation and cysteine biosynthesis, however it should be noted that 
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cysteine is a component of MC4. As deletions in both the sensor and cognate 
regulator of a TCS result in the same growth phenotype, it suggests that an 
environmental signal is not being transmitted. The gene NMV_1019 is predicted 
to encode IscR, based on 50% identity with IscR of E. coli and the suggested 
function of surrounding genes. This transcriptional regulator has been studied in 
several species, including E. coli (Schwartz et al., 2001). IscR, iron-sulphur 
cluster assembly transcriptional regulator, is suggested to regulate genes 
important for the biogenesis of iron-sulphur clusters. These clusters are important 
co-factors for many proteins involved in various cellular processes. Little is 
known about NMV_1868, which is related to a phage transcriptional regulator. A 
growth defect caused by a relA mutant has also been observed in N. gonorrhoeae 
(Fisher et al., 2005). Interestingly a spoT mutant in the meningococcus or the 
gonococcus does not have a growth defect, suggesting the accumulation of 
ppGpp appears to be solely mediated by RelA, and that RelA has a role in 
maintaining normal cellular physiology, even in the absence of nutrient stress 
(Fisher et al., 2005). It is likely that these genes have pleiotropic effects and each 
regulate the expression of many genes. Consequently, it is hard to propose a 
specific reason for the slower-growth phenotypes.  
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Figure 4.3 Growth curves and CFU counts of mutants with slower growth 
compared to the WT strain 
OD600nm measurements (i) and CFU counts (ii) of bacteria were grown in MC4 
media for 10 hours. OD600nm measurements were taken every two hours, whilst 
CFU were counted at zero, six and 10 hours. The WT strain (black) was used as 
a control in all experiments. Mutants are shown in red: (A) !0419, (B) !1019, 
(C) !1868, (D) !0125, (E) !0126 and (F) !0628. Error bars show SD of 
experiments performed in at least triplicate, * indicates P " 0.05 by a Student’s t-
test. 
 
4.3 Tfp-linked Phenotypic Analyses 
 
Tfp are complex organelles with at least 16 proteins required for pilus biogenesis 
and another seven proteins so far identified involved in Tfp biology (Brown et 
al., 2010, Carbonnelle et al., 2006, Carbonnelle et al., 2005). There is some 
evidence that the Tfp are under transcriptional control, particularly during 
adhesion to host cells (Deghmane et al., 2002, Grifantini et al., 2002, Morand et 
al., 2004, Taha et al., 1998). The 38 mutants in genes encoding proteins 
predicted to modulate transcription were therefore analysed with regard to most 
of the major aspects of Tfp-linked biology: bacterial aggregation, twitching 
motility and adhesion to human cells.  
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4.3.1 Assessment of aggregative abilities 
 
The formation of multicellular bacterial aggregates is important for virulence as 
it is the first step during adhesion of the meningococcus to human cells. 
Although a quantitative assay has been used to assess the aggregative ability of 
N. meningitidis (Helaine et al., 2005), it could not be used due to the safety 
restrictions in the biosafety level 3 laboratory at Imperial College where the 
meningococcus is handled. Consequently a qualitative assay was used. In brief, 
bacteria from plates were resuspended in pre-warmed media to give an OD600nm 
of 0.02; 400 µl of the suspension was added to the wells of a 24-well plate and 
left to incubate statically at 37 °C for three hours. During this time the bacteria 
form aggregates which accumulate on the bottom of the wells. These aggregates 
are then visualised by phase-contrast microscopy, and photographs taken using a 
high-definition camcorder mounted on the microscope (Figure 4.4). All mutants 
formed apparently normal aggregates, comparable in size and number to the WT 
strain. Therefore only images for four of the 38 tested mutants are shown in 
Figure 4.4; the remainder are in the Appendix. At the level of resolution of the 
phase-contrast microscope none of the proteins predicted to modulate 
transcription appear to be involved in the aggregation process.  
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Figure 4.4 Determination of aggregative abilities of representative mutants 
in genes encoding proteins modulating transcription 
Formation of aggregates by each of the mutants was documented after a three 
hour incubation at ! 40 magnification. The WT strain and the non-piliated pilD 
mutant strain were used as positive and negative controls respectively. The 
aggregative abilities of four mutants, "0188, "0419, "1586 and "2359 are 
shown. 
 
 
4.3.2 Assessing twitching motility 
 
N. meningitidis uses a non-flagellar based mode of locomotion called twitching 
motility, which occurs when bacteria are on a solid surface in a humid 
environment (Mattick, 2002). It is thought that twitching motility occurs by pili 
attaching to a solid surface and bacterial movement along the tethered pili as the 
pili are retracted. Our group has recently designed a novel, robust method for 
assessing twitching-motility in real-time (Brown et al., 2010). Bacteria are 
resuspended in pre-warmed media, added to wells of 24-well plates and 
incubated statically at 37 °C. By phase-contrast microscopy, bacteria within 
aggregates can be seen displaying distinct, frequent jerky movements. 
Confirmation that this motion is indeed twitching motility is demonstrated by the 
observation that the aggregates of a pilT mutant (which is required for pilus 
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retraction) do not display this motion (Brown et al., 2010). The motility was 
clearly distinguishable from the slow oscillations of Brownian motion of the 
bacteria not in aggregates.  
 
All mutant strains demonstrated twitching motility at levels similar to the WT 
strain. Thus it appears that none of the transcriptional regulators and associated 
proteins studied here influence twitching motility in the conditions tested. !
4.3.3 Quantification of adhesion to human cells 
 
The ability of N. meningitidis to adhere to human cells is critical for its virulence, 
allowing the bacteria to colonise humans and cause disease. Initial adhesion is 
mainly mediated through the Tfp (Nassif et al., 1994). The quantitative assay 
used here to assess the adhesive ability of the mutants has been used extensively 
(Carbonnelle et al., 2006, Helaine et al., 2005). Briefly, bacteria were 
resuspended in pre-warmed media and left to incubate for two hours at 37 °C, 
allowing the formation of aggregates, an essential part of the adhesion process 
(Helaine et al., 2005). The bacteria were then used to inoculate a standardised 
number of HUVECs. After 30 minutes, the media was replaced to remove non-
adherent bacteria; this was repeated every hour for a further four hours. After this 
time, the cells were washed repeatedly to remove all non-adherent bacteria. 
Adherent bacteria were recovered by adding saponin to the HUVECs and the 
resulting adherent bacteria were quantified by plating on solid media. Results are 
expressed as CFU of adherent bacteria normalised for an inoculum of 107 
bacteria (Figure 4.5). 
 
Tfp play a major role in adhesion, demonstrated by the more than 1,000-fold 
difference in adhesion between the WT strain and the non-piliated pilD mutant 
(Figure 4.5). The pilT mutant, which is unable progress from initial, localised 
adhesion to intimate diffuse adhesion, adheres at levels comparable to the WT 
strain in this adhesion assay, demonstrating that this adhesion assay is unable 
assess the progression of adhesion.  
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All the mutants adhered at levels comparable to the WT strain; although slight 
differences were observed, these are negligible when compared to the difference 
between the WT strain and the pilD mutant, and are only statistically significant 
for the NMV_0188 (P < 0.05) and NMV_0125 (P ! 0.01) mutants, that adhered 
slightly better than the WT strain. Adhesion was also visualised by phase-
contrast microscopy, and three mutants (in genes NMV_0126, NMV_1005 and 
NMV_2033) potentially adhered more slowly than the WT strain (Figure 4.6). 
As these differences were difficult to quantify, adhesion assays were repeated 
and the number of adherent bacteria measured at 30 and 90 minutes post-
challenge (Figure 4.7). 
 
There was no apparent reduction in the adhesion of the NMV_0126 mutant, 
confirming that visual assessment of adhesion was not accurate. However, 
mutants of both NMV_1005 and NMV_2033 showed lower levels of adhesion at 
both 30 and 90 minutes post-challenge compared to the WT strain. At both time 
points, the NMV_2033 mutant adhered with a significant decrease of five- and 
four-fold (P ! 0.01) compared to the WT strain at 30 and 90 minutes, 
respectively. Strain !1005 showed smaller changes compared to "2033, with a 
significant decrease of three-fold (P ! 0.05) at 30 minutes and a decrease of two-
fold at 90 minutes compared to the WT strain. As the formation of bacterial 
aggregates plays a significant role in the ability of the meningococcus to adhere, 
it is possible that these mutants have a reduced rate of aggregation. Therefore 
aggregation of these strains was assessed again, but with observations made at 
earlier time points (Figure 4.8).  
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Figure 4.5 Quantification of adhesion by mutants in genes encoding proteins modulating transcription 
Results are expressed as CFU of adhering bacteria normalized for an inoculum of 107 bacteria. Monolayers of 105 HUVECs were challenged 
with a standardised number of bacteria. Values are the mean from at least duplicate experiments. The WT strain and the non-piliated pilD 
mutant strain were used as positive and negative controls respectively, while the hyper-piliated pilT mutant was included to show that the 
inability to retract the pili has no effect in this assay (red bars). All mutants in genes encoding proteins modulating transcription were tested 
(blue bars). Error bars show the SD, ** indicates P ! 0.01 and * indicates P ! 0.05 by a Student’s t-test 
!! "#$!
!!
Figure 4.6 Visual assessment of early adhesion to HUVECs for the WT 
strain and the mutants of NMV_0126, NMV_1005 and NMV_2033 
HUVECs were infected with bacteria at a multiplicity of infection of 
approximately 200. Images were observed by phase-contrast microscopy at 30 
and 90 minutes post-challenge at ! 20 magnification. The WT strain was used as 
the positive control, while mutants of genes NMV_0126, NMV_1005 and 
NMV_2033 showed reduced adhesion.  !!
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Figure 4.7 Quantification of early adhesion by mutants of NMV_0126, 
NMV_1005 and NMV_2033 
Results are expressed as the number of adherent CFU normalized for an 
inoculum of 107 bacteria. Values are the mean from triplicate experiments. 
Adhesion was quantified at 30 minutes and 90 minutes post-challenge. The WT 
strain (black bars) was used as a positive control and mutants in genes 
NMV_0126 (white bars), NMV_1005 (red bars) and NMV_2033 (blue bars) 
were analysed. Error bars show SD of experiments performed in triplicate, ** 
indicates P ! 0.01 and * indicates P ! 0.05 by a Student’s t-test 
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Aggregation assays were repeated for both the NMV_1005 and NMV_2033 
mutants as well as the WT strain with observations at 60, 90, 120 and 180 
minutes (Figure 4.8). Both mutants formed aggregates slower than the WT strain. 
At one hour, the WT strain formed visible aggregates while none were detected 
for the NMV_1005 and NMV_2033 mutants. By 90 minutes, the NMV_1005 
and the NMV_2033 mutants started to form aggregates. By three hours, the large 
aggregates of the WT strain and the NMV_1005 mutant were indistinguishable 
from each other, while the aggregates of the NMV_2033 mutant were slightly 
smaller. Therefore the NMV_1005 and NMV_2033 mutants are impaired in the 
early formation of aggregates.  
 
The NMV_1005 gene is proposed to encode HexR, a repressor of the hex 
regulon, which includes genes involved in the catabolism of glucose by the 
Entner-Doudoroff pathway, as characterised in P. aeruginosa (Hager et al., 
2000). Although the meningococcus catabolises glucose using the Entner-
Doudoroff pathway (Baart et al., 2007, Jyssum and Jyssum, 1962), HexR has not 
been characterised in this species and it is not clear how it may affect 
aggregation. In contrast, NMV_2033 encodes FarR, which has been extensively 
characterised in the meningococcus and is a repressor of the epithelial cell-
specific adhesin nadA (Capecchi et al., 2005, Metruccio et al., 2009b, Schielke et 
al., 2009). A hypothesis for the slower aggregation seen in the farR mutant is that 
increased amounts of NadA on the surface of the bacteria reduces the ability of 
the Tfp to form interbacterial interactions and results in slower aggregation.  
 
Overall this analysis shows that none of the proteins likely to modulate 
transcription identified in this study have significant individual roles in adhesion 
under the conditions tested. However, mutants of two one-component 
transcriptional regulators, NMV_1005 and NMV_2033, encoding HexR and 
FarR respectively, show delayed aggregation and consequently lower levels of 
adhesion early on in the adhesion process.  
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Figure 4.8 Formation of aggregates over time 
Examination of aggregation kinetics of the mutants in NMV_1005 and 
NMV_2033 that show reduced early adhesion by phase-contrast microscopy at 
!20 magnification. The WT strain was included as a control. Images were taken 
at 60, 90, 120 and 180 minutes. 
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4.3.4 Progression from initial adhesion to intimate adhesion 
 
The adhesion of N. meningitidis to human cells is a two-step process. In the first step 
of initial localised adhesion, piliated bacteria aggregate on the surface of the cells 
forming microcolonies. Over time adhesion progresses to intimate, diffuse adhesion, 
whereby the bacteria spread across the surface of cells to form a mono-layer (Pujol 
et al., 1997). During intimate, diffuse adhesion the bacteria lose their pili; this is not 
likely to be due to phase variation, as cell associated colonies are piliated (Pujol et 
al., 1997). Therefore this is likely to be a regulated step (Pujol et al., 1999), and PilT 
is involved. The pilT mutant is hyper-piliated, and unable to retract its pili so is 
unable to progress to intimate, diffuse adhesion (Pujol et al., 1999). The adhesion 
assay described above is unable to distinguish between the two adhesion steps, as 
cells are only infected for 270 minutes, when localised adhesion predominates (Pujol 
et al., 1997, Pujol et al., 1999). However, during intimate adhesion, the pilT mutant 
still adheres at similar levels to the WT strain (Pujol et al., 1999). Consequently 
quantifying adherent bacteria is not a suitable method to assess intimate adhesion. 
 
Both immunofluorescence (IF) and scanning electron microscopy have been used to 
distinguish between the two steps of adhesion, by showing the loss of piliation 
(Pujol et al., 1999, Pujol et al., 1997). As we hypothesized that the retraction of pili 
upon intimate adhesion is a regulated step, we hoped to identify any transcriptional 
regulators involved by replicating the microscopy experiments and screening all of 
the mutants for the loss of piliation. Although we attempted to repeat these 
experiments, we were unable to obtain clear reproducible results with the WT strain, 
although the hyper-piliation of the pilT mutant was visible by IF. In brief, adhesion 
assays were established with a few modifications; epithelial T84 cells and HUVECs 
were grown on glass coverslips and challenged with N. meningitidis. At 270 and 540 
minutes post-challenge, the cells were examined. For IF, the samples were stained 
with 20D9, a monoclonal antibody specific for the pilus fibre of strain 8013 (Pujol et 
al., 1997). However, at late stages of infection pili were still detectable on the WT 
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strain by IF. Furthermore pili were hard to define by scanning electron microscopy. 
Thus the 38 mutants were not screened in this assay. 
 
4.4 Summary 
 
The 38 mutants in genes predicted to encode proteins involved in the modulation of 
transcription constructed in this study were screened for colony morphology, growth 
and the Tfp-linked phenotypes, aggregation, adhesion and twitching motility. One 
mutant in an uncharacterised one-component transcriptional regulator was found to 
have a small colony morphology, while six other mutants showed reduced growth 
compared to the WT strain, including mutants in a TCS, relA and three one-
component transcriptional regulators. All the mutants demonstrated twitching 
motility and aggregation after three hours of static incubation at levels comparable to 
the WT strain, although these assessments were qualitative. Quantitative measures of 
the ability of the mutants to adhere to endothelial cells showed that no mutants 
adhered in numbers significantly different to the WT strain. However two mutants in 
genes hexR (NMV_1005) and farR (NMV_2033) did display significantly reduced 
rates of adhesion early on in the assay; this was attributed to slower rates of 
aggregation compared to the WT strain, seen when the formation of aggregates was 
observed over a time course, rather than at a late, single time point.  
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5 Detailed analysis of transcriptional regulators 
NMV_2068 and NMV_1164 !!!
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5.1 Introduction 
 
Although the construction of a library of mutants in genes likely to modulate 
transcription allows phenotypic screens to be performed to elucidate their 
function, it will always be necessary to perform in-depth characterisation of any 
transcriptional regulator of interest. In this chapter, two transcriptional regulators 
were selected for further characterisation because they are encoded on genomic 
islands absent in the non-pathogenic Neisseria species, N. lactamica, and could 
therefore contribute to virulence. Gene NMV_2068, which encodes an AraC 
family regulator, is adjacent to three divergently transcribed genes including a 
putative TonB-dependent receptor, and NMV_1164 encodes a LysR family 
regulator adjacent to a divergently transcribed gene encoding a putative 
transporter. The hypothesis tested in this chapter is that the transcriptional 
regulators affect transcription of adjacent genes. This was investigated by 
reporter gene fusions and RT-PCR. To define the promoters within the intergenic 
regions (IGR) between the transcriptional regulators and adjacent genes, attempts 
were made to locate TSS and to define any regulator binding sites by EMSA. 
 
5.2 NMV_2068 
 
Expression of the transcriptional regulator NMV_2068 is induced upon iron 
limiting conditions, and is under the control of the global iron-responsive 
regulator Fur in the N. meningitidis serogroup B MC58 strain (Delany et al., 
2006). Induction upon iron starvation is perhaps unsurprising given that the 
adjacent, divergently transcribed genes are predicted to have roles in iron 
acquisition (Figure 5.1). Gene NMV_2069 is predicted to encode a putative 
ferric enterobactin uptake system-binding lipoprotein, NMV_2071 is predicted to 
encode a putative TonB-dependent siderophore receptor, while NMV_2070 has 
no predicted function. Interestingly Neisseria species do not synthesise and 
secrete any siderophores (Archibald and DeVoe, 1980, West and Sparling, 1985). 
 
Iron is an essential element for N. meningitidis, necessary for a number of 
fundamental processes and has a role in virulence. Numerous studies have shown 
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an attenuation of virulence when iron acquisition is hindered (Calver et al., 1976, 
Klee et al., 2000, Schryvers and Gonzalez, 1989, Stojiljkovic et al., 1995). The 
meningococcus can acquire iron from human sources, by sequestering iron 
complexed with transferrin or lactoferrin by use of the TonB-dependent receptors 
TbpA and LbpA, respectively, and accessory lipoproteins TbpB and LbpB 
(Schryvers and Stojiljkovic, 1999). Another TonB-dependent receptor, HmbR is 
able to sequester iron from haemoglobin (Stojiljkovic et al., 1996). Eight other 
putative TonB-dependent receptors are encoded by N. meningitidis strain 8013 
including NMV_2068 and FetA, an enterobactin receptor which has been 
characterised in the gonococcus (Carson et al., 1999). It is likely that the 
meningcocccus can use xenosiderophores, as the gonococcus does with 
enterobactin. 
 
The gene NMV_2068 encodes an AraC family transcriptional regulator. This 
family of regulators often require the binding of inducers for their activity 
(Gallegos et al., 1997). Within this family are a subset of regulators that control 
the transcription of their adjacent genes encoding proteins involved in 
siderophore utilization and biosynthesis; these include BfeR in Bordetella 
bronchiseptica (Anderson and Armstrong, 2004) and PchR in Pseudomonas 
aeruginosa (Heinrichs and Poole, 1993, Heinrichs and Poole, 1996). These 
regulators and their adjacent genes have a similar genetic organisation to the 
NMV_2068 genomic island. Here we attempted to determine if NMV_2068 
regulates its adjacent divergently transcribed genes, and see if any potential 
inducers could be identified. 
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Figure 5.1 Genetic organisation of the NMV_2068 potential regulon 
Arrows depict the predicted orientation of gene transcription and the proposed 
function of each gene product is shown. 
 
5.2.1 Development of an iron free media 
 
As NMV_2068 is known to be expressed under iron-deplete conditions (Delany 
et al., 2006) and the predicted function of the adjacent genes also suggest a role 
in iron acquisition, it was necessary to validate the use of an iron-depleted media. 
The CDM, MC4, in which N. meningitidis grows well, was chosen (Fu et al., 
1995). When Fe(III)citrate, is excluded from the media, growth is reduced as 
expected (Figure 5.2A). However to increase the depletion of trace iron, MC4 
was treated with Chelex-100. Chelex-100 is a resin of styrene divinylbenzene 
copolymer containing paired iminodiacetic ions, which chelate polyvalent metal 
ions, with a strong preference for divalent cations. Therefore the media was 
treated with Chelex prior to use. Chelex is preferable to other iron chelators such 
as Desferal and 2,2-dipyridyl, which are added directly to the media during 
bacterial growth, as the pretreatment with Chelex allows for iron-deplete media 
from the time of inoculation.  
 
Bacteria showed reduced growth in Chelex treated media compared to both MC4 
and MC4 -Fe (Figure 5.2A). However, the reduced growth was not restored 
following supplementation with iron, suggesting that the Chelex treatment had 
removed other components (Figure 5.2A). To circumvent this, after Chelex 
treatment the MC4 was supplemented with the other divalent cations including 
Mg2+ and Ca2+. Solutions of MgCl2 and CaCl2 were made in Chelex treated water 
to eliminate any potential introduction of iron. Addition of these supplements 
with iron after Chelex treatment resulted in the restoration of growth, while 
!! ""#!
growth was still reduced without additional iron (Figure 5.2B). The ability to 
alter the ionic content of the media after Chelex treatment without altering the 
iron status is another advantage of using Chelex. For clarity, MC4 with no added 
iron, treated with Chelex and then supplemented with Mg2+ and Ca2+ will be 
referred to as iron-deplete media, and MC4 with iron added termed iron-replete. 
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Figure 5.2 Development of iron-deplete media 
Growth of WT N. meningitidis in MC4 (black), MC4 treated with Chelex (red), 
and MC4 treated with Chelex and supplemented with calcium and magnesium 
(blue), either without iron (open triangles, dashed lines) or supplemented with 
iron (filled squares, solid lines). Values are the mean from triplicate experiments 
and error bars represent the SD. A When iron is not added to MC4, bacterial 
growth is reduced (black dashed line), this growth is further reduced when MC4 
is treated with Chelex (red dashed line). However, when Chelex treated MC4 is 
supplemented with iron alone (red solid line), bacterial growth is not restored to 
MC4 levels (black solid line). B Growth was restored to levels obtained with 
MC4 (black solid line) only when the Chelex treated media was supplemented 
with magnesium and calcium as well as iron (blue solid line).  
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5.2.2 Iron status has no effect upon the growth of NMV_2068 or NMV_2071 
mutants 
 
Of the four genes in the genomic island, mutants were available for NMV_2068 
and NMV_2071 from this study and the previous genome-wide mutagenesis 
(Geoffroy et al., 2003). To determine whether the loss of the regulator or the 
putative TonB-dependent receptor affects growth, growth curves were performed 
in both iron-replete and iron-deplete media (Figure 5.3). Although both of the 
mutants appear to grow slower than WT, this is only statistically significant for 
the NMV_2071 mutant in iron-deplete media at all time points (P ! 0.05). The 
difference in growth is slight so is unlikely to be due to the inability of the 
receptor to transport its cognate target.  
 
 
 
Figure 5.3 Growth of NMV_2068 and NMV_2071 mutants 
Growth curves of the WT (black) and mutant strains "2068 (red) and "2071 
(blue). Growth of all three strains is reduced in the iron-deplete media (open 
triangles, dashed lines) compared to growth in iron-replete media (filled squares, 
solid lines). Values are the mean from triplicate experiments and error bars 
represent the SD. Growth of the "2071 strain is significantly reduced at all time 
points compared to the WT strain as determined by the Student’s t-test. 
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5.2.3 Expression of the transcriptional regulator NMV_2068  
 
NMV_2068 is known to be regulated by Fur and is expressed in iron-limiting 
conditions in N. meningitidis MC58 (Delany et al., 2006). This is similar to PchR 
of P. aeruginosa but unlike BfeR of B. bronchiseptica (Anderson and 
Armstrong, 2004, Heinrichs and Poole, 1996). To confirm the upregulation of 
transcriptional regulator NMV_2068 in strain 8013 in response to our iron-
deplete conditions, a lacZ translational reporter fusion with this gene was 
constructed. 
 
5.2.3.1 Construction of lacZ reporter fusions 
 
Reporter fusions with lacZ were constructed using overlap PCR (Figures 5.4 and 
5.5). Three rounds of PCR were required. In the first round, three amplifications 
were performed. Approximately 500 bp of the region upstream of the gene, 
containing promoter sequences, ribosome binding site and the first six codons of 
the gene were amplified, with the reverse primer introducing a region 
complementary to the lacZ gene, starting at the tenth codon. Next, a 500 bp 
region downstream of the gene was amplified, with the forward primer including 
a region complementary to the 3' end of lacZ and a PacI restriction site. The final 
PCR amplified lacZ starting at its tenth codon. For the second round of PCR, the 
upstream region and lacZ fragment were amplified together. In the final round of 
PCR, the upstream-lacZ fragment was amplified with the downstream region, 
resulting in the complete fusion. 
 
The resulting fragment was ligated into pCR/8/GW/TOPO and verified by 
sequencing. To confirm that the lacZ gene was functional the plasmid was used 
to transform E. coli MC1060, a lacZ deficient strain and plated onto media 
containing the substrate X-gal. Blue colonies indicated that the lacZ gene is 
functional.  
 
The reporter fusion was introduced into N. meningitidis either at an ectopic site 
following cloning into pGCC4, or in its native chromosomal location following 
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ligation of an antibiotic resistance cassette into the PacI site. When cloned into 
pGCC4, the reporter fusion was orientated so that the IPTG-inducible promoter 
in the vector would have no effect upon expression of the fusion. Transformants 
were confirmed by PCR analysis. For NMV_2068 the lacZ reporter fusion could 
only be introduced into the ectopic site, the resulting strain is denoted as 2068!. 
 
 
 
Figure 5.4 Nucleotide sequence of the start of the lacZ fusions 
For all fusions, the lacZ gene (blue) is fused from its tenth codon to at least four 
codons of the gene (black). The start codon of the gene is shown in red.  
 
!! ""#!
 
!
 
Figure 5.5 Construction of lacZ translational reporter fusions by PCR-
mediated gene replacement  
The first round of PCRs amplify 500 bp regions upstream and downstream of the 
gene, and lacZ. Both the upR and downF primers include sequences 
complementary to lacZ; downF also includes a PacI restriction site, indicated by 
the red line. The second PCR splices together the up-gene region and lacZ by 
amplifying with upF and lacZR. The two fragments hybridise together, and serve 
as the template for PCR. The third PCR creates the final construct, splicing 
together the up-lacZ product and the downstream region. The fragments 
hybridize together due to the lacZ overlapping complementary region.  
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5.2.3.2 NMV_2068 is regulated by iron 
 
The NMV_2068 lacZ reporter strain, 2068$, was grown until mid-logarithmic 
phase when lysates were assayed for !-galactosidase activity; results are shown 
in Miller units (Figure 5.6). Expression of the reporter fusion is significantly 
higher in iron-deplete versus iron-replete conditions (P < 0.01) and MC4 media 
with iron excluded (MC4 -Fe), (P < 0.05, Student’s t-test), with negligible 
expression in the presence of iron. The iron dependent upregulation of 
NMV_2068 transcription was further confirmed by RT-PCR (Table 5.1), 
showing a seven-fold increase in mRNA levels in iron-deplete compared with 
iron-replete conditions. Thus in N. meningitidis strain 8013, the transcriptional 
regulator NMV_2068 is upregulated in the absence of iron. 
 
 
 !
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Figure 5.6 Depletion of iron causes an increase in expression of 2068-lacZ 
Cultures of N. meningitidis were grown to mid-logarithmic phase and the level 
of %-galactosidase activity of cell lysates was measured in Miller units. The 
2068" reporter levels increase with reducing amounts of iron. Treatment with 
Chelex does remove trace iron, as shown by the increased activity from 2068" 
in iron-deplete media compared to MC4 -Fe. Error bars show the SD of at least 
triplicate experiments and ** indicates P < 0.01 and * indicates P < 0.05 by the 
Student’s t-test. 
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Conditions (experimental compared to 
normal) 
Gene 
 NMV_2068 NMV_2069 NMV_2070 NMV_2071 fetA mtrF 
Iron-deplete compared to iron-replete 
in WT 
6.81 ± 1.21 1.60 ± 0.45 1.50 ± 0.24 1.25 ± 0.13 
19.97 ± 
4.52 
-1.42 ± 
0.19 
Iron-deplete compared to iron-replete 
in !2068 
- 1.43 ± 0.21 1.31 ± 0.15 1.37 ± 0.29 
15.62 ± 
4.03 
1.89 ± 0.21 
!2068 compared to WT in iron-replete - 1.76 ± 0.17 1.75 ± 0.21 1.27 ± 0.52 1.61 ± 0.89 1.45 ± 1.43 
!2068 compared to WT in iron-deplete - 1.64 ± 0.41 1.33 ± 0.27 1.49 ±0.75 1.40 ± 1.21 1.20 ± 1.29 
 
Table 5.1 Comparative quantification of transcription with regard to iron status and NMV_2068 
The amount of mRNA of the gene of interest is expressed as fold change relative to the ‘normal’ condition, which is indicated in the 
table. The fold change value is the mean fold change from three independent experiments, each of which was performed in 
triplicate; the SD is also shown. If the quotient was less than one, the reciprocal value was taken and a minus sign added. 
Comparative quantification was calculated using the Rotor-Gene 300 software, and expression of housekeeping gene gdph was used 
as the control. 
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5.2.4 NMV_2068 does not auto-regulate its own expression in MC4 
 
To determine if NMV_2068 regulates its own expression, the lacZ translational 
reporter fusion was introduced into the NMV_2068 mutant strain. The resulting 
2068!/"2068 strain was grown in iron-replete and iron-deplete conditions, and 
#-galactosidase levels in cell lysates compared with those from strain 2068! 
(Figure 5.7). Expression of 2068-lacZ was comparable in the two strains and not 
statistically significant when grown in the same media. This result is similar to 
BfeR, but different from PchR which represses its own transcription (Anderson 
and Armstrong, 2004, Heinrichs and Poole, 1996). However, it is possible that 
NMV_2068 is auto-regulated, but requires an inducer not present in MC4, 
although PchR auto-regulates in the presence and absence of its activating ligand 
(Heinrichs and Poole, 1996). 
 !
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Figure 5.7 NMV_2068 is not auto-regulated in MC4 
Cultures of N. meningitidis were grown to mid-logarithmic phase and the #-
galactosidase activity of cell lysates measured in Miller units. Experiments were 
performed at least in triplicate and the error bars represent the SD. Expression of 
the reporter fusion 2068! in the WT background (open bars) was compared to 
expression in the "2068 mutant (black bars) in both iron-replete and iron-deplete 
media.  
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5.2.5 NMV_2069 and NMV_2071 are not expressed and not induced upon 
NMV_2068 expression in iron-deplete media  
 
To assess the transcription of the putative uptake system-binding lipoprotein and 
TonB-dependent receptor protein (NMV_2069 and NMV_2071 respectively), 
lacZ translational reporter fusions were constructed as for NMV_2068 (Figures 
5.4 and 5.5). The lacZ reporter construct for NMV_2069 was introduced into N. 
meningitidis both ectopically and in its native location, resulting in strains 2069! 
and 2069!N respectively. For NMV_2071 the lacZ reporter fusion could only be 
introduced in its native location, resulting in strain 2071!N.  
 
To determine whether the putative lipoprotein or the putative TonB-dependent 
receptor protein are transcribed in iron-replete or iron-deplete media, the lacZ 
reporter strains were grown to mid-logarithmic phase, and lysates were assayed 
for "-galactosidase activity (Table 5.2). There was negligible expression of the 
reporter for all three strains in iron-replete or iron-deplete media, with similar 
activity detected in the lysate from the WT strain, which does not contain a lacZ 
gene. The results for NMV_2071 are in agreement with a study in which a poly-
clonal antibody to NMV_2071 was unable to detect expression in 28 N. 
meningitidis strains grown in iron-deplete media (Turner et al., 2001). 
 
The NMV_2069 and NMV_2071 lacZ reporter fusions were also introduced into 
two different strains to determine if the transcriptional regulator NMV_2068 has 
any affect on their transcription; the strains were the NMV_2068 transcriptional 
regulator mutant, #2068, and a strain in which the regulator had been c-Myc 
tagged and was under the control of an IPTG-inducible promoter, Ind2068. 
Expression of the induced regulator was confirmed in N. meningitidis by 
immunoblotting to detect the c-Myc tag (Figure 5.8). It should be noted that the 
lacZ reporter strains introduced into Ind2068 have the fusions in the native locus 
as the ectopic site used contains the IPTG inducible regulator. The activity of the 
reporters was assessed by visual inspection; activity of a reporter was initially 
judged by the colour of reactions and comparison to known standards. In the 
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absence of a visible colour change, no activity was seen in any of the strains and 
conditions tested (data not shown).  
 
RT-PCR was also performed to determine mRNA levels of NMV_2069, 
NMV_2071, and NMV_2070. RNA was isolated from the WT strain and the 
NMV_2068 mutant grown in both iron-replete and iron-deplete media. Although 
transcripts were detectable for all genes, the fold changes in mRNA levels 
between conditions were less than two and with large SD values (Table 5.1), 
indicating there was no detectable regulation by NMV_2068 or the iron status.  !
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Figure 5.8 Induction of c-Myc tagged NMV_2068 
Western analysis using anti-c-Myc antibody to detect Myc-tagged NMV_2068. 
Induction with 0.5 µM IPTG is indicated by +, and – indicates no IPTG was 
added. Whole cell extracts were prepared from N. meningitidis cultures of the 
WT strain with IPTG, and the Ind2068 strain with and without IPTG induction. 
Proteins were separated by SDS-PAGE.  
 
5.2.6 Testing of potential inducers 
 
Although NMV_2068 is upregulated in iron-limiting conditions, no conditions 
were found that lead to the upregulation of the neighbouring genes. The AraC 
family transcriptional regulators that control transcription of adjacent siderophore 
utilisation and biosynthesis genes require inducers (usually their cognate 
siderophores) as well iron-limiting conditions for their activation. For example, 
BfeR requires the presence of enterobactin for its activity (Anderson and 
Armstrong, 2004), while PchR requires pyochelin for its activity (Heinrichs and 
Poole, 1993, Heinrichs and Poole, 1996). Therefore several potential inducers 
were tested for their effect on regulation.  
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5.2.6.1 FBS 
 
Expression of the NMV_2071 gonococcal homologue could not be detected in 
23 strains grown in iron-deplete media using a poly-clonal antibody (Turner et 
al., 2001), or by RT-PCR to detect mRNA (Hagen and Cornelissen, 2006). 
However, NMV_2071 specific mRNA could be detected when bacteria were 
grown in cell culture media containing FBS, and the mRNA levels decreased 
when the cultures were supplemented with iron (Hagen and Cornelissen, 2006, 
Turner et al., 2001). This result suggest that FBS contains an inducer. Therefore 
10% FBS from two different sources was added to the iron-deplete media and 
expression of 2068-lacZ, 2069-lacZ and 2071-lacZ were assessed by !-
galactosidase assay (Table 5.2). Addition of FBS provides an iron source, as 
expression of 2068-lacZ was reduced compared to expression in iron-deplete 
media (Figure 5.9). However reporter activity for 2069-lacZ and 2071-lacZ was 
negligible, suggesting no suitable inducer is present in FBS.  
 
5.2.6.2 Cell lysates 
 
Replication of N. gonorrhoeae in epithelial cells is dependent on the NMV_2071 
homologue (Hagen and Cornelissen, 2006). Furthermore, in N. meningitidis an 
unidentified TonB-dependent receptor has been implicated in its ability to 
replicate in epithelial cells (Larson et al., 2002). It has been proposed that the 
iron source utilized by intracellular bacteria is derived from degradation of 
ferritin (Larson et al., 2004). Consequently, it was decided to examine whether 
cell lysates could induce expression of the genes, NMV_2069 and NMV_2071.  
 
Briefly, Detroit cells or Chang cells were grown to approximately 90% 
confluence. For iron starved cells, FBS was removed from the growth media for 
the final 12 hours of growth. Cells were lysed by sonication, and lysates were 
added to bacterial cultures in iron-deplete media. !-galactosidase assays were 
performed and visual assessments were made. Addition of the cell lysates did not 
induce the expression of 2069-lacZ or 2071-lacZ, as all reactions were colourless 
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(data not shown), suggesting that no suitable inducer was present. Unsurprisingly 
2068-lacZ was expressed (Figure 5.10). No iron source appeared to be provided 
by the cell lysates as the expression levels of 2068-lacZ were comparable to 
those grown in iron-deplete media in the absence of lysates (Figure 5.10). 
 
5.2.6.3 Human serum 
 
Humans are the only known host of Neisseria. In rare cases the bacterium can 
enter the bloodstream causing septicemia (Rosenstein et al., 2001). Thus heat-
inactivated human serum was tested for the presence of any potential inducers. 
Bacteria were grown in iron-deplete media supplemented with 0.5% serum until 
mid-logarithmic stage. The addition of human serum did not induce expression 
of 2079-lacZ or 2071-lacZ (Table 5.2). The expression of 2068-lacZ was reduced 
slightly from the levels found in iron-deplete media (Figure 5.9) suggesting that 
serum provided bacteria with iron. 
 
5.2.6.4 Siderophores 
 
The most common and well characterised inducers of TonB-dependent receptors 
expression are their cognate siderophores. For example pyochelin induces the 
expression of its cognate receptor fptA in P. aeruginosa (Heinrichs and Poole, 
1996). However, the inducers can be produced by other organisms. For example, 
Bordetella does not produce enterobactin, yet this siderophore induces 
expression of the receptor bfeA. The siderophores enterobactin, aerobactin and 
salmochelin were selected to determine their potential as inducers for 
NMV_2069 and NMV_2071 expression; 5 µM of each siderophore was added to 
iron-deplete cultures. Due to the limited availability of siderophores, a single set 
of !-galactosidase experiments was conducted and RT-PCR performed (Table 
5.3). Activity of 2069-lacZ and 2071-lacZ was not induced upon addition of any 
of the siderophores, (data not shown), and there were no increases in mRNA 
levels (Table 5.3). The expression of NMV_2068 was decreased in the presence 
of all three siderophores, especially aerobactin and enterobactin (Figure 5.9); but 
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no reduction in mRNA levels was seen with the addition of salmochelin (Table 
5.3).  
 
5.2.6.5 Catechol 
 
The BfeR regulator of Bordetella is activated by the presence of xenosiderophore 
enterobactin (Anderson and Armstrong, 2006). This is surprising as enterobactin 
is most commonly produced by bacteria that reside in the gastrointestinal tract, 
while Bordetella occupies the upper respiratory tract. Consequently it was shown 
that compounds containing the catechol group, which is found in enterobactin, 
were able to induce transcription of bfeA (Anderson and Armstrong, 2006). Thus 
50 µM catechol was added to iron-deplete media to see if this could could induce 
the transcription of 2071-lacZ (Table 5.2). The addition of catechol did not 
induce the expression of 2069-lacZ or 2071-lacZ, nor, as expected did catechol 
provide any iron source as 2068-lacZ expression levels were indistinguishable 
from those grown in unsupplemented iron-deplete media (Figure 5.9).  
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Table 5.2 Activity levels of NMV_2068, NMV_2069 and NMV_2071 reporter fusions in the presence of potential inducers.  
Cultures of N. meningitidis were grown to mid-logarithmic phase and the level of !-galactosidase activity of the lysates measured in 
Miller units. Various supplements were added to iron-deplete media: 10% FBS (two different versions were used, Old is Premium 
FBS from Lonza and Gold is from PAA laboratories), 0.5% heat inactivated human serum, and 50 µM catechol. Experiments were 
performed at least in triplicate and the SD is shown. 
 
 
 
Strain Media Potential inducers added to iron-deplete medium 
 Iron-replete Iron-deplete 10% FBS Old 10% FBS Gold 0.5% Serum Catechol 
2068" 0.99 ± 1.11 42.21 ± 7.62 15.03 ± 3.40 5.44 ± 2.09 30.39 ± 8.46 44.17 ± 12.98 
2069" 0.02 ± 0.62 0.03 ± 0.62 -0.17 ± 0.50 -0.28 ± 0.19 0.74 ± 0.74 0.13 ± 0.40 
2069"N -0.03 ± 0.50 0.09 ± 0.39 -0.08 ± 0.36 -0.35 ± 0.37 0.61 ± 1.07 -0.06 ± 0.47 
2071"N 0.05 ± 0.47 0.06 ± 0.20 -0.30 ± 0.36 -0.29 ± 0.29 0.24 ± 0.13 -0.27 ± 0.78 
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Figure 5.9 Expression of NMV_2068 reporter fusion with potential inducers 
Cultures of N. meningitidis strain 2068! were grown to mid-logarithmic phase 
and %-galactosidase activity of cell lysates was measured in Miller units. 
Experiments were performed in triplicate and the error bars represent the SD. 
The bacteria were grown in iron-replete media, iron-deplete media and iron-
deplete supplemented with 10% FBS Gold or Old, 0.5% serum or 50 µM 
Catechol.  
 
 
!
Figure 5.10 Expression of NMV_2068 reporter fusion with cell lysates 
Cultures of N. meningitidis were grown to mid-logarithmic phase and "-
galactosidase activity of cell lysates was measured in Miller units. Experiments 
were performed in duplicate and the error bars represent the SD. Expression of 
the reporter fusion 2068! in the WT background (open bars) was compared to 
expression in the mutant #2068 background (black bars), in both iron-deplete 
media and iron-deplete media supplemented with 5% Chang cell lysate or 
Detroit cell lysate, that had been grown with or without FBS.  
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Conditions (experimental compared 
to  normal) 
Gene 
 NMV_2068 NMV_2069 NMV_2071 
Enterobactin compared to iron-
deplete 
-2.50 -1.07 1.03 
Aerobactin compared to  iron-
deplete 
-5.58 -1.79 -1.45 
Salmochelin compared to iron-
deplete 
-1.07 -1.20 -1.38 
 
Table 5.3 Comparative quantification of transcription in the presence of 
siderophores  
The amount of mRNA of the gene of interest is expressed as fold change relative 
to the ‘normal’ condition, which is indicated in the table. The fold change value 
is the mean fold change from three independent experiments, each of which was 
performed in triplicate; the SD is also shown. If the quotient was less than one, 
the reciprocal value was taken and a minus sign added. Comparative 
quantification was calculated using the Rotor-Gene 300 software, and expression 
of housekeeping gene gdph was used as the control. 
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5.2.7 Mapping the TSS of NMV_2068 
 
Although it is known that the AraC type regulator NMV_2068 is regulated by 
Fur which binds to the promoter region (Delany et al., 2006), the TSS of 
NMV_2068 has not been determined. To locate the TSS we employed DMTSS 
(Mendoza-Vargas et al., 2009), which is modified from 5' RACE. In brief, WT 
bacteria were grown in iron-deplete media, RNA isolated, reverse transcribed, 
and the 3' ends labeled with a homopolynucleotide tail using terminal transferase. 
The labeled cDNA is then amplified using a primer, DMTSS1, which hybridizes 
with the homopolynucleotide tail and incorporates an adaptor sequence. Gene-
specific PCRs are then performed using a primer which binds in the gene and 
primes towards the promoter, while the other primer, DMTSS4 anneals to the 
adaptor sequence introduced by the DMTSS1 primer. Resulting products are 
sequenced. 
 
A PCR product for DMTSS of NMV_2068 was detected and sequenced (Figure 
5.11A). The sequence terminated at a G residue before a series of T residues, 
corresponding to the polyA tail. The G residue is also next to a triplet of Ts in the 
promoter region of NMV_2068; consequently it was not possible to determine 
which nucleotide was the TSS and the procedure was repeated adding a different 
homopolynucleotide tail. This confirmed that the G residue is the TSS of 
NMV_2068 (Figure 5.11B). The TSS agrees with the position of predicted -10 
and -35 promoter regions, and two Fur boxes, as detected by Virtual Footprint, 
which overlap the promoter region. 
 
5.2.8 Protein purification of NMV_2068 
 
To determine if NMV_2068 binds to the promoters of itself and the adjacent 
genes, it was expressed as a recombinant protein in E. coli and purification 
attempted. The NMV_2068 gene was amplified and ligated into pET-28b(+) 
downstream of an IPTG inducible promoter. Denaturing conditions were 
required for purification of soluble protein (Figure 5.12A). Attempts to renature 
the protein by dialysis against decreasing concentrations of urea in the presence 
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of salmon sperm DNA, a method previously used for a transcriptional regulator 
belonging to the AraC family, were unsuccessful (Recchi et al., 2003), (Figure 
5.12B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 !!!
 
 
 
Figure 5.11 TSS mapping of NMV_2068 
A PCR product obtained using primers DMTSS4 and TSP2068 amplifying from 
cDNA generated from meningococcal RNA. B Nucleotide sequence of the 
promoter region of NMV_2068, start codons of NMV_2069 and NMV_2068 are 
in bold, with the arrow denoting the NMV_2068 ORF. The TSS is in red with 
predicted -10 and -35 regions highlighted in blue. Predicted overlapping Fur 
binding sites are underlined.  
A 
B 
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Figure 5.12 Denaturation and attempted renaturation of NMV_2068 
E. coli BL21 containing pET2068 was grown to mid-logarithmic phase before 
induction and then grown for a further two hours. A SDS-PAGE analysis of the 
purified, denatured protein. Bacteria were lysed and proteins denatured by the 
addition of urea, the insoluble cell debris discarded and the soluble fraction was 
mixed with Ni-NTA slurry, and protein was eluted at different pHs. Lane 
numbers correspond to elution fractions. A protein of the predicted molecular 
mass was purified. B SDS-PAGE analysis of renaturation. Denatured protein 
was dialysed against decreasing concentrations of urea in the presence of salmon 
sperm DNA. Both insoluble (I) and soluble (S) fractions are shown, with the 
concentration of salmon sperm DNA indicated above. Denatured protein (D) is 
also shown. 
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5.2.9 Analysis of expression of other genes NMV_2068 is suggested to 
regulate 
 
The MtrCDE efflux pump, which mediates resistance against antimicrobial 
hydrophobic agents, requires expression of another protein, MtrF, to confer high-
level constitutive resistance in the gonococcus (Veal and Shafer, 2003). The 
gonococcal NMV_2068 homologue represses mtrF (Folster and Shafer, 2005). 
Consequently the transcription of the meningococcual mtrF homologue 
(NMV_0649) in the presence and absence of NMV_2068 was assessed by RT-
PCR (Table 5.1). The result seen in the gonococcus was not reproduced in N. 
meningitidis strain 8013; there was no increase in mtrF transcript levels in the 
absence of NMV_2068 (Table 5.1). 
 
Unpublished data has suggested a role for NMV_2068 in activating the 
expression of FetA in N. gonorrhoeae under iron-deplete conditions (Hollander 
et al, abstract from International Pathogenic Neisseria Conference 2010). Using 
RT-PCR we found that fetA was not diminished in the absence of NMV_2068 
under iron-deplete conditions in N. meningitidis (Table 5.1). 
 
5.2.10 Summary of results with NMV_2068  
 
Using RT-PCR and reporter fusions, we have shown that the AraC type regulator 
NMV_2068 is iron regulated with expression increased in the absence of iron. 
However no conditions were found to induce the expression of the genes 
divergently transcribed from the regulators despite testing numerous potential 
inducers.  
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5.3 NMV_1164 
 
Both NMV_1163 and NMV_1164 are absent from the non-pathogenic Neisseria 
strains. The NMV_1164 gene is predicted to encode a protein belonging to the 
LysR type transcriptional regulator (LTTR) family, which is the most common 
prokaryotic DNA-binding protein. Inducers are often necessary for the function 
of LTTRs and are commonly a product or intermediate of a metabolic or 
synthesis pathway, usually activated by an LTTR. Members of this family can 
act as either activators or repressors of single or operonic genes, and have roles 
in diverse functions such as virulence, quorum sensing and cell division (Cao et 
al., 2001, Lu et al., 2007, Russell et al., 2004, Maddocks and Oyston, 2008). 
LTTRs were originally described as exhibiting negative auto-regulation and as 
activators of single divergently transcribed genes. From initial observation, this 
organisation could be relevant for NMV_1164 and the divergently transcribed 
adjacent gene NMV_1163 (Figure 5.13). NMV_1163 encodes a 52.6 kDa 
putative transporter of the major facilitator superfamily, and is predicted to have 
11 transmembrane helices; it is separated from a LTTR by a 257 bp intergenic 
region (IGR). Here we attempted to determine whether NMV_1164 regulates 
NMV_1163. 
 
 
 
 
Figure 5.13 Genetic organization of the potential NMV_1164 regulon 
Arrows depict the orientation of the genes. The proposed function of each gene 
product is shown. 
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5.3.1 Neither NMV_1163 nor NMV_1164 has any effect upon growth in 
MC4 or GCB 
 
A mutant strain of NMV_1163 was already been obtained in construction of the 
genome-wide mutant library (Geoffroy et al., 2003) and a NMV_1164 mutant 
was constructed in this study. The growth of these strains was compared with the 
WT N. meningitidis strain 8013 in two media; MC4 and GCB. MC4 was 
supplemented with iron, and GCB is a complex media composed primarily of 
undefined proteose peptone supplemented with various salts and nutrients 
(Shockley et al., 1980). Both media were used to increase the possibility of 
discovering what NMV_1163 transports, or the potential inducer of NMV_1164. 
In both media the growth of the mutant strains was comparable to that of the WT 
strain (Figure 5.14). Thus neither the LTTR nor the putative transporter is 
necessary for growth in MC4 or GCB.  
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A 
 
B 
 
Figure 5.14 Growth of !1163 and !1164  
Growth of WT (black) was compared to mutant strains #1163 (red) and #1164 
(blue), in GCB media (A) and MC4 media (B). Experiments were performed in 
triplicate and error bars show the SD. 
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5.3.2 Expression of NMV_1163 and NMV_1164 
 
To assess the expression of the LTTR and the putative transporter, NMV_1164 
and NMV_1163 respectively, lacZ translational reporter fusions were 
constructed as for NMV_2068 (Figures 5.4 and 5.5). The lacZ reporter fusions 
for both NMV_1164 and NMV_1163 were introduced into N. meningitidis in 
ectopic and native sites, resulting in strains 1164!, 1163! and 1163!N, where 
N denotes the native locus. 
 
5.3.2.1 NMV_1164 negatively auto-regulates its own expression 
 
To determine if NMV_1164 regulates itself, the 1164-lacZ fusion was introduced 
into the NMV_1164 mutant, yielding strain 1164!/#1164. Cultures of N. 
meningitidis were grown to mid-logarithmic phase in both MC4 and GCB, and %-galactosidase activity was measured from cell lysates (Figure 5.15). In the 
absence of the regulator, expression of 1164-lacZ is significantly increased by 
three-fold and two-fold compared to expression in the WT background in MC4 
and GCB respectively. Therefore NMV_1164 negatively regulates it own 
expression in both MC4 and GCB. 
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Figure 5.15  NMV_1164 is negatively auto-regulated 
Cultures of N. meningitidis strains 1164! (black bars) and 1164!/#1164 (white 
bars) were grown to mid-logarithmic phase in MC4 and GCB media. The level 
of %-galactosidase activity of cell lysates was measured in Miller units. 
Experiments were performed in triplicate, error bars show the SD and ** 
indicates P < 0.01 by Student’s t-test. 
 
5.3.2.2 Effect of NMV_1164 and NMV_1163 on expression of NMV_1163  
 
To assess the effect of the LTTR, NMV_1164, on NMV_1163, the 1163-lacZ 
reporter fusion was introduced into the regulator mutant and a strain in which the 
LTTR regulator was c-Myc tagged and under the control of an IPTG-inducible 
promoter, resulting in strains 1163!/#1164 and 1163!N/Ind1164 respectively. 
Expression of the induced regulator was confirmed in N. meningitidis by 
immunoblotting to detect the c-Myc tag (Figure 5.17). Cultures of N. 
meningitidis were grown to mid-logarithmic phase in MC4 and GCB, and %-
galactosidase activity was measured from cell lysates (Figure 5.16). Expression 
of 1163-lacZ is significantly greater in MC4 media compared to GCB (P < 0.01) 
(Figure 5.16A), in agreement with RT-PCR results (Table 5.4). Deletion of the 
regulator resulted in significantly reduced expression of 1163-lacZ in both media 
by approximately two-fold (P < 0.01). These changes were not detected by RT-
PCR (Table 5.4). Over-expression of NMV_1164 had no effect upon 1163-lacZ 
activity in either GCB or MC4 (Figure 5.16B). However, it should be noted that 
this strain lacks NMV_1163, as the NMV_1163 reporter fusion had to be 
introduced in its native site, as the ectopic site contains the IPTG inducible 
regulator. 
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To see if deletion of the transporter had any effect on its own expression the 
1163-lacZ reporter fusion was introduced into the transporter mutant, yielding 
the strain 1163!N/#1163. Cultures were grown to mid-logarithmic phase in 
MC4 and GCB, and %-galactosidase activity was measured from cell lysates 
(Figure 5.16A). Deletion of the putative transporter, NMV_1163, resulted in 
markedly increased 1163-lacZ expression in MC4 (P < 0.01), but not in GCB. 
 
 
 
 
Figure 5.16 The effect of NMV_1163 and NMV_1164 upon expression of 
1163-lacZ 
Cultures of N. meningitidis were grown to mid-logarithmic phase and the level 
of %-galactosidase activity measured in Miller units. A Comparison of 1163-lacZ 
expression in strains 1163! (black bars), 1163!/#1164 (white bars) and 
1163!/#1163 (blue bars) in both MC4 and GCB media. B Comparison of 1163-
lacZ expression in strain 1163!N (black bars) and 1163!N/Ind1164 (white 
bars) where NMV_1164 is under IPTG-inducible expression, in both MC4 (i) 
and GCB (ii) media. Experiments were performed in triplicate, error bars show 
the SD, ** indicates P < 0.01 by Student’s t-test. 
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Figure 5.17 Detection of c-Myc tagged NMV_1164 
Western analysis using an anti-c-Myc antibody to detect Myc-tagged 
NMV_1164. Induction with 0.5 µM IPTG is indicated by +, and – indicates no 
IPTG was added. Whole cell extracts were prepared from N. meningitidis 
cultures of the WT strain with IPTG, and the Ind1164 strain with and without 
IPTG induction. Proteins were separated by SDS-PAGE.  
 
 
 
 
Conditions (experimental 
compared normal) 
Gene 
 NMV_1163 NMV_1164 
MC4 compared to GCB in WT 2.34 ± 0.88 -1.20 ± 0.20 
MC4 compared to GCB in #1164 1.62 ± 0.43 - 
#1164 compared to WT in GCB 1.84 ± 0.80 - 
#1164 compared to WT in MC4 -1.21 ± 
0.33 
- 
 
Table 5.4 Comparative quantification of NMV_1163 and NMV_1164 
The amount of mRNA of the gene of interest is expressed as fold change relative 
to the ‘normal’ condition, which is indicated in the table. The fold change value 
is the mean fold change from three independent experiments, each of which was 
performed in triplicate; the SD is also shown. If the quotient was less than one, 
the reciprocal value was taken and a minus sign added. Comparative 
quantification was calculated using the Rotor-Gene 300 software.  
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5.3.3 Location of TSS of NMV_1163 and NMV_1164 
 
To determine the TSS of both NMV_1163 and NMV_1164, 5' RACE was 
performed. RNA was isolated from cultures of N. meningitidis grown to mid-
logarithmic phase and cDNA was generated from RNA using reverse 
transcriptase, and a NMV_1163 or NMV_1164 specific primer. Further rounds 
of PCR were performed using nested primers. PCR products were analysed by 
agarose gel electrophoresis and sequenced. The TSS of NMV_1163 was located, 
from which putative -10 and -35 binding sites were inferred (Figure 5.18).  
 
Attempts to locate the TSS of NMV_1164 were unsuccessful, despite the use of 
numerous different gene-specific primers. Amplified DNA products all 
terminated within a nine residue polyA tract in the IGR (Figure 5.18). Due to 
sequencing difficulties, it could not be determined if the TSS was within that 
tract, or if it was not possible to sequence through the tract. However, it does 
suggest that the TSS is likely to be at least 141 bp away from the start codon of 
NMV_1164 and the promoter region will overlap with that of NMV_1163. 
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Figure 5.18 TSS mapping of NMV_1163 
Nucleotide sequence of the NMV_1163-1164 IGR. The start codons of 
NMV_1163 and NMV_1164 in bold; with the arrow denoting the NMV_1163 
ORF. The TSS is in red with predicted -10 and -35 regions highlighted in blue. 
Underlined is the tract where the PCR products for mapping of NMV_1164 
terminate.  
 
 
5.3.4 Protein purification of NMV_1164 
 
To determine if NMV_1164 binds to the NMV_1163-1164 IGR, it was 
expressed as a recombinant protein in E. coli and purified. The NMV_1164 gene 
was amplified and ligated into the expression vector pET-28b(+) downstream of 
an IPTG inducible promoter. Growth of bacteria containing the plasmid was 
reduced, possibly due to leaky expression. Consequently the plasmid was 
introduced into the E. coli Bl21 strain containing the pLysS plasmid which 
encodes T7 lysozyme, thus preventing leaky expression from the T7 promoter. 
The induced protein was detected in the soluble fraction from 500 ml of bacterial 
culture induced at exponential phase with 1 µM IPTG for three hours at 25 °C. 
The protein was purified on a 1 ml His-trap column, eluted with imidazole in the 
presence of a HEPES buffer (Law et al., 2009), (Figure 5.19A). 
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5.3.5 Analysis of purified NMV_1164 binding to the NMV_1163-1164 IGR 
 
The NMV_1163-1164 IGR was amplified by PCR using primers incorporating a 
biotin label. Binding reactions were performed with 0.5 nM biotinylated IGR and 
between 0 and 2.8 µM of purified NMV_1164. Reactions were separated on a 
10% native polyacrylamide gel for three hours, followed by chemiluminescent 
detection (Figure 5.19B). Analysis of free DNA yields multiple bands; which gel 
purification of the IGR did not resolve. At a protein concentration of 2.8 µM, all 
of the labeled DNA was shifted and did not migrate into the gel. Between 
concentrations of 0.01 and 1.4 µM, intermediate levels of shifting were observed. 
Binding of purified NMV_1164 to the NMV_1163-1164 IGR demonstrated 
specificity, as binding was inhibited upon addition of unlabelled NMV_1163-
1164 IGR DNA (Figure 5.19C). Inhibition was observed in the presence of 200 
nM of unspecific NMV_2068-2069 IGR DNA, while only 50 nM of specific 
NMV_1163-1164 IGR DNA was required to inhibit the binding.  
 
To determine the binding site(s) of purified NMV_1164 within the IGR, 
overlapping biotinylated DNA fragments were generated to cover the entire IGR, 
(Figure 5.20A and C). EMSAs were performed with (1 nM) each region with a 
protein concentration of 40 nM. Reactions were separated on 6% native 
polyacrylamide gels for one hour (Figure 5.20B). All regions, except for region 5 
showed a shift. Although densiometry was not performed, region 4 shows the 
greatest degree of shifted DNA, followed by region 2. As regions 3 and 6 both 
show a faint shift, an exact binding site can not be determined. However, regions 
2 and 4 contain a consensus sequence for an LTTR box, ATC-N9-GAT (Figure 
5.20C).  
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Figure 5.19 Over-expression, purification and binding of NMV_1164 to the 
NMV_1163-1164 IGR. 
A SDS-PAGE analysis of purified NMV_1164. Bacteria were lysed with a 
French Press, and the soluble fraction loaded on to a His-trap column. Fractions 
were eluted with imidazole. Lane numbers correspond to elution fractions. A 
protein of the predicted molecular mass was present in fractions 7 to 11. B 
EMSA using the biotinylated NMV_1163-1164 IGR. Binding reactions were 
performed for 25 minutes with 0.5 nM of biotinylated IGR DNA and 10 ng/µl of 
poly(dI:dC); the concentration of purified NMV_1164 protein is indicated above 
lanes. Binding is specific, as shown by competition EMSAs with unlabelled 
NMV_1163-1164 IGR DNA as a specific competitor (C) and unlabelled 
NMV_2068-2069 IGR DNA as the nonspecific competitor (D). Concentration of 
competitor DNA is indicated above the lanes. For the competition EMSAs 
biotinylated NMV_1163-1164 IGR DNA was used at a concentration of 1 nM 
and purified NMV_1164 protein at 80 nM. All reactions were separated using 
10% native polyacrylamide gels followed by chemiluminesecent detection. 
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Figure 5.20 Binding of NMV_1164 to lengths of NMV_1163-1164 IGR 
A Multiple overlapping fragments of the IGR were used to locate the binding 
site of NMV_1164. B EMSA of each region using DNA at a concentration of 1 
nM and NMV_1164 at 40 nM. Binding reactions were run on a 6% native 
polyacrylamide gels. C Complete nucleotide sequence of region 4. Overlapping 
regions are underlined: region 2 (green), region 3 (black), region 5 (blue), and 
region 6 (red). The predicted LTTR box is in a larger font. 
CGTAACCCCATTTAAAGCCCAAACAGGCAATAAAACCAATCTTTTTTTT
TGATAACCATCATCCGGAAAACTGATACAATTTACAAACCACTTGATTAA 
277 bp 
160 bp 
118 bp 
98 bp 
1 
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4 
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5 6 
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5.3.6 Summary of results with NMV_1164  
 
Although we have shown that the LTTR, NMV_1164, is negatively auto-
regulated and able to bind specifically to the NMV_1163-1164 IGR, its role in 
the regulation of the divergently transcribed putative transporter NMV_1163 
remains undefined. Deletion of the regulator had little effect upon the expression 
of NMV_1163, while over-expression of NMV_1164 had no effect upon 
expression of the putative transporter. If, as is common for LTTRs, an inducer is 
required for the LTTR to activate or repress its cognate gene, this result may 
reflect the absence of the inducer. Interestingly, deletion of the putative 
transporter, NMV_1163, increased expression from the NMV_1163 promoter, as 
shown by reporter fusion. It is possible that NMV_1163 or a byproduct produced 
downstream of it may be involved in the repression of the transporter, possibly 
as a co-repressor; so mutation of the transporter results in its upregulation. 
Alternatively, in the absence of the transporter, it is possible an inducer for 
NMV_1164 is somehow present and results in the upregulation of NMV_1163. 
As this result is only seen in the MC4 media, it suggests that the components of 
MC4 as opposed to GCB are required.  
 
5.4 Summary 
 
The aim of the work in this chapter was to undertake an in-depth 
characterization of two transcriptional regulators, with the hypothesis that they 
regulate the transcription of adjacent, divergently transcribed genes. Although 
we applied several relevant approaches, we have been unable to fully 
characterise either system. A significant issue is that the absence of any evidence 
of regulation can not be conclusive as the activity of each regulator might 
require the presence of specific inducer molecules not present in these 
experiments. 
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6 Discussion 
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N. meningitidis encodes relatively few transcriptional regulators given the size of 
its genome (2.1 Mb). However, the number of transcriptional regulators encoded 
by bacteria is linked to the complexity of the environments they encounter, and 
the meningococcus is primarily a commensal in the nasopharynx of humans. 
Therefore the reduced number of transcriptional regulators encoded by the 
meningococcus is likely to result from the limited environmental niches to which 
it must adapt. In agreement, the respiratory pathogen H. influenzae (genome size 
1.9 Mb), which is another cause of meningitis, encodes a similar number of 
transcriptional regulators as the meningococcus (Harrison et al., 2005, Tatusov et 
al., 1996). In contrast, S. pneumoniae (genome size 2.2 Mb) also inhabits the 
human nasopharynx, but encodes more regulators (Tettelin et al., 2001); this 
probably reflects its more complex lifecycle, as it is not restricted to humans. 
However, the N. meningitidis genome has a high prevalence of sequences which 
can mediate phase variation (Laskos et al., 2004, Saunders et al., 2000, Snyder et 
al., 2001), but these changes to gene expression are uncontrolled, unlike 
regulation by transcriptional regulators. By utilising the relatively low number of 
transcriptional regulators encoded by the meningococcus, the first aim of this 
study was to construct mutants lacking every predicted regulator using a recently 
modified in vitro transposon mutagenesis approach (Pelicic et al., 2000, Rusniok 
et al., 2009) to establish a comprehensive library of mutants. The resulting 
mutants were subjected to phenotypic analyses with regard to growth and to one 
of the major virulence determinants of N. meningitidis, Tfp. In parallel, two 
transcriptional regulators, encoded on genomic islands absent in the non-
pathogenic Neisseria species, N. lactamica, underwent further characterisation. 
 
The identification of genes modulating transcription was facilitated by the use of 
a dedicated database, NeMeSys, designed for the functional analysis of Neisseria 
species (Rusniok et al., 2009). Overall 28 HTH transcriptional regulators and 4 
TCS were selected for mutagenesis. Additionally, a sensor protein with a 
truncated response regulator was included. N. meningitidis encodes four putative 
$ factors; however $54 is truncated and thus non-functional, whilst $70 was not 
selected for mutagenesis as it is likely to be essential (Laskos et al., 2004). Four 
other genes were also chosen, including two genes which encode IHF, and the 
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genes encoding RelA and SpoT. Therefore a total of 43 genes were selected for 
mutagenesis; of these, 20 mutants had already been obtained by genome-wide 
mutagenesis (Geoffroy et al., 2003), leaving 23 genes requiring mutagenesis. 
 
All of the transcriptional regulators identified in the meningococcus contain the 
HTH motif, an ancient conserved feature of the transcriptional apparatus 
(Aravind et al., 2005, Rosinski and Atchley, 1999). The majority of prokaryotic 
transcriptional regulators contain the HTH motif (Ulrich et al., 2005). Members 
of the ribbon-helix-helix superfamily are also able to bind DNA, and 
transcriptional regulators containing this motif have been identified, including 
MetJ, the methionine repressor from E. coli (Somers and Phillips, 1992). 
Although the gonococcus encodes a protein with the ribbon-helix-helix motif, 
FitA, which binds DNA upon interaction with FitB (Wilbur et al., 2005, 
Mattison et al., 2006), there is no homologue in the meningococcus.  
 
Initially, the efficiency of the in vitro transposon mutagenesis approach was 
improved (Pelicic et al., 2000, Rusniok et al., 2009). Mutagenised target 
plasmids were selected in E. coli before introduction into the meningococcus. 
Previously this had not been possible, as both the donor and target plasmids 
could replicate in E. coli, making it impossible to identify mutagenised plasmids. 
Consequently, an R6K origin of replication was introduced into the donor 
plasmid, which prevents replication in E. coli DH5%. Initially the efficiency of 
this approach was tested. A single transposition reaction produced approximately 
700 transformants in E. coli, of which 15-20% harboured the transposon in the 
insert of the target plasmid. Analysis of transformants in E. coli by restriction 
mapping revealed co-transformation of the target and mutated target plasmid in 
30% of transformants. Although co-transformation of plasmids containing the 
same origin of replication should not occur due to incompatibility, it can occur 
(Velappan et al., 2007). To decrease the occurrence of co-transformation, the 
amount of the transposition reaction used to transform E. coli could be reduced. 
The resulting mutant constructs were then integrated into the meningococcus 
genome by homologous recombination. 
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Systematic mutagenesis using in vitro transposon mutagenesis resulted in the 
construction of 41 mutated target plasmids for the 43 genes selected. The ihf-! 
gene was refractory to cloning. Although 196 E. coli transformants were 
analysed for a suitable mutated target plasmid of gene NMV_0757, none were 
identified. This is likely to be due to the small size of NMV_0757 (357 bp). A 
suitable mutated target plasmid was constructed by ligating a kanamycin 
resistance cassette into the NMV_0757 gene.  
 
Integration in the meningococcal genome was successful for 88% of the mutated 
target genes. The five mutants that could not be obtained were for genes 
encoding IHF-%, IHF-", RpoH ($32), Fur and MisR.  
 
Putative IHF binding sites occur throughout the Neisserial genomes (Hill et al., 
2002) and are present in Correia elements (Buisine et al., 2002). IHF has so far 
been implicated in the regulation of capsule biosynthesis (Hill et al., 2002, Tzeng 
et al., 2001, Von Loewenich et al., 2001) and NadA (Martin et al., 2005). It is 
possible that IHF is essential and is likely to have important roles in regulating 
the transcription of numerous genes. 
 
RpoH is important for activating transcription of genes required during 
conditions of stress (Grossman et al., 1984, Bloom et al., 1986). Although RpoH 
has not been widely investigated in the meningococcus, attempts to obtain rpoH 
mutants in the gonococcus have been unsuccessful (Laskos et al., 2004); 
therefore, it may also be essential in the meningococcus.   
 
Although a fur mutant has been successfully constructed in the meningococcus in 
strain MC58 (Delany et al., 2003), it was not obtained in this study. Introduction 
of the fur mutation was attempted in a strain with induced expression of aat, the 
gene downstream of fur, as aat may be essential and affected by polar effects of a 
fur mutation (Delany et al., 2003). However no fur mutants were obtained, 
suggesting that fur may be essential in N. meningitidis strain 8013. Although it 
should be noted that without production of an antibody to Aat, it was not possible 
to confirm that its expression had been successfully induced. It would be 
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interesting to obtain the genomic DNA of the MC58 fur mutant and examine 
whether if it can be introduced into strain 8013.  
 
Mutants of misR have been obtained in several meningococcal strains (Johnson 
et al., 2001, Newcombe et al., 2004, Newcombe et al., 2005, Tzeng et al., 2004, 
Tzeng et al., 2008, Tzeng et al., 2006), but not in strain 8013. Interestingly, a 
mutant of the cognate sensor of MisR, misS, was obtained in strain 8013, 
suggesting that MisR may be essential in strain 8013, while MisS is not. This 
would suggest that MisR is capable of interacting with sensor proteins from other 
TCS for its activation (Laub and Goulian, 2007).   
 
Another approach would be to construct conditional mutants of ihf-!, ihf-", 
rpoH, fur and misR to determine if they are essential in N. meningitidis strain 
8013. 
 
The resulting 38 mutants in genes encoding transcriptional regulators were then 
screened for their colony morphology and growth phenotype. As assessed by 
eye, only the colonies of the strain with a mutation in gene NMV_0419 were 
different from the WT strain. The colonies of the NMV_0419 mutant strain were 
considerably smaller than the WT strain when grown on GCB. Interestingly, this 
mutant strain, along with five other strains, showed reduced growth in liquid 
MC4 media. None of the genes mutated in these six mutants with growth defects 
have been characterised previously in the meningococcus. The strain with a 
mutation in gene NMV_0628, which encodes RelA, has been constructed in the 
gonococcus where it also shows a growth defect (Fisher et al., 2005). This 
suggests that RelA, which is normally associated with nutrient stress, has a role 
in maintaining normal cellular physiology even during growth in complete 
media. The NMV_0419 gene encodes a transcriptional regulator belonging to the 
LTTR family and has 50% amino acid identity with CysB from E. coli, 
suggesting a role in cysteine biosynthesis; however cysteine is present in MC4 
media. A strain with a mutation in gene NMV_1019 also had a growth defect. 
The NMV_1019 gene is proposed to encode IscR based on homology with IscR 
in other organisms, including 50% amino acid identity with IscR in E. coli 
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(Schwartz et al., 2001). IscR regulates genes important for Fe-S cluster 
assembly; these clusters are important co-factors for numerous proteins, critical 
for a variety of cellular process. Also showing a growth defect are mutants in 
both the sensor and response regulator of a TCS, NMV_0125 and NMV_0126. 
However, it is possible that these genes are co-transcribed, and the mutation of 
the sensor (NMV_0125) also results in disruption of the regulator (NMV_0126). 
The final strain with a growth defect has a mutation in gene NMV_1868, which 
encodes a regulator related to phage transcriptional regulator. The genes adjacent 
to NMV_1868 encode uncharacterised hypothetical proteins, thus the role of the 
regulator can not be deduced from its surrounding genes.  
 
All of the disrupted genes should be complemented in trans to confirm that the 
mutated gene is the cause of the growth defect. It would be interesting to see if 
these growth defects are specific to the media by growing the mutant strains in a 
variety of different media. It is likely that these regulators have pleiotropic 
effects and regulate the expression of many genes. Therefore it may be 
interesting to perform microarray studies on these mutants. 
 
The Tfp-linked phenotypes of the mutants were also analysed. Tfp are complex 
structures, with 16 proteins essential for the biosynthesis of the Tfp, and another 
seven proteins have so far been identified as important for the biology of the Tfp 
(Brown et al., 2010, Carbonnelle et al., 2006, Carbonnelle et al., 2005). In 
pathogenic Neisseria species Tfp are important for twitching motility (Merz et 
al., 2000), aggregation of the bacteria (Swanson et al., 1971), adhesion 
(Swanson, 1973, Virji et al., 1991) and competence for DNA transformation 
(Seifert et al., 1990). Tfp are also important virulence determinants of 
meningococci and mediate adhesion to host cells, a process important for both 
colonisation by the bacteria and disease progression. The mutant strains 
constructed in this study were assessed for their ability to undergo twitching 
motility, form multicellular aggregates and adhere to human cells.   
 
During initial assessment, all of the mutants appeared to behave like the WT 
strain in the Tfp-linked phenotypes tested. However, closer visual assessment of 
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the adhesion process, confirmed by a quantifiable assay, identified two mutants 
which appeared to be adhering more slowly to endothelial cells compared to the 
WT strain. These strains contained mutations in the one-component 
transcriptional regulators NMV_1005 and NMV_2033. Aggregation plays an 
important role in the ability of N. meningitidis to adhere to human cells; rates of 
adhesion are higher when cells are challenged with an inoculum containing 
bacterial aggregates compared to an inoculum in which the bacteria are dispersed 
(Helaine et al., 2005). Consequently the two mutant strains were closely 
examined for their ability to form aggregates over time. Both mutants aggregated 
more slowly than the WT strain. However it should be noted that these 
assessments of aggregation were qualitative; quantitative measurements for 
meningococcal aggregation are established (Helaine et al., 2005), but could not 
be undertaken in this study. It would be interesting to quantify the aggregative 
ability of these mutant strains. Furthermore, the disrupted transcriptional 
regulators should be complemented in trans to confirm that the aggregation 
defect is due to the absence of the regulator and not polar effects caused by the 
insertion of the transposon. 
 
Aggregation depends on the Tfp accessory protein PilX, which is incorporated 
into pilus fibres (Helaine et al., 2005, Helaine et al., 2007). Mutants of pilX, 
although piliated, are unable to form aggregates, and purified PilX has 
aggregative abilities (Helaine et al., 2005). Consequently defects in aggregation 
maybe linked to reduced or delayed PilX expression. The NMV_1005 gene is 
proposed to encode HexR, due to 49% amino acid identity with HexR of E. coli. 
HexR has not been characterised in N. meningitidis, but its role has been deduced 
in studies with Pseudomonas aeruginosa, in which it acts as a repressor of the 
hex regulon (Hager et al., 2000). The hex regulon is composed of genes encoding 
enzymes that catabolise glucose to pyruvate and glyceraldehyde 3-phosphate by 
the Entner-Doudoroff pathway. This is the pathway the meningococcus primarily 
uses to catabolise glucose to pyruvate (Baart et al., 2007, Jyssum and Jyssum, 
1962). Furthermore hexR is located on the meningococcal genome adjacent to 
many of the genes proposed to be members of the hex regulon. Although the 
meningococcus catabolises glucose using the Entner-Doudoroff pathway (Baart 
!! "*)!
et al., 2007, Jyssum and Jyssum, 1962), HexR has not been characterised in this 
species and it is not clear how it may affect aggregation.  
 
In contrast, NMV_2033 encodes FarR, which has been extensively characterised 
in the meningococcus. FarR is a repressor of the epithelial cell-specific adhesin 
NadA (Capecchi et al., 2005, Metruccio et al., 2009b, Schielke et al., 2009). A 
hypothesis for the slower aggregation seen in the farR mutant is that the resulting 
increase of NadA on the cell surface disrupts the display of other surface 
expressed components, including Tfp, and may reduce the ability of the Tfp to 
mediate interbacterial interactions. Consequently, it would be interesting to see if 
disrupting nadA in the farR mutant could abrogate the slow aggregating 
phenotype. According to microarray data, FarR influences the transcription of 
four genes other than nadA (Schielke et al., 2011) none of which appear to be 
linked with piliation. However, FarR could still directly influence the 
transcription of pilX; as the microarray was performed with RNA from shaking 
bacterial cultures, the influence of FarR maybe different in static cultures where 
aggregation occurs more readily. It would be interesting to introduce pilX 
reporter fusions into the hexR and farR mutants to see if they have a role in PilX 
expression.  
 
Assessing the in vivo relevance of the slow aggregating and adhering phenotypes 
is complicated as the human specific nature of the meningococcus makes animal 
models unsuitable. Alternatively the mutants could be assessed for adherence to 
cells under flow conditions, which are used to replicate binding to brain 
endothelial cells (Mairey et al., 2006). Tfp mediate efficient adhesion to 
endothelial cells under shear stress and although interactions between adherent 
bacteria and bacteria in flow are negligible in flow models, aggregation is 
thought to be important during growth of the colonies on the cells (Mairey et al., 
2006). Also, a pilV mutant which forms loose aggregates (Brown et al., 2010) 
has a low tolerance for shear stress caused by liquid flow (Mikaty et al., 2009), 
again suggesting a link between aggregation and effective adhesion.  
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The adhesive abilities of all of the transcriptional regulatory mutants could be 
examined under flow, although this assay would be difficult to establish in the 
facilities available at Imperial College due to safety constraints. Although all the 
mutant strains tested adhered to endothelial cells at levels similar to the WT 
strain in this study, these results could be different under laminar flow, and 
potentially relevant in pathogenesis. 
 
Overall, this study has shown that individual transcriptional regulators do not 
have a major impact on Tfp function. Previous studies have provided evidence of 
Tfp regulation at the transcriptional level affecting pilC1, pilE, pilP and pilT 
(Deghmane et al., 2002, Grifantini et al., 2002, Morand et al., 2004, Taha et al., 
1998). Much work has focused on the upregulation of pilC1 upon contact with 
host cells and subsequent downregulation during intimate adhesion (Morand et 
al., 2004, Taha et al., 1998). Numerous regulators have been implicated in this 
process including CrgA (NMV_2045) (Deghmane et al., 2002, Deghmane et al., 
2004, Deghmane et al., 2000), MisS/MisR (NMV_1819/1818) (Jamet et al., 
2009) and NMV_0774 (Jamet et al., 2010). However, none of these regulators 
had an effect in this study.  
 
Although CrgA has been implicated in regulation of Tfp during adhesion to cells 
and therefore the loss of pili (Deghmane et al., 2002, Deghmane et al., 2004, 
Deghmane et al., 2000), there is conflicting evidence with a crgA mutant found 
to have no overall defect in other studies (Morelle et al., 2003), or here. It is 
possible that phenotypic differences may only be demonstrated over a longer 
time frame during progression from localised to intimate adhesion.  
 
The TCS, MisS/MisR, has been suggested to be responsible for the upregulation 
of pilC1 upon host-cell contact (Jamet et al., 2009). However no defect in 
adhesion was observed for a misS mutant in a colonisation competition model 
(Jamet et al., 2009), and the misS mutant adhered at similar levels to the WT 
strain.  
 
!! "*+!
The response regulator encoded by gene NMV_0773 has also been suggested to 
repress pilC1 (Jamet et al., 2010). As with crgA and misR mutants, neither the 
NMV_0773 mutant nor the NMV_0774 mutant demonstrated any phenotypic 
alteration compared to the WT strain in the adhesion assay. However, as with 
crgA and misS/misR, the gene might contribute to Tfp function at later time 
points, after initial adhesion.  
 
The progression to intimate adhesion involves the retraction of pili, which is 
mediated by PilT (Pujol et al., 1999). There is evidence that during intimate 
adhesion, the genes involved in Tfp biogenesis are downregulated (Deghmane et 
al., 2002, Dietrich et al., 2009, Grifantini et al., 2002). How this occurs is 
unknown. It is unlikely to result from phase variation as this mechanism is 
uncontrolled and not influenced by extracellular signals (van der Woude and 
Baumler, 2004). Although we attempted to assess the transition to intimate 
adhesion, neither IF nor scanning electron microscopy demonstrated consistent 
loss of piliation by the WT strain during intimate adhesion as previously reported 
(Pujol et al., 1997, Pujol et al., 1999). It is not clear why previous findings could 
not be replicated, and unfortunately due to time pressure we were unable to 
continue optimising these experiments.  
 
The extent of piliation of each of the mutants could be assessed by enzyme-
linked immuno-sorbant assays, which could detect if any of the mutants have 
slight differences in their levels of piliation (Helaine et al., 2005). In addition it 
would interesting to analyse the incorporation of the minor pilins (ComP, PilX 
and PilV) into the Tfp and also assess the degree of post-translational 
modification of the mutant pili. Furthermore it would be interesting to investigate 
the DNA competence abilities of the mutants, the only major Tfp-linked 
phenotype not tested in this study.   
 
A limitation of this study is that transcriptional regulators acting together in 
concert may not be identified due to redundancy of function. This could be the 
case for regulation of pilC1, for which there are three regulators proposed. 
Alternatively Tfp may not be extensively regulated at the transcriptional level. 
!! "*,!
Phase variation, post-translational modifications and small non-coding RNAs, 
could all be involved instead. 
 
The final part of this study was an in-depth characterisation of two transcriptional 
regulators, NMV_2068 and NMV_1164, which, along with their divergently 
transcribed genes are absent from the non-pathogenic Neissera species, N. 
lactamica (Rusniok et al., 2009). Therefore it was hypothesised that the 
regulators regulate transcription of their adjacent genes. 
 
NMV_2068 is an iron-regulated member of the AraC family of regulators, and is 
part of the Fur regulon (Delany et al., 2006). Upregulation of the regulator in 
iron-deplete conditions was confirmed in strain 8013. There is a subset of 
regulators within the AraC family which control the transcription of adjacent 
genes involved in siderophore utilization and biosynthesis. NMV_2068 is 
divergently transcribed from genes predicted to encode a TonB-dependent 
siderophore uptake system, although Neisseria species do not express 
siderophores (Archibald and DeVoe, 1980, West and Sparling, 1985).  
 
Neither deletion nor overexpression of NMV_2068 had any effect upon the 
expression of the adjacent genes NMV_2069 (which encodes a putative uptake 
system lipoprotein) or NMV_2071 (which encodes a putative TonB dependent 
siderophore receptor protein). Although it should be noted that NMV_2068 was a 
recombinant protein when overexpressed and this may effect its ability to 
function correctly. However, this was unsurprising as regulators of the AraC 
family often require the binding of a specific inducer molecule for their 
activation. Potential inducers were chosen for their ability to activate AraC 
regulators that control transcription of TonB-dependent receptors. Addition of 
FBS, cell lysates, siderophores, human serum and catechol were all tested; 
however none induced the expression of the NMV_2069 and NMV_2071 
reporter fusions. 
 
It would be interesting to establish a meningococcal intracellular replication 
assay in an epithelial cell line, and test the expression of the gene reporter 
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fusions, as the NMV_2071 gonococcal homolog is required for replication in 
endocervical cells (Hagen and Cornelissen, 2006). Furthermore, an unidentified 
TonB-dependent receptor has also been implicated in intracellular replication of 
the meningococcus in endocervical cells (Larson et al., 2002). Therefore, cell 
lysates were added to meningococcal cultures to see if they harboured an 
inducer, but no activation of expression was seen. However, the cells may 
require infection with N. meningitidis or the preparation of the cell lysates may 
not have been adequate for the maintenance of the inducer.  
 
Interestingly the addition of the siderophores enterobactin and aerobactin 
reduced the expression of NMV_2068, suggesting that they were acting as an 
iron source. Iron-loaded forms of three siderophores were tested; enterobactin 
and aerobactin, which are used as xenosiderophores by the gonococcus (Beucher 
and Sparling, 1995, Carson et al., 1999), and salmochelin. As the siderophores 
had been stored at -20 °C for a long time, the integrity of the siderophores could 
not be assumed. Therefore it is possible that they contained free iron which was 
not complexed to the siderophores.  
 
The translational reporter fusions were introduced into both their native sites in 
the meningococcal genome, and in an ectopic site, which left the wild-type copy 
of the gene intact. However, the reporter gene fusion for NMV_2071, the 
putative TonB-dependent receptor, could only be integrated into the 
meningococcus in its native site. Consequently the NMV_2071 reporter fusion 
strain is also a NMV_2071 mutant. Frequently, the inducer of the transcriptional 
regulator is also the target of the TonB-dependent receptor, so detecting 
expression of the NMV_2071 reporter fusion could be affected by the loss of 
NMV_2071 function. However, if the inducer was present, expression of 
NMV_2069 would also be expected and its reporter fusion was present both in 
its native location and ectopically. 
 
The TSS of NMV_2068 was mapped, and its location is consistent with the 
predicted position of the core promoter and Fur binding sites. DNase footprinting 
with purified Fur protein could be performed to confirm the binding site. 
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Unfortunately purification of recombinant NMV_2068 was unsuccessful, so it 
was not possible to see if the regulator binds to the IGR between NMV_2068 and 
adjacent genes.  
 
The putative TonB-dependent uptake system may not be involved in iron uptake. 
TonB-dependent uptake systems have been found to be involved in the uptake of 
other metals (Stork et al., 2010). However, assuming that NMV_2068 regulates 
the putative TonB-dependent uptake system, the iron dependent regulation of 
NMV_2068 would suggest that the entire uptake system is linked with iron 
acquisition. 
 
NMV_1164, was also investigated. This is a member of the LTTR family that is 
divergently transcribed from NMV_1163, a member of the major superfacilitator 
family of proteins. Through gene reporter fusions, it was shown that NMV_1164 
is negatively auto-regulated. However its role in the regulation of NMV_1163 
remains undefined. Members of the LTTR family often require an inducer which 
is usually a product or intermediate of the metabolic pathway activated by the 
LTTR (Maddocks and Oyston, 2008). Therefore NMV_1164 may also require an 
inducer to influence transcription of NMV_1163. Interestingly, expression of the 
NMV_1163 reporter fusion was significantly increased when NMV_1163 was 
disrupted. It is possible that disrupting NMV_1163 activated expression of 
another transporter and it, or an intermediate of its pathway may act as an 
inducer for the activation of NMV_1163. Alternatively, the upregulation of 
NMV_1163 maybe a result of derepression caused by the disruption of 
NMV_1163, possibly a co-repressor is generated downstream of the undefined 
pathway in which the transporter is involved. Interestingly, this result was only 
seen in MC4 media, suggesting a component from this media is required for this 
response. It would be interesting to assess the expression of NMV_1163 in 
response to the composition of MC4. Additionally, NMV_1164 may not be 
responsible for regulating NMV_1163, or it may be one of a number of 
regulators involved in combinatorial control.  
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Determining the function of NMV_1163 could provide insights to the identity of 
the potential inducer. However transporters belonging the major facilitator 
superfamily transport a wide variety of small solutes (Pao et al., 1998). Therefore 
an alternative approach to analyse the behaviour of the mutant would be to use a 
Phenotypic MicroArray such as those provided by the Biolog company, USA. 
 
The TSS of NMV_1163 is located within the IGR between NMV_1164 and 
NMV_1163. Unfortunately the TSS of NMV_1164 could not be mapped. 
Recombinant NMV_1164 binds specifically to the NMV_1163-1164 IGR, 
although the exact binding site was not defined. It would be interesting to 
perform DNase footprinting to determine the exact binding site and also, to see 
how the affinity is altered by the LTTR box, both by EMSAs and analysis of 
reporter fusions in the meningococcus. 
 
A long-term aim, facilitated by this study, is to attempt to establish the 
transcriptional regulatory networks of the meningococcus, through assessment of 
the transcriptional profiles or the ‘transcriptomes’ for each of the transcriptional 
regulators. One possible approach would be to use the technology RNA-Seq. In 
RNA-Seq, RNA is isolated and reverse transcribed to cDNA which is then 
subjected to a high-throughput sequencing, the resulting sequences are aligned to 
a reference genome and gene expression levels are determined from the number 
of reads aligning with each sequence (Nagalakshmi et al., 2008, Wilhelm et al., 
2008). This technology has been used to identify new members of the OmpR 
regulon in Salmonella typhi by comparing the RNA-Seq data produced from the 
WT strain with a strain deficient in the global transcriptional regulator OmpR 
(Perkins et al., 2009). Preliminary RNA-Seq data with N. meningitidis strain 
8013 has been generated. By subjecting all of the transcriptional regulators 
mutants constructed in this study to RNA-Seq it would be possible to start 
establishing the transcriptional regulatory networks of the meningococcus. 
Another approach would be to utilise Chromatin Immunoprecipitation (ChIP), as 
was done to establish the transcriptional regulatory networks in Saccharomyces 
cerevisae (Harbison et al., 2004, Lee et al., 2002). In this technique proteins 
bound to DNA in vivo are crosslinked by the addition of formaldehyde, this is 
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followed by cell lysis and sonication to shear the DNA. The DNA fragments 
crosslinked to a protein of interest are enriched by immunoprecipitation with 
antibodies to the protein of interest. After reversal of the cross-linking, the 
region of DNA the protein was bound to can be identified either through 
microarray analysis (ChIP-chip) (Ren et al., 2000) or by sequencing (ChIP-Seq) 
(Johnson et al., 2007). In this study two of the regulators, NMV_1164 and 
NMV_2068 are already c-Myc tagged, thus it would be feasible to trial this 
approach with these regulators, using an anti-C-myc antibody for the 
immunoprecipitation step.  
 
In summary, a library of mutants in genes predicted to encode transcriptional 
regulators was constructed, resulting in 38 mutants. This mutant library could be 
constructed due to the relatively low number of transcriptional regulators in the 
meningococcus. All of the mutants were then tested for Tfp-linked phenotypes. 
In this study, I have shown for the first time that two HTH transcriptional 
regulators HexR (NMV_1005) and FarR (NMV_2033) influence the aggregative 
abilities of the meningococcus, and mutations in these genes result in a slow 
aggregating, and consequently, slow adhering phenotype. The relevance of these 
phenotypes to pathogenesis remains uncertain. However no other transcriptional 
regulators, when individually tested, appeared to have roles in the Tfp-linked 
phenotypes tested in this study. Consequently mechanisms of gene regulation 
involved in Tfp biosynthesis and biology remain unknown. Additionally, this 
study has found no evidence for the role of the regulators CrgA, MisR or 
NMV_0774, in the Tfp-linked phenotypes tested, although it is not possible to 
exclude that they are involved. Finally two transcriptional regulators were chosen 
for further characterisation. Further studies on meningococcal specific regulators 
highlight the need to identify relevant inducer molecules to study the regulatory 
circuits governed by transcription factors. This is a particular challenge for a 
human adapted pathogen such as the meningococcus which will have evolved to 
recognise and take advantage of molecules present in the host. 
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